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Studies were conducted to investigate the in vivo and in vitro responses of caprine
mast cells to challenge with gastro-intestinal nematode parasites. Initial work concentrated on
the isolation and purification of a mast cell-specific neutral granule protease, termed goat mast
cell protease (GMCP), from homogenates of caprine intestinal tissue. Immunological,
biochemical and molecular characterisation studies localised the enzyme to caprine mast cells,
confirmed its similarity to a sheep mast cell protease (SMCP), uncovered cDNA coding for a
second mast cell protease (termed GMCP II) and highlighted a dual chymotrypsin and trypsin-
like substrate specificity. This latter finding categorised it alongside SMCP and bovine
duodenase as a member of the novel 'janus' class of dual-specific ruminant serine esterases.
Polyclonal and monoclonal antibodies were raised against GMCP and an enzyme linked
immunosorbent assay (ELISA) constructed which was used to determine the functional
activity of mast cells. This was achieved initially in the tissues of animals undergoing
experimental infections with nematodes and subsequently in ex vivo populations of isolated
intestinal mast cells and bone marrow derived mast cells grown in vitro.
In vivo studies comparing yearling goats and kids with lambs undergoing primary and
secondary infections with Telodorsagia circumcincta demonstrated that after secondary
infections the goat and kid abomasal tissues retained more worms and, after both primary and
secondary infections, contained considerably less GMCP than the equivalent lamb abomasal
tissues. A significant mastocytosis response following repeated exposure to the parasites was
also demonstrated in both species, although the secondarily infected goats and kids contained
proportionately more globule leukocytes (GL) than the lambs. Blood and tissue eosinophil
responses were variable, but measurements for total serum IgE demonstrated that the goats,
kids and lambs developed increased mean total serum IgE levels after primary and secondary
exposure to nematodes.
Caprine mast cells were also studied in isolation through ex vivo purification of
caprine intestinal mucosal mast cells (MMC) and GL and in vitro growth of bone marrow
marrow derived mast cells (BMMC) from haemopoietic precursor cells using recombinant
ovine cytokines. Caprine and ovine BMMC cultures were characterised in terms of their cell
morphology, GMCP, SMCP and acid hydrolase content during cytokine dose and time
response experiments, which demonstrated the significant effects of ovine stem cell factor on
BMMC proliferation and long term culture viability when used in combination with ovine
interleukin-3. Biochemical and morphological studies, including the use of electron
microscopy, were carried out to compare isolated goat MMC with goat and sheep BMMC as
well as with isolated sheep MMC. These highlighted significant differences in the mediator
content of the different cell populations with markedly less protease in caprine BMMC when
compared with ovine BMMC and caprine MMC.
Goat MMC and BMMC were stimulated to release the contents of their cytoplasmic
granules in the presence of synthetic secretogogues and crude nematode antigen preparations.
Initial results showed that calcium ionophore A21387 produced the greatest dose-related
release of mediators from caprine BMMC, indicating that the majority of the cells present in
these cultures possessed a functional phenotype similar to that associated with MMC.
Subsequent studies involving crude antigen preparations derived from T. circumcincta and
Haemonchus contortus demonstrated that they were capable of inducing BMMC activation.
This activation response could also be enhanced after passive sensitisation of the cells with
IgE-containing serum or lymph preparations obtained from animals undergoing experimental
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1.1 Gastro-intestinal nematode parasitism in goats
1.1.1 Introduction
Gastro-intestinal parasitism is an endemic problem amongst ruminant livestock
throughout the world, with species of the Trichostrongylid nematode superfamily
prevalent amongst sheep and goats (Urquhart, Armour, Duncan, Dunn and Jennings
1987). The effects of intestinal parasitism range from mild, asymptomatic infections
caused by low parasitic burdens, to overwhelming clinical infections which may, under
extreme circumstances, cause the death of the host (Holmes 1985). Increased
livestock mortality is an obvious source of economic and welfare concern, but even
sub-clinical infections may result in marked loss of productivity in individual animals
(Barger 1985), necessitating the development of strategies to minimise levels of
infection within flocks and herds.
In goats and sheep, the detrimental effects of parasitic infection on meat, milk,
wool / fibre production, liveweight gain and fertility have been recognised for many
years (Barger and Southcott, 1975; Lipson and Bacon-Hall, 1976; Kloosterman,
Borgsteede and Eysker, 1985; Hoste and Chartier, 1993; Barger 1985). However, the
majority of available epidemiological and economic data relates almost exclusively to
sheep. This is despite the fact that approximately 600 million goats are currently kept
(FAO/OIEAVHO survey, 1994) equalling approximately half of the total world
population of sheep or cattle. The reason for this lack of information on goats,
despite their large numbers, is that in contrast to the agriculturally intensive sheep
industry common in many developed countries, the majority of farmed goats are
found in Third World countries where they are maintained in small numbers under
semi-intensive or subsistence conditions (Lloyd 1987). In all the developed countries,
FAO/OIEAVHO (1985) figures show that goats constitute less than 5% of the total
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small ruminant population, while in the UK alone, where approximately 84,000 goats
arc kept, goat numbers are well under 1% of the numbers of sheep. Nevertheless,
recent surveys by the Meat and Livestock Commission suggest that goat numbers in
the U.K., in common with other Western countries, are currently increasing as farmers
search for further product diversification. This has led to increasingly intensive
husbandry methods being applied to the production ofgoat fibre, milk and meat,
creating similar ecological conditions for the propagation of parasitic nematode
infections in goats to those previously observed in sheep (Pomroy, 1985). In addition,
the requirements for diversifying output have also increased the practice of
maintaining goats and sheep together on shared pasture which, as discussed in 1.1.4,
has major implications for speeding the spread of anthelmintic-resistant nematode
species from goats into the susceptible sheep population (Coles and Roush, 1992).
1.1.2 Prevalence andpathogenesis ofcommon gastro-intestinal
nematodes affecting small ruminants in temperate climates.
Prevalence
In the U.K., the most common clinically important nematodes encountered by
sheep and goats are Telodorsagia (Ostertagia) circumcincta, Trichostrongylus
vitrinus
, Trichostrongylus colubriformis, Nematodirus battus and, in the warmer
climate of southern England, Haemonchus contortus (Parnell, Rayski, Dunn and
MacKintosh, 1954; Boag and Thomas, 1971, 1977; Thomas and Boag, 1972, 1973;
Waller and Thomas, 1978; Urquhart et al, 1987). Economically, the abomasal
parasite T. circumcincta is the most significant nematode parasite to affect the U.K.
sheep and goat industry (Armour, Jarrett and Jennings, 1966) although N. battus and
T. vitrinus may cause significant infections in the small intestines of young lambs
during their first grazing season (Urquhart et al, 1987).
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Pathogenesis
The epidemiology and pathogenesis of gastro-intestinal nematode infections
in small ruminants are broadly comparable (Thomas and Boag 1973). Therefore,
findings from numerous equivalent studies carried out on the pathogenesis of
nematode infections in sheep may be extrapolated to the goat (Lloyd, 1987).
Severe disruption of the host's gastro-intestinal mucosa is caused by the
parasites as they develop from L3 to L5 larvae and emerge from the tissues, as well
as by inflammatory changes caused by the host's response to infection (Miller, 1984;
Miller, 1987). In T. circumcincta infections these changes are maximal as adults
emerge from the gastric glands at about day 18 after the ingestion of infective
whilst in T. vitrinus infections, damage occurs in the intestinal mucosa at 10-12 days
post infection. Disruption of the gastric gland mass by developing T. circumcincta
larvae results in damage to epithelial cells and hydrochloric acid producing parietal
cells present within the mucosa. The parietal cells are replaced with rapidly dividing,
undifferentiated, non-secreting cells which eventually spread, as the larvae develop, to
encompass other surrounding, non-parasitised glands (Armour etal., 1966). These
changes produce an increase in the abomasal pH from 2.5 to 4.0 or 7.0, which
prevents the activation of pepsinogen to pepsin and also causes a loss of bacteriostatic
effect within the abomasum. In addition, there may be disruption of cell junctional
complexes leading to an increase in abomasal epithelial permeability to
macromolecules which may, in heavy infections, result in elevated levels of
pepsinogen within the plasma as well as a concomitant hypoalbuminamia due to
increased losses of plasma proteins into the intestinal lumen (Holmes, 1985;
MacKellar, 1993).
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1.1.3 Factors influencing the development of immunity to gastro-intestinal
parasites.
Studies by Barger (1985) and Riffkin (1988) have shown that in a typical herd
or flock, the spread of parasitic infection is not uniformly distributed, with often a
relatively small number of individuals responsible for producing the majority of
parasite eggs deposited on the pasture. Post-mortem analyses also show that these
animals are responsible for harbouring the largest numbers of nematodes. This
suggests a role for host-derived factors in producing this irregular spread of infection
which has previously been described as an 'overdispersed' population distribution
(Barger 1985).
Factors involved in regulating the host's ability to resist parasitic infections are
complex and are still poorly understood. Areas which have received the greatest
attention include host gender, breed, age, reproductive status and nutrition as well as
the presence of immunity to the parasites (Barger, 1993; Gray, 1991; Gregg, Dineen,
Rothwell and Kelly, 1978; O'Sullivan and Donald, 1973; Abbot, Parkins and Holmes,
1985). In terms of the work presented in this thesis the most important factor
controlling the gastro-intestinal nematode infra-population is the presence of either
innate or acquired immunity to parasite infection. Innate immunity is defined as the
inherent ability of the host to regulate parasite establishment, development,
persistence and fecundity, whereas acquired immunity is an active response which
improves with repeated exposure to the same or similar pathogens (Patterson, 1996).
In ruminants maintained under intensive production systems, it is probably the
development of acquired immunity which has the greatest effect on reducing parasite
burdens following periods of exposure (Barger, 1985), although the presence of
innate immunity may influence the establishment and fecundity of primary infections in
young animals. Acquired immunity manifests itself by causing a variety of
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behavioural, functional, morphological and biochemical changes in nematode parasites
(see 1.2.1) ultimately resulting in the expulsion of established and incoming worms
from the alimentary tract (Rothwell, 1989). Thus, as immunity develops, the host's
susceptibility to infection decreases as incoming infective larvae fail to establish in the
mucosa (Miller, 1984), and already established worms fail to mature and reproduce
leading to a decrease in faecal egg output (Dineen and Windon, 1980; Seaton,
Jackson, Smith and Angus, 1989 a and b; Gill, Gray and Watson, 1991). As full
acquired immunity is achieved, both incoming larvae and adult parasites may be
expelled in a rapid 'self-cure' response first described in H. contortus-infected sheep
(Stewart, 1953) or by density-dependent losses of adult worms as seen in
Trichostrongylid infections in sheep (Waller and Thomas, 1981; McClure, Emery,
Wagland and Jones, 1992). Factors influencing the onset and effectiveness of the
acquired immune responses to helminths include the age of the host (Colditz, Watson,
Gray and Eady, 1996), host nutrition (Holmes, 1985; Blackburn, Rocha, Figueiredo,
Berne, Vieira, Cacalcante and Rosa, 1991), the size and duration of the larval
challenge (Seaton et al., 1989 a and b), host grazing behaviour (see 1.1.4) and, under
managed systems, the effects of chemotherapy (Gibson, Parfitt and Everett, 1970;
Barger, 1988).
1.1.4 Comparative studies on sheep and goat responses to intestinalparasitic infections
Over the last 20 years, a number of comparative studies involving goats and
sheep have been carried out to determine the kinetics of infection in the two species
and to determine whether increased host resistance occurs in goats with age and
exposure to challenge (Le Jambre and Royal, 1976; Anon, 1982; Brunsdon, 1983;
Brunsdon, 1986; Kettle, Vlassoff, Reid and Horton, 1983; McKenna 1984; Le
Jambre, 1984; Pomroy, Lambert and Betteridge, 1986; Watson and Hosking, 1989;
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Woolaston, Singh, Tabunakawai, LeJambre, Banks and Barger, 1992; Jallow,
McGregor, Anderson and Holmes, 1994; Huntley, Patterson, Mackellar, Jackson,
Stevenson and Coop, 1995). The results obtained all indicate much larger differences
between goats and sheep than expected, do not support the view that parasitic
infections progress in an identical manner in the two species and may be summarised
as follows (reviewed by Lloyd, 1987). Significantly higher total worm burdens are
found in goats when compared to sheep following either natural or experimental
challenge (LeJambre and Royal, 1976; LeJambre, 1984; Huntley et al., 1995).
Following natural infection at pasture, faecal egg output is generally greater in goats
than in sheep, (Le Jambre and Royal, 1976; Anon., 1982; Brunsdon, 1983; Le Jambre,
1984; Pomroy et al., 1986; Watson and Hosking, 1989; Jallow et al., 1994; Huntley
et al., 1995). The development of age and experience-related resistance to
nematodes, whilst well recognised in sheep, is controversial in goats, although there is
some evidence to suggest that older goats may be better able to withstand the
pathological effects of heavier worm burdens (Brunsdon, 1983). Finally, many
anthelmintics appear to be less effective at removing worms from goats than sheep
although, as will be discussed, this may be due to differences in the pharmacokinetics
of anthelmintics in goats as well as the presence of increased numbers of anthelmintic-
resistant strains of nematodes.
Overall, these findings demonstrate that there are major functional
differences in the immune responses to nematodes between the two species, with
particular controversy as to whether adult goats are able to mount an adequate
acquired immune response against nematodes. Comparative studies designed to
investigate this have provided inconclusive results. Several reported the absence of
any acquired immunity in adult goats (Brunsdon, 1983; Kettle et al., 1983; Pomroy
and Charleston, 1989b; Watson and Hosking, 1989; Woolaston et al., 1992), whilst
others demonstrated a degree of responsiveness that is markedly inferior and later in
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onset than, that shown by sheep (Pomroy et al., 1986, Pomroy and Charleston,
1989a).
Several hypotheses have been put forward to account for the apparent
deficiency of the adult goat's acquired immune response to nematodes, with the
widely accepted view now being that since goats are selective browsers, they would
normally be less exposed to parasitic challenge than equivalent grazing animals
(LeJambre and Royal, 1976). As a consequence, they have not undergone natural
selection for immunity to parasites and are therefore unable to respond vigorously to
large scale larval challenges encountered under farmed or experimental conditions.
This has been borne out by the observation that goats appear to be much more
susceptible in terms of faecal egg output and total worm burdens when grazed at
identical stocking rates to sheep (LeJambre, 1984). However, recent studies on the
grazing behaviour exhibited by the two species (Jallow et al., 1994) have also shown
that goats tend to ingest significantly larger numbers of larvae when grazed on the
same pasture, possibly exaggerating this effect of increased susceptibility.
1.1.5 Strategiesfor reducing exposure to parasites, and anthelmintic resistance
As yet, effective commercial vaccine preparations for immunising animals
against gastro-intestinal nematodes have still to be developed (Miller, 1996a;
Meeusen, 1996). With the exception of an irradiated larval vaccine developed against
Dictyocaulusfilahae in cattle (reviewed, Clegg and Smith, 1978) and an experimental
vaccine produced from isolated intestinal antigens ofH. contortus (Smith and Smith,
1993), the complex way in which nematodes interact with their hosts has generally
prevented the exploitation of host immune mechanisms to allow protection under field
conditions. Therefore, it is the use ofmanagement methods, such as controlled
grazing to reduce levels of larval challenge, along with the prophylactic use of
anthelmintic drugs to minimise the effects of established infections, that still form the
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backbone of current parasite control strategies (Coles, 1991). However, these
schemes are not without their practical difficulties, especially where current intensive
farming practices and the long term survival of some infective parasitic larvae on grass
make the continual provision of 'clean' pasture for grazing susceptible animals
difficult (Bairden, Armour and Duncan, 1995). Also, the more recent phenomenon of
nematode resistance to the effects of anthelmintic drugs has created the possibility of
susceptible animals being challenged with high levels of uncontrollable nematode
larvae (Coles and Roush, 1992). This may lead to many more cases of overt clinical
parasitism with associated production losses and increased mortality.
Another problem associated with the widespread use of anthelmintics has been
the issue of increased drug residues in the environment, including residues found in
animal products. This has led to much tighter restrictions regarding the licensing of
anthelmintics in different species as well as increased drug withdrawal times prior to
human consumption ofmilk or meat products from treated animals (Donald, 1994).
Increased milk withdrawal times are of particular significance in the UK goat industry
where larger numbers are kept for dairy production compared to sheep. As a
consequence, many farmers may find that it is uneconomic to give prophylactic
anthelmintic treatment during lactation, resulting in increased nematode populations
within the herd (Lloyd 1987).
After the initial isolation of a phenothiazine resistant strain ofH. contortus
from goats 40 years ago (Drudge, Leland and Wyant, 1957), reports of anthelmintic
resistant strains of nematodes have been increasing rapidly for at least the past fifteen
years. Recent data has demonstrated the presence of benzimidazole resistant H.
contortus, T. colubriformis and T. circumcincta in herds in New Zealand and
Australia (Kettle et al. 1983; McKenna 1984; Barton, Trainor, Urie, Pyman and
Wolstencrofit, 1985; Scherrer, Pomroy and Charleston, 1989; Badger and McKenna,
1990; McKenna, Badger, McKinlay and Taylor, 1990), whilst strains that are
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additionally resistant to levamisoles, salicylanides and avermectins either individually
or in combination have also been isolated in these areas (Kettle et al. 1983; McKenna
et al., 1990; Watson and Hosking, 1990). In the northern hemisphere (reviewed
Borgsteede and Coles, 1994), goat farm surveys based on faecal egg count
reductions and in vitro egg hatch assays have shown that benzimidazole resistance
exists in the UK (Scott, Bairden, Holmes and McKellar 1989; Jackson, Coop,
Jackson, Scott and Russel, 1992a; Jackson, Jackson, Little, Coop and Russel, 1992b)
and in France (Kerboeuf and Hubert 1985), whilst the first European combined
benzimidazole/avermectin resistant strain of T. circumcincta has been isolated from a
goat herd in Scotland (Jackson et al. 1992a). Overall, comparative data indicates that
numbers of resistant nematodes are on the increase, and that cross-host infection
between goats and sheep is occurring (Coles & Roush 1992, Borgsteede and Coles,
1994).
In view of these findings, there are a number of physiological, immunological
and management factors associated with goats that make them a suitable reservoir for
disseminating anthelmintic resistant nematodes. As discussed above, goats mount a
relatively poor immune response when compared to sheep in the face of parasitic
infection. Therefore, unlike sheep, both young and adult goats may harbour large
populations of egg-producing worms. As a result, goats act as a continuous source
infective larvae which may establish in other species grazed on the same pasture. In
response, the farmer is required to treat his or her young and adult goats repeatedly
with anthelmintics which are generally administered at the dose required for
equivalent sized sheep. However, work carried out on the pharmacokinetics of
different levamisoles and benzimidazoles in goats have shown that they are
metabolised at a faster rate than in sheep, resulting in a much shorter period during
which the drug's minimal inhibitory concentration (MIC) is achieved (Galtier, Escoula,
Camguilhem and Alvinerie, 1981; Hall, Ritchie and McDonell, 1981; Kettle et al.
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1983; Gillham and Obendorf, 1985; McKenna and Watson, 1987; Bogan, Benoit and
Delatour, 1987; Sangster, Rickard, Hennessy, Steel and Collins, 1991; Hennessy,
Sangster, Steel and Collins, 1993). This results in the intestinal nematodes being
exposed to sub-optimal anthelmintic doses which, when combined with frequently
repeated dosing at intervals matching the pre-patent period of the nematode, rapidly
selects for resistant adult worms (Coles 1991). The presence of anthelmintic resistant
nematodes in goats, as opposed to susceptible worms that have simply not been
removed due to underdosing, has also been demonstrated through transfer of
apparently resistant strains to sheep where they remained unresponsive despite dosing
with the same drug at the correct MIC (McKenna 1984).
To combat this, special strategies have been advocated for the dosing of goats.
These measures are based on the usage of anthelmintics at experimentally determined
higher recommended dosage rates for each drug type in order to achieve the required
MICs. Frequency of dosing at pasture, is reduced to no more than once every 3-4
weeks in both young and adult animals, whilst ensuring that different classes of
anthelmintic are rotated at least annually. In addition it has also been recommended
that goats and sheep should not be grazed on the same pasture, whilst any goats
bought in should be treated with a known efficacious drug, eg. avermectin, and
quarantined for at least 24hrs prior to turnout to prevent pasture contamination with
resistant larvae (Scott et al 1989; Coles and Roush 1992).
These measures, if properly co-ordinated, may have the desired effect in the
interim, although there is also recent evidence to suggest that simply increasing the
dose of orally administered anthelmintics given to individual goats may not be
sufficient to correct the effects of underdosing (Sangster et al. 1991). This is
possibly due to the increased prevalence of oesophageal groove closure in goats at the
time of drenching. In any case, the use of high doses of anthelmintics in individuals
contributes to increases in the risk of drug toxicity (particularly with imidazothiazole
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drugs such as levamisole, morantel and pyrantel) as well as management costs and
increased residues in tissues and milk.
Therefore, in the longer term, it is important to improve our understanding of
the function and regulation of mucosal immune mechanisms involved in host
resistance to nematodes, to maximise the possibility of producing vaccines as an
effective alternative to anthelmintics (Miller, 1996a). The following section
summarises current knowledge regarding acquired ruminant mucosal immune
effector mechanisms, with particular reference to possible regulatory roles played by
intestinal mucosal mast cells (MMC). The final section concentrates on the biology
and effector functions ofMMC themselves and examines recent evidence for
differences in the MMC responses shown by goats and sheep infected with gastro¬
intestinal nematodes.
1.2 Review of the ruminant mucosal responses to intestinal nematodes
1.2.1 Introduction
From the outset, it should be noted that the majority of data from ruminant
studies applies almost exclusively to sheep and cattle with very little direct
information available regarding the goat. Where data on ruminants are lacking,
experimental evidence obtained from equivalent studies carried out in laboratory
animals and humans will be discussed.
As outlined in 1.1.3, mucosal immunity manifests itself by altering the
establishment and maintenance of parasite infections within the gut. If successful, the
host effector response will generally result in one or more of the following
modifications to parasite behaviour (reviewed Miller, 1984; Miller, 1987, Rothwell,
1989): Retardation or hypobiosis of larval development, morphological evidence of
damage to the parasite including stunting of adult worms; reduced fecundity of the
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adult females; redistribution of the parasite's predilection site within the intestine and
expulsion of incoming or established larvae and/or adults from the intestine.
How resistant individuals actually bring about these modifications remains
largely unknown, although numerous studies have implicated roles for a variety of
overlapping specific and non-specific immune response mechanisms acting against
larvae or adults present in both the intestinal lumen and within the mucosal tissues
(Fig. 1.1) (reviewed Befus and Bienenstock, 1982; Miller, 1984, Miller, 1987,
Rothwell, 1989, Miller, 1996a). The following section describes some of these
responses, investigates how they may be initiated and regulated, as well as examining
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Fig. 1.1 Diagrammatic representation of specific and non-specific immune response
mechanisms known to occur against intestinal nematodes (modified from Miller,




Information on how ruminants process nematode antigens for presentation to
the immune system is currently incomplete. The induction of IgA production from B-
lymphocytes in rat Peyer's patches has been demonstrated (Cebra and Shroff, 1994),
therefore it is possible that dendritic cells (DCs) in gut associated lymphoid tissue
(GALT) process and present nematode antigens to T cells in parasitised ruminants via
the same route. This may result in the upregulation of IgA blast responses in ovine
afferent gastric lymph as they develop immunity (Smith, Jackson, Jackson and
Willams, 1983; Smith, Jackson, Jackson, Williams and Miller, 1984a; Smith, Jackson,
Graham, Jackson and Williams, 1987). Circulating DCs have also been shown to drain
from the GALT tissues in rat afferent intestinal lymph in response to the presence of
endotoxin (Macpherson, Jenkins, Stein and Edwards, 1995), ending up as
interdigitating cells in the mesenteric lymph node paracortex (Fossum, 1988). Here,
the presence of these antigen presenting cells (APCs) within the lymph node may
sensitise B-lymphocytes to induce preferential production of IgE, which is a
ubiquitous feature of nematode infections (Jarrett and Miller, 1982), and has been
localised to draining mesenteric lymph nodes in N. brasiliensis infected rats
(Mayrhofer, Bazin and Gowans, 1976). It has also been hypothesised that circulating
enteric DC's in ruminants possess low affinity surface receptors for the Fc components
of parasite-specific IgE and IgG (Miller, 1996a) in a similar fashion to the expression
of low affinity FcsRII (CD 23) receptors on human dermal DC's (Sutton and Gould,
1993). This may enable increasingly more efficient uptake and presentation of parasite
allergens and antigens by DCs and B-lymphocytes within the lymph node as the
immune response progresses (Harkiss, Hopkins and McConnell, 1990). This would
have the effect of amplifying the mucosal antibody response, most notably of the IgE
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isotype, resulting in increased mast cell activation via cross linking of parasite
allergen-specific IgE bound to high affinity FcsRI receptors present on the mast cell
surface (Godfrey and Gradidge, 1978; Jarrett, Mackenzie and Bennich, 1980,
Metzger and Kinet, 1988). In addition, the discovery that major histocompatibility
complex (MHC) class II molecules are found the surface of rat bone marrow-derived
mast cells (BMMC) grown in vitro (see 1.3.3), and that these cells are also able to
process and present immunogenic peptides to CD 4+ T cell hybridomas, suggests that
intestinal mucosal mast cells (MMC) may act as APCs themselves (Frandji, Tcaczyk
and Oskeritzian, 1995). Therefore, MMC may also possess an innate ability to
stimulate T cell-mediated activation of humoral immune responses, including IgE
synthesis (see 1.2.4; and Fig 1.2 on p 26), following exposure to parasite antigens.
1.2.3 T cell cytokine-mediated regulation of immune responses against nematodes
Unlike in murine experimental models and man (reviewed Del Prete, Maggi
and Romagnani, 1994) the responses of ruminant CD4+ (in sheep, SBU T4+
(Maddox, Mackay and Brandon, 1985)) T helper (Th) cell subsets have yet to be
segregated into the functional categories of Thl and Th2 on the basis of the
cytokines they secrete. Despite this, the overall importance of Th cell-mediated
responses in regulating ovine immunity to nematodes has now been demonstrated by
the detection of increased numbers of CD4+ T cells in the lamina propria of sheep
immune to T. colubriformis (McClure et al., 1992; Kambara and Macfarlane, 1996)
as well as by rendering H. contortus resistant sheep susceptible to challenge by
antibody-mediated depletion of ovine CD4+ but not CD8+ cells (Gill, Watson and
Brandon, 1993 a). In the goat, the presence of distinct T cell subsets has yet to be
defined, however cross reactivity with monoclonal antibodies to bovine lymphocyte
antigens has demonstrated the presence of CD2+, CD4+, CD8+ and y/5 T-cell
subsets (Navarro, Caro, Seva, Rosillo, Gomez and Gallego, 1996).
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Studies examining the T cell responses of mice experimentally infected with
Nippostrongylus brasiliensis, where the induction ofmast cell, eosinophil and IgE
responses typical of ruminant helminth infections occur (Miller, 1984), has shown
that the type II (Th2) response predominates in these animals (Finkelman, Pearce,
Urban and Sher, 1991; Finkelman and Urban, 1992; reviewed Urban, Fayer, Sullivan,
Goldhill, Shea-Donohue, Madden, Morris, Katona, Gause, Ruff, Mansfield and
Finkelman, 1996; Finkelman, Shea-Donohue, Goldhill, Sullivan, Morris, Madden,
Gause and Urban, 1997). This results in the expression of high levels of EL-4, IL-5,
IL-6, IL-9 and IL-10, in the absence of EL-2 or IFN-y which are generally associated
with type I (Thl) responses to viruses and other intracellular pathogens (Sher,
Gazzinelli, Oswald, Clerice, Kullberg, Pearce, Berzofsky, Mossman, James, Morse
and Shearer, 1992). It has also been demonstrated in similar experiments that during
this Th2 response, it is the production of IL-4 which appears to upregulate the
production of other Th2 cytokines (Fernandez-Botran, Sanders, Mossman and
Vitetta, 1988; reviewed Del Prete et al. 1994; Urban et al., 1996). Meanwhile,
cytokine depletion experiments carried out in sheep have demonstrated a role for the
Thl-associated cytokine IFN-y in retarding the development of naturally acquired
immunity to T. colubriformis, probably through the downregulation of Th2 cytokine
expression (McClure, Davey, Emery, Colditz and Lloyd, 1996). These findings
suggest that the pivotal role for IFN-y in influencing Thl:Th2 cytokine ratios in
parasitised laboratory animals (Gajewski and Fitch, 1988) is also of significance
during ovine infections and underlines the probable importance of Th2 responses in
the development of ruminant mucosal immunity to nematodes.
In laboratory animals, the host protective effects of IL-4 in particular have
recently been demonstrated in mice infected with Trichinella muris and
Heligmosomoidespolygyrus (reviewed Finkelman et al., 1997). Experiments
involving the administration of anti-IL-4 or anti-anti-IL-4R monoclonal antibodies
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(mAb) block host immunity to a challenge H. polygyrus infection (Urban, Katona,
Paul and Finkelman, 1991). Similarly, treatment with anti-IL-4R mAb (which in
addition to blocking IL-4 also blocks the effects of IL-13 which produces synergistic
effects with IL-4 in the upregulation of IgE isotype switching, see 1.2.4 below) causes
chronic T. muris infections in normally resistant mice (Finkelman et al., 1997). The
importance of IL-4 in controlling these infections has also been demonstrated in
experiments in which mice with chronic infections were treated with a formulation of
IL-4 that has a long half-life in vivo (IL-4 complexes (IL-4c) prepared by mixing IL-4
and a neutralizing anti-IL-4 mAb at a 2:1 molar ration, so that the antibody acts as a
carrier protein that protects the cytokine from degradation and secretion (Finkelman,
Madden, Morris, Holmes, Boiani, Katona and Maliszewski, 1993)). Treatment with
IL-4c cures even established primary T. muris and H, polygyrus infections (Else,
Finkelman, Maliszewski and Grencis, 1994; Urban, Maliszewski, Madden, Katona and
Finkelman, 1995) whilst treatment also terminates chronic N. brasiliensis infections
that develop in anti-CD4+ mAb treated or SCID mice but not normal mice (Urban et
al., 1995). This latter finding indicates that IL-4 stimulates host protective
mechanisms that are normally redundant in N. brasiliensis infections but become
critical when other CD4+ T cell-dependent mechanisms are blocked. Reports of
increased numbers of muscle larvae in IgE-depleted, T. spiralis-infected rats and of
transfer of rapid expulsion with purified IgE antibody (Harari, Russell and Castro,
1987; Ahmad, Wang and Bell, 1991) also support a protective role for IL-4, because
nematode infection-induced IgE production is IL-4 dependent (Finkelman, Katona,
Urban, Snapper, Ohara and Paul, 1986; see 1.2.4 below). Established effects of IL-4
that may influence worm expulsion include stimulation of IgE responses (Finkelman et
al., 1986; see 1.2.4 below), stimulation of mucosal mastocytosis (Finkelman et al.,
1993; Madden, Urban, Ziltener, Schrader, Finkelman and Katona, 1991; see 1.3 .3
below), further promotion of Th2 cytokine responses (see above), stimulation of T
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cell growth (Spits, Yssel, Takebe, Arai, Yokota, Lee, Arai, Banchereau and de Vries,
1987) and enhancement of VCAM-i expression, (the endothelial cell receptor for the
integrin VLA-4, which is involved in the migration of macrophages, lymphocytes and
eosinophils across venous high endothelium) (Elices, Osborn, Takada, Crouse,
Luhowskyj, Hemler and Lobb, 1990; Schleimer, Sterbinsky, Kaiser, Bickel, Klunk,
Tomioka, Newman, Lucinskas, Gimbrone, Mclntyre and Bochner, 1992).
Recent findings also suggest that Th cells alone do not retain a monopoly on
cytokine production in infected mucosa, and many regulatory cytokines including
IFN-y, IFN-a,.TGF-P, IL-4, IL-5, IL-6, IL-10 and EL-13 are also produced by CD4"
T cells, natural killer (NK) cells, macrophages and mast cells (see table 1.1) (Mond
and Brundswick, 1987; Plaut, Pierce, Watson, Hanley-Hyde, Nordan and Paul, 1989;
Burd, Rogers, Gordon, Martin, Jayaraman, Wilson, Dvorak, Galli and Dorf, 1989;
Galli, Gordon and Wershil, 1992; Ramsay, Husband, Ramshaw, Bao, Matthaei,
Koehler and Kopf, 1994; Burd, Thompson, Max and Mills, 1995). Therefore, these
cells may also play a significant role in either suppressing or augmenting Th2 cytokine
responses to helminths. In particular, the finding that mast cells produce significant
amounts of IL-4 protein in response to IgE mediated activation by allergens (see table
1.1 and Fig. 1.2, page 28) (Burd P.R, 1989; Galli et al. 1992) suggests that intestinal
mast cells may have a major role in initiating and amplifying Th2-mediated mucosal
immune responses during nematode infections (Del Prete et al., 1994).
18
Cytokine Evidence for mast cell-derived mRNA or
bioactivity*
Function**
Interleukin-1 (IL-1) a Burd et al., 1989 Activation ofT cells
IL-3 a Burd el al., 1989 Stimulates proliferation of haemopoietic
precursor cells including other mast cells
IL-4 a Plaut et al., 1989 TlgE production by B cells,induction ofTh2
cell phenotype, ftrans-endothelial migration of
eosinophils.
IL-5 b Burd et al., 1989
Plaut et al., 1989
Promotes growth, adhesion,transendothelial
migration,chemotaxis, activation and survival
ofeosinophils.! IgA synthesis
IL-6 a Burd et al., 1989
Plaut et al., 1989
tlgE synthesis by B cells,promotes growth,
differentiation and activation ofT cells. T IgA
synthesis




Burd et al., 1989 Promotes development/differentiation of
granulocyte/macrophage (GM) progenitor cells




factors e.g. ECF-A and TCA3
Burd et al., 1989
Galli, Wershil, Gordon and Martin, 1989




Gordon and Galli,1994 Fibroblast growth factor, chemoattractant for
mast cells, modulates anti-apoptotic effect of
stem cell factor (SCF) on mast cells in





Cohn, and Galli, 1987
Enhances cytotoxicity, promotes histamine and
protease release from mast cells, promotes
transendothelial migration of leukocytes
Table 1.1 Summary of selected cytokines and chemokines known to be produced by
mast cells. * first citation of their production by mast cells (nb. data from human,
rodent and murine cell sources only). ** selected effector functions which might have
implications for mucosal immunity to parasites (see text). a Protein demonstrated, b
mRNA only demonstrated
1.2.4 Immunoglobulin responses
Three immunoglobulin isotypes have received the most attention in terms of
research into humoral responses towards nematode parasites (Miller, 1996a). These
are IgA, IgG and IgE. In terms ofmast cell responses to nematodes, IgE is probably
the most significant (Jarrett & Miller, 1982, Metzger and Kinet, 1988).
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Host immunoglobulins within the mucosa and intestinal lumen have been
intensively studied for many years to elucidate their effector role against nematode
antigens processed by APCs within the mucosa and local lymph nodes (Sarles and
Taliaferro, 1936; Mulligan, Urquhart, Jennings and Neilson, 1965; Ogilvie and Jones,
1968; Neilson, 1969; Miller, 1980a; reviewed Miller, 1984). Overall, IgAhas
probably received the greatest attention due to its ability to migrate transepithelially
into the lumen of the intestine (Brandtzaeg, 1981; Cebra and Shroff; 1994). Work
carried out by Smith, Jackson, Jackson and Williams (1985) indicated that the
mucosal IgA response is important for determining the onset of age-immunity in
young lambs, and that immunity to H. contortus and T. circumcincta can be
transferred to histocompatible naive sheep by immune lymphocytes in a process which
involves the transfer of IgA memory (Smith, Jackson, Jackson, Williams, Willasden
and Fehilly, 1984b; Smith, Jackson, Jackson, Graham, Williams, Willasden and
Fehilly, 1986). Further studies by Gill, Gray, Watson, and Husband (1993b) and Gill,
Husband, Watson and Gray (1994) also demonstrated that IgA levels are increased in
sheep selectively bred for nematode resistance. Meanwhile, studies on unselected
adult Blackface sheep have shown that a negative correlation exists between abomasal
IgA concentrations, adult female T. circumcincta worm lengths and egg production,
but that a positive correlation exists between IgA responses and inhibition ofL4
larvae (Stear, Bishop, Doligalska, Duncan, Holmes, Irvine, McCririe, McKellar,
Sinski and Murray, 1995). Despite these findings, the exact anti-parasitic function of
IgA in parasitized ruminants is not known, although strong negative correlations
observed between intestinal IgA levels and worm length suggest that mucosal IgA
may interfere with the feeding processes of the parasites (Smith, 1988).
The work of Gill et al. (1993b) also indicated that sheep selectively bred for
resistance to H. contortus demonstrated elevated levels of IgG] subclass
antibodies.The mechanisms by which immunity to parasites is conferred by this
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antibody isotype are again largely unknown, although IgGj -mediated entrapment of
worms in intestinal-mucus has been noted in immune rats (Appleton, Schain and
McGregor, 1988) (see 1.2.5). This mechanism has not yet been observed in
ruminants, but the translocation of IgG into the gastro-intestinal tract during parasitic
infections has been demonstrated in sheep (Yakoob, Holmes and Armour, 1983).
Although until recently, there were no reagents available for the specific
measurement of ruminant IgE, elevated serum levels of both parasite-specific and
non-specific IgE during nematode infections of rodents and man have been described
on numerous occasions (reviewed Jarrett and Miller, 1982). IgE production from B
cells is determined by the relative concentrations of cytokines, predominantly
produced by Th cells, and by surface contact between the B cells and other cells
within their microenvironment via a number of adhesion molecules and receptors
(reviewed Ishizaka, 1989; Zanders, Harris, Buckham and Quint, 1992). These include
the Th cell receptor CD4 (when the B-cell itself acts as an APC presenting MHC class
II bound antigen to Th cells), CD40L and CD23 (FcsRII). Of particular interest are
interactions between B-cells expressing CD40 and cells expressing the receptor ligand
CD40L which has been shown to induce strong proliferation of human B cell
populations in vitro, and in the presence of the correct cytokine milieu to promote
IgE isotype switching, resulting in the production of IgE secreting plasma cells
(Gascan, Gauchat, Aversa, van Vlasselaer and de Vries, 1991; Sutton and Gould
1993; Banchereau, Bazan, Blanchard, Briere, Galizzi, van-Kooten, Liu, Rousset and
Saeland, 1994). Isotype switching from IgG to IgE in these cells is upregulated in the
presence of IL-4, with a synergistic effect provided by IL-5 and IL-13, and down
regulated in the presence of IL-2 and IFN-y (Zanders et al., 1992; Purkerson and
Isakson, 1992). As discussed in 1.2.3, this cytokine profile probably occurs during
Th2 responses occuring in intestinal nematode infections. Evidence from human
studies also suggests that CD40L is expressed on a number of cell types other than T
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cells, including freshly isolated mast cells and basophils, which are also able to
induce the production of IgE directly (Gauchat, Henchoz, Mazzei, Aubry, Brunner,
Blasey, Life, Talabot, Flores-Romo and Thompson, 1993). This indicates that mast
cells, with their ability to produce Th2-like cytokines including IL-4, IL-5 and IL-13
(Table. 1.1), may play a key role in regulating IgE production independently of T
cells. This mast cell-mediated autocrine regulation of IgE synthesis, in conjunction
with mast cell influences on Th cell responses discussed in 1.2.3, is possibly important
for amplifying local IgE concentrations (see Fig. 1.2, page 28) within the ruminant
intestinal mucosa during intestinal nematode infections (Miller, 1984; Rothwell, 1989;
Huntley, Newlands, Jackson and Miller, 1992b) and may thereby also promote the
development ofMMC-mediated type I hypersensitivity responses (Miller, 1996 a and
b).
In addition to the putative role for mast cells in both promoting and executing
the IgE-mediated responses, there is also evidence that the presence of IgE alone in
the absence of an MMC response may be sufficient for promoting immunity to
certain parasites (Bell, 1996). This hypothesis has been suggested by data from
studies on Schistosoma mansoni infections in both humans and rats and T. spiralis
infections in rats which demonstrated high correlations between host resistance to the
parasites and host serum IgE titres (Dunne, Butterwoth and Fulford, 1992;
Verwaerde, Joseph, Capron, Pierce and Dammoneville, 1987; Wang, Korenaga,
Greenwood and Bell, 1990). This resistance could also be passively transferred by
either administering large amounts ofmonoclonal rat IgE antibody to S. mansoni to
infected recipients (Verwaede et al., 1987) or, in susceptible rats infected with T.
spiralis, by administering physiological doses of anti-7! spiralis IgE purified from
serum after an initial 'priming' dose of purified 'Th2-like' thoracic duct CD4+
CD45RC" lymphocytes from T.spiralis infected donor animals (Wang et al 1990). In
the passive transfer experiments, host protection could also achieved in the apparent
22
absence of an intestinal mastocytosis suggesting that it is the presence of parasite-
specific IgE itself that is critical for the development of immunity rather than any
effector function attributable to MMCs (Bell, 1996). In this respect, IgE has also been
implicated in vitro in antibody-mediated cellular cytotoxicity reactions against
nematodes present in host tissues via the activation ofmacrophages and eosinophils
which, like mast cells, also possess surface Fes RI and FcsRII receptors respectively
(Sutton and Gould, 1993). In vivo IgE is also involved in the generation of CI"
dependent increases in intestinal secretory mechanisms which act to 'flush' the
intestine (Baird and O'Malley, 1987) and may also be involved in other changes to
intestinal physiology resulting in the altered transit times and co-ordination of normal
gut peristalsis evident in parasitised hosts (reviewed Miller, 1984). Furthermore, it
may also have a more direct effect on the parasites themselves after secretion at high
concentrations into the intestinal lumen (Bell, 1996).
1.2.5 Goblet cells, mucus andphysiological responses
One of the first manifestations of immunity to nematode parasites shown by
laboratory animals and ruminants is the rapid exclusion of increasing numbers of
incoming infective larvae from the intestinal mucosa (McCoy, 1940; Russell and
Castro, 1979; Cheijina and Sewell, 1974; Miller, Huntley and Wallace, 1981;
reviewed Miller, 1984 ; Miller, 1987; Rothwell 1989). In experiments where immune
sheep are infected with H. contortus or T. circumcincta L3 changes to enteric
epithelial and mucus-producing goblet cells contribute to this reduction in larval
establishment in a process termed 'immune exclusion' (Miller, Jackson, Newlands and
Appleyard, 1983).
Hyperplasia of goblet cells occurs in parasitised sheep (Newlands, Miller and
Jackson, 1990). Studies have also shown that such upregulation is probably immune-
mediated and that mucus is important for reducing larval establishment since the
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protective response against H. contortus L3 is lost in immune sheep pre-treated with
mucolytics or corticosteroids (Miller and Huntley, 1982). Earlier in vitro studies by
Lee and Ogilvie (1981 and 1982) showed that rat intestinal mucus contains both non¬
specific and specific heat-sensitive components that promote the exclusion of larvae.
These were subsequently shown to consist of complement and IgG| antibodies that
are able to bind to T. spiralis larvae in passively immunised rats. In combination,
these components create conditions which are favourable for increased physical
trapping of larvae within the mucus layer (Appleton et al., 1988). Altered gut
physiological mechanisms have also been demonstrated in rodents, including
intestinal smooth muscle hyperplasia (Castro and Harari, 1982) and active secretion of
chloride ions into the intestinal lumen by epithelial cells (Harari et al., 1987; Baird and
O'Malley, 1993). Both contribute to increased intestinal motility and fluidity, thus
minimising the chances of successful larval attachment to the mucosa.. Findings by
Australian workers suggest that the above mechanisms also occur in parasitized sheep
(McClure et al, 1992; Jones, Emery, McClure and Wagland, 1994) augmenting
previous studies demonstrating the presence of 5,6 - leukotrienes (LTC4, LTD4 and
LTE4) in sheep gastro-intestinal (GI) mucus that inhibit larval motility (Douch,
Harrison, Buchanan and Greer, 1983). LTC4 is found in ovine BMMC grown in vitro
(see 1.3.3) (Huntley, 1991), whilst work using isolated sheep mast cells and ex vivo
intestinal loops from parasitised and control animals has demonstrated that ovine
MMC are an important souce of leukotriene-mediated anti-parasitic activity in vivo
(Douch, Morum and Rabel, 1996; Pernthaner, Cabaj, Shaw. Rabel, Shirer,
Stankiewicz, and Douch, 1996). Sheep mast cell protease (SMCP), which is found in
ovine MMC (see 1.3.5 below), has also been detected in increased amounts in mucus
from sheep infected with H. contortus (Huntley et al., 1992b), Tcircumcincta
(Stevenson, Huntley, Smith and Jones, 1994) or T. colubriformis (Jones et al., 1994;
Pernthaner et al., 1996). Elevations in mucus SMCP concentrations coincide with
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reductions in faecal egg counts from animals undergoing primary challenge, implying
that release of SMCP into intestinal mucus is associated with the onset of immunity
(Jones etal., 1994).
1.2.6 Eosinophils
Elevated numbers of eosinophils in the blood and mucosal tissues of rodents,
ruminants and humans infected with gastro-intestinal nematodes have been noted in
many studies (reviewed Befus and Bienenstock, 1982; Miller, 1984; Rothwell, 1989;
Buddie, Jowett, Green, Douch and Risdon, 1992; Jones, 1993). Comparable
increases in tissue eosinophil numbers have also been described in goats and sheep
infected with T. circumcincta and T. vitrinus (Huntley et al., 1995).
Despite the positive relationship between eosinophil numbers and parasite
infection, their role against nematodes within mucosal tissues remains to be
established due to conflicting results in the studies carried out to date (reviewed
Rothwell, 1989, Miller, 1984; Butterworth 1984; Miller, 1996a). However, the
presence of high individual blood eosinophil counts in lambs has been associated with
resistance and the suppression of faecal egg counts (Buddie et al., 1992 ; Kimambo,
MacCrae, Walker, Watt and Coop, 1988).
In terms of the regulation of eosinophil responses, in vitro and in vivo studies
in rodents and in vitro studies in humans have shown that, like mast cells, eosinophil
proliferation, differentiation and recruitment is controlled by Th2 cytokines
(Korenaga and Tada, 1994). These include IL-5 and IL-3 in the bone marrow which
promote selective eosinopoiesis from haemopoietic stem cells (Saito, Hatake, Dvorak,
Leiferman, Donnenberg, Arai, Ishizaka and Ishizaka, 1989; Dvorak, Saito, Estrella,
Kissell, Arai and Ishizaka, 1989) and the local production of IL-3, IL-5 and
granulocyte macrophage colony stimulating factor (GM-CSF) within the lamina
propria of the intestine. These cytokines are thought to promote eosinophil
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recruitment, proliferation, differentiation and survival within the mucosa in response
to the presence of intestinal parasites (Korenaga and Tada, 1994). IL-5 is currently
the best characterised of the locally produced cytokines, playing a significant role
during eosinophil recruitment in murine tissues in vivo (Sher, Cofifman, Hieny, and
Cheever, 1990, Horn and Estridge, 1994). MMC have been implicated as an
important source of this cytokine in mucosal tissues (Plaut et a/., 1989; Bradding,
Feather, Wilson, Bardin, Heusser, Holgate and Howarth, 1993) (Table. 1.1). Similar
mechanisms may be operating in the parasitised intestine to those described in the
asthmatic lung (reviewed Kroegel, Virchow, Luttmann, Walker and Warner, 1994;
Warner and Kroegel, 1994). Here, allergen-mediated mast cell activation appears to
drive eosinophil recruitment via the production of IL-5, IL-4 and TNF-a, eosinophil
chemotactic tetra-peptide factors (ECFs), such as ECF-A (Table. 1.1), and 'newly
synthesised' arachidonic acid metabolites including leukotrienes, platelet activating
factor (PAT) and prostaglandin D2 (PGD2) (see 1.3 .4 and Fig 1.2). In addition to
these cytokines and peptides, a particularly potent eosinophilotactic factor has also
been described (Griffiths-Johnson, Collins, Rossi, Jose and Williams, 1993). Termed
eotaxin, this member of the C-C or beta subfamily ofmonocyte chemoattractant
proteins has been isolated and characterised in guinea-pigs, mice, humans and rats,
where it has generally been localised to epithelial and vascular endothelial cells in the
lung (reviewed, Luster and Rothenburg, 1997). Eotaxin has yet to be described in
ruminants, and its production by mast cells has also yet to be shown in any species.
However, recent experiments involving the use of normal and genetically mast cell
mast cell deficient (see 1.3.3 below) W/Wv mice have shown a delay the onset and
reduction in the total numbers of eosinophils present in the peritoneum of W/Wv
mice but not normal mice following the intra-peritoneal administration of recombinant
murine eotaxin (Harris, Komater, Marett, Wilcox and Bell, 1997). This suggests that
mast cells may play a role in amplifying eotaxin-induced tissue eosinophilia, although
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the mechanisms involved, failing the direct production of eotaxin by the mast cells
themselves or the synergistic effect of other mast cell-derived mediators, are currently
unknown.
In summary, there are a number of different physiological, cellular and
humoral mechanisms which are thought to influence the course of nematode infections
in vivo. The interactions occurring between these effector mechanisms are becoming
more evident as the inter and intra-cellular signalling pathways involved in regulating
mucosal immunity are dissected, and it is interesting to note the prominent role played
by MMC in this respect, with their particularly rich content of pharmacologically
active mediators, chemokines and cytokines (reviewed Schwartz and Austen, 1984;
Schwartz, 1994; Gordon, Burd and Galli, 1990, see table 1.1 and Fig. 1.2). If
successful vaccines to nematodes are to be produced, an approach might be to
manipulate MMC responses in an attempt to mimic the mechanisms which occur
during natural immunity. Whether these responses can be influenced by immunisation
with natural or recombinant antigens remains unknown and a fuller understanding of
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Fig 1.2 Summary of possible interactions between mast cells, T cells and B cells for the
upregulation of IgE production as well as possible cytokine influences on the ontogeny and the
development of MMC within intestinal tissues. Mast cell-derived cytokines and mediators
released in response to cell activation are also summarised (see text; data from Schwartz and
Austen, 1984, Schwartz, 1994). * Pre-formed and newly-synthesised mediators that have been
identified in isolated sheep MMC/GL and mesenteric lymph node conditioned medium (LNCM)
stimulated sheep BMMC (Huntley, 1991; Huntley et al., 1992; Bendixsen et ah. 1995).
**Immunohistochemical staining for tryptase has been observed in ovine MMCs using a
polyclonal anti-human mast cell tryptase antibody (J. Huntley, H.R.P. Miller, personal
communication)
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1.3 Functional biology of mucosal mast cells and globule leukocytes and
their role in the ruminant immune response against nematodes
I.3.1 Introduction
A key feature of the developing host immune response to nematodes involves
the induction of IgE-mediated type I hypersensitivity reactions within the gut mucosa
(Jarrett and Miller, 1982, Fig. 1.1). These reactions may be responsible for promoting
the expulsion of nematodes by a variety ofmechanisms (reviewed Miller, 1996b)
including : the release of low molecular weight inflammatory mediators which directly
affect worm survival from allergen activated cells (Rothwell, 1989; Douch et al.,
1996), an IgE-mediated epithelial chloride ion secretory response which helps to flush
the parasites from the mucosal surface (Harari, Russell and Castro, 1988; Baird and
O'Malley, 1993, see 1.2.4 above); and increased mucosal permeability during gut
anaphylaxis, promoting the pathotopic transfer of immunoglobulins and antigens
across the epithelial barrier (Scudamore, Thornton, McMillan, Newlands and Miller,
1995a). This final effect may help to ensure the optimal 'priming' ofAPC dependent
immune effector mechanisms outlined in the previous section by increasing their
exposure to parasite-derived antigens.
The cells responsible for mediating such reactions are likely to be the MMC,
since they possess FcsRI receptors necessary for the binding of parasite specific IgE,
they the release of a wide variety of mediators following cross-linking of surface
bound IgE by parasite antigens, and they also usually increase markedly in number in
intestinal tissues duiing parasitic infection (Jarrett and Miller, 1982; Miller, 1984;
Huntley, 1992). Intestinal mastocytosis has been triggered experimentally by infecting
both laboratory animals and ruminants with helminths. These include N. brasiliensis
and T. spiralis infections in rats and mice (Taliaferro and Sarles, 1939; Miller and
Jarrett, 1971; Ruitenberg and Elgersma, 1976) and T. colubrifirmis, H. contortus and
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T. circumcincta infections in sheep (Murray, Miller and Jarrett, 1968; O'Sullivan and
Donald, 1973; Gregg et al., 1978). The use of highly sensitive immunoassays for mast
cell-specific granule-associated neutral proteinases have demonstrated that MMC are
functionally active and release these mediators at the time of nematode expulsion
from the immune host. This activity was originally demonstrated in rats infected with
N. brasiliensis, and T. spiralis (Woodbury, Miller, Huntley, Newlands, Palliser,
Wakelin, 1984) but has also been described in mice infected with T. spiralis (Huntley,
Gooden, Newlands, MacKellar, Lammas, Wakelin, Tuohy, Woodbury and Miller,
1990) and sheep infected with T. circumcincta (Huntley, Gibson, Brown, Smith,
Jackson and Miller, 1987).
In the following section, the origin, development and intrinsic functions of
MMC in response to intestinal nematode infections will be described. The discussion
will also examine a further population of intra-epithelial cells called globule-
leukocytes (GL), which may be derived from MMC in the sheep (Huntley, Newlands
and Miller, 1984a) and are usually found in increased numbers in parasitised
ruminants (reviewed Askpavie and Pirie, 1989, Huntley, 1992).
1.3.2 The origin and heterogeneityofmast cells
Origin
Mast cells are derived from pluripotential haemopoietic stem cells which
originate in the bone marrow (Crowle and Reed, 1984; Kitamura, Shimada, Hatanaka
and Miyano, 1977; Haig, 1993) and migrate via the bloodstream as immature CD
34+, FcsRl- committed progenitor cells (Kitamura, Matsuda and Hatanaka, 1979;
Metcalfe, Mekori, Rottem, 1995) (Fig. 1.2). They complete their differentiation into
mature FcsRI+ve mast cells in peripheral tissue sites (Kitamura et al. 1979). As will
be discussed further below, full cell differentiation involves development into a
functional mast cell phenotype within the destination tissue. This latter step appears to
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be largely dependent on relative cytokine concentrations present within the local
tissue micro-environment (Kitamura, Kanakura, Sonoda, Asai and Nakano, 1987;
Gurish, Pear, Stevens, Scott, Sokol, Ghildyal, Webster, Hu, Austen and Baltimore,
1995). In sheep, increased generation ofmultipotential eosinophil, macrophage and
mast celFbasophil colony forming cells (CFCs) in bone marrow has been
demonstrated within 10 days of primary or challenge infections with T. circumcincta.
This indicates that an increase in myelopoiesis, including the production of ruminant
mast cell precursors, occurs in response to nematode infections (Haig, Stevenson,
Thomson, Percival and Smith, 1995)
Heterogeneity
Mast cells in peripheral tissues exhibit metachromasia when stained with
thiazine dyes and are present within the tissues of a wide variety of vertebrate species
(reviewed Riley, 1959; Selye, 1965; Huntley, 1992). In ruminants, their tissue
distribution has been described in cattle (Kim and Lee, 1985) and sheep (Chen, Alley,
Manktelow and Davey, 1990; Sture, Huntley, Mackellar and Miller, 1995), whilst
studies carried out in the goat demonstrated their presence in biliary (Rahko, 1972 a
and b) and gastro-intestinal tissues (Huntley et al., 1995). As a cell population, they
exhibit considerable structural, biochemical and functional heterogeneity which
appears to be dependent on the species and tissue location under investigation
(reviewed Huntley, 1992). For example, early studies in rats utilising different tissue
fixatives and staining with thiazine or copper pthalocyanine histochemical dyes
demonstrated different sub-populations ofmast cells present in the gut mucosa and
the connective tissues of the rat dermis (Enerback, 1966 a and b). After staining with
an alcian blue/safranin sequence the cytoplasmic granules of MMC stained blue
whereas the majority of dermal connective tissue mast cells (CTMC) stained red
(Enerback, 1966b). This effect was found to be due to differences in the degree of
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sulphation of intragranule glycosaminoglycans present within the cells (reviewed
Enerback, 1986), and provided the first evidence that MMC possess distinct
phenotypic characteristics. Studies into rat mast cell heterogeneity were extended by
biochemical analyses ofmast cell granule constituents (reviewed Huntley, 1992),
when it was demonstrated that heterogeneity also occurs in the distribution of two
isolated intra-granule neutral proteases. These were termed rat mast cell protease I
(RMCP-I) and rat mast cell protease II (RMCP-II) (Woodbury, Gruzenski and
Lagunoff, 1978; Woodbury and Neurath, 1980). Differences in antigenicity between
the two proteases enabled the production of specific antibodies against each (Gibson
and Miller, 1986), and using dual immunofluorescence, it was demonstrated that rat
MMC and CTMC represent two approximately separate populations ofmast cells
containing RMCP-II and RMCP-I respectively (Gibson, Mackellar, Newlands and
Miller, 1987). Further studies showing MMC and CTMC granule protease
heterogeneity have now been carried out in other species including mice (Newlands,
Gibson, Knox, Grencis, Wakelin and Miller, 1987; Le Trong, Newlands, Miller,
Charbonneau, Neurath and Woodbury, 1989, Newlands, Knox, Pirie-Shepherd and
Miller, 1993), humans (Miller and Schwartz, 1989; Irani and Schwartz, 1994) and
dogs (Schechter, Slavin, Fetter, Lazarus and Fraki, 1988; Myles, Halliwell, Ballauf
and Miller, 1995) (see chapter 4), whilst recent work in sheep (Sture et al. 1995)
indicated that mast cell heterogeneity may also occur in this species, based on the
distribution of a sheep mast cell granule protease (SMCP). In this latter study, it was
found that the majority of intestinal MMC stained positive for SMCP, whilst only a
small percentage of dermal and hepatic mast cells contained the enzyme. This
indicates the presence of a possible ovine CTMC subset in these tissues. Equivalent
studies have yet to be carried out in goats, although Huntley et al. (1995)
demonstrated that goat MMC stain positive with antibodies to SMCP, indicating that
antigenic cross reactivity occurs between SMCP and a putative intestinal goat mast
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cell protease. Recent studies carried out on mast cells in human respiratory tissues
have also demonstrated the presence ofmast cell heterogeneity on the basis of their
cytokine content (Bradding, Okayama, Howarth, Church and Holgate, 1995). This
suggests that the biologic functions ofmast cell sub-populations may also differ as a
result of their capacity to generate and release different cytokine profiles, although
these findings have not been extended to other species.
Functional heterogeneity ofmast cell sub-populations has been defined in both
in vitro and in vivo derived mast cells from a number of species through their
responses to chemical secretogogues (reviewed Barrett and Pearce, 1993). This effect
was initially demonstrated in vivo in the rat by injecting the polycationic secretogogue
Compund 48/80 which depleted peritoneal CTMC but not MMC of their mediators
(Enerback, 1966c). The neuropeptide substance P (sP) has been used to distinguish
MMC from CTMC in a variety of species (reviewed Regoli, Bondon and Fanchere,
1994) and it activates human cutaneous CTMC but not intestinal MMC via a cell-
receptor dependent pathway (Church, Benyon, Rees, Lowman, Campbell, Robinson
and Holgate, 1989). In contrast, calcium ionophore A 21387 acts by non-specifically
increasing intracellular calcium levels in a variety of cell types, activating calcium-
dependent cytoplasmic granule release mechanisms. Its effects are not entirely
restricted to mast cells, a&fit has been shown to activate both CTMC and MMC
populations present in laboratory animals (Pearce, 1986) and man (Benyon, Lowman
and Church, 1987, Cohan, Massey, Gittlen, Charlesworth, Warner, Kagey-Sobotka
and Lichtenstein, 1989). Currently, there is no data on the existence of functional
heterogeneity in goat mast cells, although studies carried out in vitro on ovine
BMMC grown cells in the presence of mesenteric lymph node conditioned medium
(LNCM) or recombinant ovine interleukin-3 (rOvIL-3) (see 1.3.3) have shown that
they are activated in the presence of A 21387 (Huntley et al, 1992a; Sture, 1996).
Moreover, ovine BMMC grown in rOvIL-3 are also relatively refractory to
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stimulation with compound 48/80 or sP (Sture, 1996). This, in combination with the
fact that the majority of these cells contain SMCP, (Huntley et al., 1992a, Sture,
1996) indicates that they may possess an MMC phenotype, making them a potentially
useful tool for investigating ruminant intestinal MMC responses in vitro.
1.3.3 The development ofMMC in vivo and in vitro
MMC hyperplasia is a T cell-dependent process (Jarrett and Miller, 1982 ;
Miller, 1996b). This was demonstrated by the finding that athymic or T cell depleted
rats or mice as well as human AIDS patients have reduced numbers ofmast cells in
their mucosal tissues (Mayerhofer and Fisher, 1979; Ruitenberg and Elgersema, 1976;
Irani and Schwartz, 1989). In parasitised hosts, experiments involving the adoptive
transfer of immune rat mesenteric lymph node cells or T-cell enriched thoracic duct
lymphocytes produce a mastocytosis in N. brasiliensis infected recipients (Nawa and
Miller, 1979) whilst experiments utilising antibodies to the Th2 associated cytokines
IL-3 and IL-4 suppress helminth-induced mastocytosis by up to 90% in mice infected
with N. brasiliensis (Madden et al., 1991). In sheep, the administration of
immunosuppressive doses of glucocorticoids abolishes MMC hyperplasia in H.
contortns infected animals (Huntley et al., 1992b).
As discussed in 1.2.3 murine and human studies have now shown that it is the
production of Th2 cytokines which promote characteristic host responses to
nematode infections including MMC hyperplasia, upregulation of IgE production and
recruitment of eosinophils to the intestine (Del Prete et al., 1994). This correlates
with earlier in vitro experiments demonstrating that T cell-derived cytokines,
including IL-3 (Ihle, 1985), are responsible for the in vitro growth and differentiation
of rat BMMC which exhibit the phenotypical characteristics of enteric MMC (Haig,
McKee, Jarrett, Woodbury and Miller, 1982; Haig, McMenamin, Redmond, Brown,
Young, Cohen and Hapel 1988a). However, similar experiments carried out in mice
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have shown that murine BMMC grown in the presence of EL-3 alone (Razin, Ihle,
Seldin, Mcncia-Huerta, Katz, LeBlanc, Hein, Caulfield and Austen, 1984) do not fully
differentiate into MMC-like cells since they do not contain mouse mast cell
proteinase-1 (MMCP-1), an enzyme found in all murine enteric MMC cytoplasmic
granules in vivo (Miller, Huntley, Newlands and Irvine, 1990). To induce these cells
to express this proteinase in vitro also requires IL-4 and IL-10 (Ghildyal, McNeil,
Stetchshulte, Austen, Silberstein, Gurish, Sommerville and Stevens, 1992), whilst IL-
9 induces the accumulation of mMCP-1 mRNA transcripts (Eklund, Ghildyal,
Austen, Stevens, 1993). This indicates that full control ofMMC development and
phenotypic expression in this and possibly other species, is likely to be under the
control of at least four Th2 derived cytokines, namely EL-3, IL-4, IL-9 and IL-10
(reviewed Sutton and Gould, 1993; Del Prete et al. 1994; Rennick, Hunte, Holland
and Thompson-Snipes, 1995).
A non T cell-derived cytokine which has also received a lot of attention in
terms ofmast cell development is stem cell factor (SCF), also known as the c-kit
ligand because it binds to c-kit tyrosine kinase receptors (Zsebo, Williams, Geissler et
al., 1990b). C-kit is expressed on the surface of 1-5% of CD34+ haemopoietic
precursor cells within the bone marrow, in certain human leukaemic blood cell lines,
and on the surface of both immature and mature mast cells (Galli, Zsebo and Geissler,
1994). The importance of SCF in regulating mast cell ontogeny and differentiation
was first recognised when it was found that Sl/Sl^ and WAW strains of inbred mice,
exhibiting spontaneous mutations at the loci responsible for SCF and c-kit receptor
expression respectively, exhibited a profound reduction in their numbers of tissue
mast cells (Kitamura, Go and Hatanaka, 1978; Kitamura and Go, 1979; reviewed
Galli et al. 1994). SCF has now been cloned and expressed from a variety of species
including mice, rats, humans and sheep (Galli et al. 1994; C. Mclnnes, personal
communication) and is expressed as a transmembrane polypeptide on the surface of
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murine liver stromal cells (Zsebo, Wypych, McNiece et al., 1990a), murine and
human bone marrow stromal cells (McNiece, Langley and Zsebo, 1991; Aye,
Hashemi, LeClair, Zeibdawi, Trudal, Halpenny, Fuller and Cheng, 1992), rat thymic
stromal cells (Williams, Bertoncello, Kavnoudias, Zsebo and McNiece, 1992), murine
3T3 fibroblasts (Zsebo et al., 1990b) and human vascular endothelial cells (Aye et al.,
1992). Soluble SCF is generated either by alternative splicing ofmRNA transcripts or
from the membrane bound form by proteolytic cleavage (Galli et al., 1994). In
experiments carried out in vivo in rodents, the intravenous administration of
recombinant rat SCF for a period of two weeks doubled the numbers of rat enteric
MMC whilst the administration of anti-SCF antibodies profoundly reduced the
MMC population in normal rats (Newlands, Miller, Mackellar and Galli, 1995) and
mice (Grencis, Else, Huntley and Nishikawa, 1993), 1993). In vitro experiments
involving rat BMMC cultures demonstrated that SCF alone could stimulate and
maintain the production of rat mast cells although it also caused a concomitant
reduction in the granule content of the MMC-associated chymase RMCP-II when
compared with cells generated using IL-3 or LNCM (Haig, Huntley, MacKellar,
Newlands, Inglis, Sangha, Cohen, Hapel, Galli and Miller, 1994). Furthermore, the
addition of SCF to cultures enhances IgE dependent mediator release from rat
BMMC (Hill, Macdonald, Thornton, Newlands, Galli and Miller, 1996). This
indicates that SCF has an important role in regulating the growth, differentiation and
activation of MMC in rats and that it acts to maintain MMC numbers within
peripheral tissues of both rats and mice. In humans, the presence of SCF, as shown
either from the addition of i ecombinant SCF or by co-culture with fibroblasts
expressing SCF, is required for the generation ofmast cells from bone marrow cells,
peripheral blood mononuclear cells or umbilical cord haemopoietic precursor cells
(Valent, Sanblochl, Sperr, Sillaber, Zsebo, Agis, Strobl, Geissler, Bettelheim and
Lechner, 1992; Durand, Migliaccio, Yee, Eddleman, Huima-Byron, Migliaccio,
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Adamson, 1994) and also enhances IgE-dependent mediator release (Valent et al.,
1992). Unlike rodents and ruminants, human cultures stimulated with IL-3 alone
produce basophils instead ofmast cells (Kirschenbaum, Golf, Dreskin, Irani, Schwartz
and Metcalfe, 1989). In vitro experiments have shown that once human mast cell
precursors target to peripheral tissues, their survival may be dependent upon local
production of SCF, since withdrawal or antibody-mediated neutralisation of the
cytokine results in mast cell apoptosis (Metcalfe et al., 1995).
In ruminants, studies on the development ofmast cell populations in vivo and
in vitro have been hampered by the lack of recombinant cytokine reagents. As in the
rat (Haig et al, 1982), early in vitro studies using ovine bone marrow cells
demonstrated that mast cells could be grown in cultures stimulated with LNCM from
mitogen-activated mesenteric lymph node cells harvested from nematode-infected
sheep (Haig, Blackie, Huntley, Mackellar and Smith, 1988b). Although described as
being morphologically immature, these cells contain the MMC-like neutral granule
protease SMCP and possess functional and biochemical characteristics analogous to
those found in MMC isolated from the intestines of parasitised sheep (Huntley et al.,
1992a). More recently, the gene for ovine IL-3 has been cloned and expressed
(Mclnnes, Haig and Logan, 1993) and initial studies have been carried out which
demonstrate that ovine BMMC can be generated in the presence of rOvEL-3 alone
(Sture, 1996). These cells also appear immature in terms ofmorphology and mediator
content when compared with isolated ovine MMC, although, as discussed in 1.3.2,
they are functionally active, demonstrating characteristics analogous to those found in
isolated MMC (Sluie, 1996). As yet, no studies have been carried out to assess the
effects of recombinant ovine SCF (rOvSCF) on ovine bone marrow cultures either
alone or in combination with ovine IL-3, nor any experiments done to determine
whether these ovine cytokines influence the development and phenotype ofmast cells
in goat bone marrow cultures. These two questions will be addressed during the
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course of these studies in order to provide populations ofmast cells for analysing the
effects of nematode antigens on the functional activity of ruminant MMC in vitro.
1.3.4 Mucosal mast cell mediators and the role ofneutral granule
proteinases in intestinal hypersensitivity reactions
Isolated sheep MMC release their mediators following parasite antigen cross-
linking of surface-bound antigen specific IgE (Jones, Huntley and Emery, 1992). In
addition, activation of MMC has been recorded in IgE-deficient mice (Oettgen,
Martin, Wynshaw-Boris, Deng, Drazen and Leder, 1994), and in the apparent absence
of an IgE response during the expulsion of T. spiralis infections in rats (Miller,
Woodbury, Huntley and Newlands, 1983) indicating that activation ofMMC may
also occur through other, non-IgE mediated mechanism (Miller, 1996a). These may
include, antigen-mediated cross-linking of surface bound IgG (Ishizaka and Ishizaka,
1984; Katz, Raizman, Gartner, Scott, Benson, Austen, 1992), the release of antigen-
specific T cell-derived factors (Askenase, Rosenstein and Ptak, 1983), and histamine
releasing factors (HRFs) from a variety of other cell types (reviewed MacDonald,
1996), as well as the surface binding of complement fragments including C3a and
C5a (Pearce, 1989; Mousli, Hugh, Landry and Bronner, 1992). Selected
secretogogues and neuropeptides produced in vivo have also been implicated in non
Ig-mediated MMC activation including somatostatin, vasoactive intestinal peptide
(VIP) and neurotensin (Barrett and Pearce, 1993; Selbekk, 1983; reviewed Tarn,
1995). Recent reports also suggesting that these neuropeptides may mediate their
effects via direct contact between MMC and intestinal nerves (reviewed Tarn, 1995).
In addition, there is evidence for mast cell mediators themselves being able to
upregulate mast cell responses with RMCP II able to activate mast cells in vitro
(Schick, Austen and Schwartz, 1984; Schick and Austen, 1986) whilst other non mast
cell-derived allergenic proteases such as bee venom allergen phospholipase A2 also
cause IgE-independent activation in a process that requires functional activity of the
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enzyme (Dudler, Machado, Kolbe, Annand, Rhodes, Gelb, Koelsch, Suter and Helm,
1995). Finally, studies on the in vitro development ofmast cells have also
demonstrated the release ofmast cell mediators in the apparent absence of
immunoglobulins, secretogogues or antigen, indicating a regulatory role for
constitutive and induced release of mediators following exposure to cytokines and
growth factors in the tissue micro-environment (see section 1.3.3 ). Most notably
these include the ability of SCF to cause direct mediator release in rat BMMC and rat
peritoneal mast cells (Haig et al., 1994; Taylor, Galli and Coleman, 1995) as well as
MMCP-1 release from murine BMMC exposed to IL-9 and TGF-p (H.R.P. Miller,
personal communication). The importance of EL-9 and the activation ofmouse MMC
in parasite infections has also been demonstrated in vivo during T. spiralis infections
in mice. In these experiments, accelerated worm expulsion seen after the
administration of recombinant murine IL-9 was prevented by the administration of
antibodies to c-kit (see section 1.3.3) which block the development of mucosal
mastocytosis (Grencis et al., 1993, reviewed Finkelman et al., 1997).
The recognition that non-Ig specific mechanisms are capable of causing
mediator release from mast cells has increased recent interest in their role during the
initiation and development of innate responses which may occur on initial exposure to
parasites or bacteria (Galli and Wershil, 1996; Mecheri and David, 1997). In this
respect, innate mediator release from mast cells, including their ability to generate
cytokines, may have a direct effect on pathogens as well as being able able to
influence the development of subsequent acquired specific immune responses through
Th2 cytokine-mediated IgL isotype switching (see section 1.2.4). This innate ability
has been characterised most recently in experiments which demonstrate that the
release of pre-formed mast cell-derived TNFa is critical in vivo for promoting the
clearance of virulent strains ofKlebsiella pneumoniae from the lungs and peritoneal
cavities of mice (Malaviya, Ikeda, Ross and Abraham, 1996) and reduces mortality in
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a mouse model of induced septic peritonitis (Echtenacher, Mannel and Hultner,
1996). Work is now currently under way to determine whether similar innate
responses can be induced after exposing mast cells to nematode allergens and antigens
both in vivo and in vitro.
Whichever mechanism is employed, MMC activation usually results in the
release of a range of'pre-formed' and 'newly-synthesised' mediator substances into the
local tissue micro-environment (see Fig. 1.2, page 28) (reviewed Schwartz and
Austen, 1984, Schwartz, 1994) as well as a variety of cytokines and chemokines
which may promote the intestinal allergic-immune responses through the upregulation
of IgE production and recruitment of pro-inflammatory cells including further MMC
and eosinophils (Table 1.1) (reviewed Gordon etal., 1990; Bradding, 1996).
Pre-formed mediators are generally associated with the mast cell cytoplasmic
granules where they are held in the quiescent cell by ionic interactions with a
negatively charged heparin or chondroitin-sulphate proteoglycan matrix . These
include biogenic amines such as histamine, 5 hydroxytryptamine (serotonin, 5-HT)
and dopamine; acid hydrolases such as P-hexosaminidase and arylsulphatase, and the
mast cell-specific neutral granule proteases (Fig. 1.2). Newly-synthesised mediators,
on the other hand, are produced at the time of cell activation from cell membrane
phospholipids, processed by either the cyclo-oxygenase or lipoxygenase pathways of
arachidonic acid metabolism to produce prostaglandins (PGD2) and thromboxanes
(Tx) or leukotrienes (LTB4, LTC4, and LTD4) respectively (Fig. 1.2).
In ruminants, elevated serum and intestinal histamine levels have been
recorded in a number of in vivo experiments involving sheep infected with intestinal
nematodes (Stewart 1953 ; Jones, Windon, Steel and Outteridge, 1990; Jones et al.,
1994). Experiments involving isolated MMC as well as in vitro derived ovine BMMC
have demonstrated that these cells also contain histamine, serotonin (5-HT) and
dopamine (Bendixsen et al., 1995; Huntley et al., 1992a) and, in the case of the
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isolated cells, are able to release histamine on exposure of the cells to larval antigens
(Bendixsen et al., 1995). The precise effects of these biogenic amines on nematodes in
the intestine are unknown, although experiments carried out in guinea pigs infected
with T. colubriformis have implicated histamine in the expulsion of adult worms in
this species (reviewed Rothwell, 1989). Experiments involving the use of lambs
challenged with T. colubriformis also showed negative relationships between GI
mucus histamine levels, adult worm fecundity and larval motility (Jones et al, 1990;
Jones et al., 1994). As discussed in 1.2.5, newly synthesised eicosanoid mediators
possess a direct anti-parasitic activity by inhibiting larval migration in GI mucus and
also promote the recruitment of eosinophils. Like histamine, the production of
leukotrienes from isolated ovine MMC and GL has been stimulated in vitro using T.
colubriformis and H. contortus larval antigens (Bendixsen et. al. 1995), implicating
these cells as a major source of the mediators in vivo.
As outlined in the introduction to this section, the most convincing evidence
that mast cells are functionally active during nematode infections has come from
immunoassay techniques measuring mast cell neutral granule protease concentrations
in tissues, serum, gastric lymph and GI mucus (reviewed Miller, 1996b). These
proteases (proteolytic enzymes) are classified as serine esterases due to the presence
of a serine residue in the catalytic site and also because they possess a characteristic
'catalytic-triad' of histidine^, aspartate 102 anc} serine^ residues positioned around
the substrate binding pocket (Springman and Serafin, 1995). Classically, these
enzymes have been divided into groups of chymotrypsin-like ('chymase') or trypsin-
like ('tryptase') enzymes depending on their substrate specificities (Hartley, 1960).
Mast cell chymase enzymes have been described in man, rat, mouse, dog and sheep
(Schechter, Fraki, Geesin and Lazarus, 1983; Woodbury, Everitt and Neurath, 1981;
Le Trong et al. 1989; Caughey, Viro, Lazarus and Nadel, 1988; Huntley, Gibson,
Knox and Miller 1986) whilst mast cell tryptases are found in humans, dogs, rats,
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mice and cattle (Schwartz, Lewis and Austen, 1981; Caughey, Viro, Ramachondran,
Lazarus, Borson and Nadel, 1987; Reynolds, Stevens, Lane, Carr, Austen and Serafin,
1990; Kido, Yokogoshi and Katanuma, 1988, Shikimi and Kobayashi, 1986). In
humans, active mast cell tryptase is a tetramer comprised of four 32-34 kilodaltons
(kD) subunits which are inactive when dissociated (Schwartz, 1994), whereas human
and sheep mast cell chymases are active as 30 kD and 28kD monomers respectively
(Schechter, 1995, Miller, Huntley and Newlands, 1995). In terms of substrate
specificity, tryptases cleave peptides with basic/positively charged lysine or arginine
residues at the P] (C -terminal) substrate cleavage site (Schwartz, 1985, Schwartz,
1994) whilst chymases cleave peptides with large hydrophobic residues such as
tyrosine, phenylalanine and leucine at the PI site (Powers, Tanaka, Harper,
Minematsu et al., 1985).
Sheep mast cell chymase (SMCP) was first isolated from ovine abomasal
MMC (Huntley et. al., 1986) and was originally classified as a serine endopeptidase
enzyme with chymotrypsin-like activity on the basis of its substrate specificity (Knox,
Gibson and Huntley, 1986; Knox and Huntley, 1987). Antibodies raised against the
enzyme demonstrated its immunohistochemical localisation to mast cells in the ovine
gut as well as other tissues (Huntley et al., 1986; Sture et al. 1995) and has also
allowed the construction of an ELISA for quantifying SMCP concentrations in
intestinal tissue samples (Huntley et al., 1987). These antibodies also show cross-
reactivity with a putative enzyme present in goat MMC and GL (Huntley et al., 1995)
and a principal objective of this study will be to isolate and characterise such a caprine
protease as a potential marker for mast cell activation in goats. More recent
characterisation carried out on SMCP (Pemberton, Huntley and Miller, 1997a;
Pemberton, Belham, Huntley, Plevin and Miller, 1997b) involving NH2-terminal
amino acid sequence analysis of peptide substrate cleavage products has shown that,
in addition to its chymotrypsin-like properties, SMCP possesses catalytic activity
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normally associated with tryptases. This property has been seen in another ruminant
intestinal protease recently isolated from bovine duodenal mucosa termed bovine
duodenase (Zamolodchikova, Vorotyntseva and Antonov, 1995a; Zamolodchikova,
Vorotyntseva, Nazimov and Grishina, 1995b). Comparisons of the known amino acid
sequences of these two proteases indicate that duodenase is likely to be the bovine
equivalent of SMCP (Pemberton et al. 1997a). As a result, they have now been
recognised as members of a new class of dual-specific ruminant chymases analogous
to the 'janus-faced' human cathepsin G protease, which is able to cleave substrates
with either phenylalanine or lysine residues at their PI site. This is possibly due to the
presence of a positively charged glutamate226 residue which divides the base of the
enzyme's substrate binding pocket (Hof, Mayr, Huber, Korzus, Potempa, Travis,
Powers and Bode, 1996). In the course of these studies, it will be interesting to
determine whether the putative goat mast cell protease also shares these unusual
catalytic properties.
Apart from their usefulness as markers for mast cell activity, the biological
function ofmast cell proteases is currently under intensive research to elucidate their
roles in a number of physiological and pathological states (reviewed Caughey, 1995).
However, in terms of the gastro-intestinal response to nematodes, recent work
carried out in rats has demonstrated a potentially important role by causing increased
mucosal epithelial permeability following their release from MMC granules. Using an
ex vivo perfusion system of the mesenteric vasculature and jejunal lumen it was
shown that anaphylactic release ofRMCP-II in response to administration ofN.
brasiliensis antigens results in a significant increase in intestinal epithelial permeability
to macromolecules (Scudamore et al. 1995a). In addition, direct infusion ofRMCP-II
into the mesenteric artery results in increased mucosal permeability to albumin within
three minutes of infusion but does not produce any significant histological lesions
within the epithelium (Scudamore, Pennington, Thornton, McMillan, Newlands and
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Miller, 1995b). This implies that in addition to previous hypotheses which suggested a
role for mast cell proteases in causing non-specific disruption to the Type IV collagen
anchoring the epithelial cells to the intestinal basement membrane (Patrick, Dunn,
Buret, Miller, Huntley, Gibson and Gall, 1988), RMCP-II is also responsible for
altering epithelial permeability via a paracellular route by substrate-specific proteolysis
of epithelial junction complex proteins (Scudamore et. al., 1995b; reviewed Miller,
1996a). These findings may explain why it is advantageous to have increased numbers
ofMMC in close contact with the epithelium in the parasitized mucosa, where they
may play a role as 'epithelial-gatekeepers' allowing the pathotopic transfer of plasma
proteins (including antibodies), inflammatory mediators and worm antigens to and
from the gut lumen (Miller, 1996a).
1.3.4 Globule leukocytes; their derivation from mucosal mast cells
Globule leukocytes (GL), with their characteristic acidophilic staining intra-
cytoplasmic granules or globules, are found within the intestinal mucosal epithelium in
a variety of species including rats (Taliaferro and Sarles, 1939; Ruitenberg and
Elgersma, 1979), mice (Crandall, Crandall and Franco, 1974), humans (Gustowska,
Ruitenberg, Elgersma and Kockiecka, 1983), cattle (Miller, Murray and Jarrett, 1967;
Murray, Miller and Jarrett, 1968); sheep (Sommerville, 1956; Miller et al., 1967,
Murray et al. 1968) and goats (Huntley et al., 1995). They are particularly prominent
in laboratory animals and ruminants infected with intestinal nematodes (Taliaferro and
Sarles, 1939; Sommerville, 1956; reviewed Gregory, 1979) especially goats (Huntley
et al., 1995). T he origin of these cells has been controversial (reviewed Askpavie and
Pirie, 1989; Huntley, 1992) with some workers maintaining that they are derived
either from modified plasma cells (Dobson, 1966), or lymphocytes (Kent, 1966) and
not from mast cells (Whur, 1966). However, early ultrastructural and histochemical
studies (Jarrett et al., 1967; Miller et al., 1968) suggested that GL may be end-stage
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cells resulting from MMC degranulation since intermediate transitional cell (TC)
stages were detected between degranulating MMC and GL in rats, sheep and cattle.
This hypothesis was later strengthened by work carried out on mast cell deficient
W/Wv mice infected with T. spiralis where the proliferation ofGL seen in normal,
mast cell-positive control mice was found to be absent (Kamiya, Oku, Fukomotu and
Ooi, 1983). Links between the cell types in sheep were also confirmed by
histochemical and ultrastructural studies carried out on MMC, TC and GL isolated
from the abomasa of animals challenged with T. circumcincta (Huntley, Newlands
and Miller, 1984a).
The presence of elevated numbers ofGL in sheep is normally associated with
repeated nematode infections and resistance to challenge (O'Sullivan and Donald
1973, Stankiewicz, Pernthaner, Cabaj, Jonas, Douch, Bisset, Rabel, Pfeffer and
Green, 1995). In the goat, the association between resistance to challenge and the
presence of relatively large numbers ofGL appears to be weaker, since they harbour
large parasite burdens despite an abundant population of mucosal GL (Huntley et al.,
1995). This lack of correlation suggests that caprine GL may be less effective than
ovine GL in any effector function against nematodes, or that they are not important in
the process. During the present studies efforts will be made to determine whether goat
GL are also derived from degranulated MMC, since their continued presence in the
face of the large numbers of retained worms (Le Jambre and Royal, 1976; LeJambre,
1984, Huntley et al., 1995) may indicate deficiencies in MMC/GL-associated immune
mechanisms against nematodes in this species.
1.3.6 Comparative mucosal mast cell/globule leukocyte responses in goat and
sheep nematode infections
To date, only one study has been carried out to measure differences in the
functional activity and numbers ofMMC/GL in goats, sheep and lambs infected with
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T. circumcincta and T. vitrinus. (Huntley et al 1995). In this experiment the putative
inter-species cross reactivity of a polyclonal antibody to SMCP was utilised to
compare the responses, both immunohistochemically in tissue sections and by
immunoassay of SMCP concentrations in abomasal and jejunal homogenates. SMCP
analyses were accompanied by conventional histochemical assessments ofMMC and
GL numbers achieved with toluidene blue (Enerback, 1966a) and carbol chromotrope
(Lendrum, 1944) stains respectively. Cellular responses were considered in relation to
the worm burden carried by the goats and sheep in order to determine whether levels
of MMC/GL activity might have any bearing on parasite survival in the host.
The results confirmed previous findings (LeJambre and Royal, 1976;
LeJambre, 1984) that adult goats are more susceptible to nematode infections than
adult sheep, with significantly higher total worm burdens being recovered from the
goat abomasal and jejunal tissues after challenge. Results for mast cell numbers and
protease levels in the abomasum and jejunum also showed fundamental differences
between the two species. In goats there were larger numbers ofGL with relatively
few MMC compared to the sheep, whilst substantially higher SMCP concentrations
were demonstrated in the gastro-intestinal tissues of sheep compared to the goats.
This may indicate that the presence of increased mast cell protease concentrations is a
significant component of the acquired immune response to nematodes and, although
goats showed a significant increase in GL, their relative lack ofMMC and
significantly lower concentrations of putative granule SMCP-like protease may have
contributed to their continued susceptibility.
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1.4 Aims
Work arising from this thesis will hopefully resolve some of the questions
regarding the functional capabilities of goat MMC and GL through the development
of specific, homologous techniques for the detection and characterisation of a putative
goat mast cell protease (GMCP). This will allow in vivo and in vitro assessments of
mast cell responses in goats undergoing infections with GI nematodes and will be
achieved as follows:
1) The purification, biochemical characterisation and raising of antibodies to a
goat mast cell protease (GMCP) isolated from nematode-infected goat intestinal
tissues.
2) The immunological and histological characterisation of GMCP;
determining its immunoreactivity with SMCP as well as defining its distribution within
goat mast cell and GL populations from a variety of tissues.
3) The molecular characterisation of GMCP by the sequencing of cDNA
isolated from goat BMMC.
4) Experiments examining the in vivo functional activity ofmast cells in goats
and sheep undergoing both primary and secondary infections with T. circumcincta.
5) In vitro generation of caprine BMMC, with the recombinant ovine
cytokines and ex vivo isolation ofMMC from parasitised goat intestinal tissues
enabling their morphological, ultrastructural and functional characterisation.
6) Functional activation studies on goat and sheep BMMC to examine
whether granule-associated mediator release occurs after their exposure to a variety




2.1 Chemicals and Buffer recipes
All chemicals used (unless indicated otherwise) were analytical or general
purpose reagent grade purchased from BDH Ltd. or Sigma, Poole, Dorset, UK.
Recipes for the buffers, culture media, fixatives and histochemical stains are given in
detail in Appendix A 'Buffers and Fixatives'.
2.2 Procedures involving the use of animals
Animal use was kept to a minimum throughout this study. Where they were
necessary, all procedures were carried out in strict accordance with Home Office




To minimise catalytic breakdown ofGMCP, all tissues, purification fractions
and enzyme preparations were maintained on ice at all times throughout the
purification procedure. FPLC purification steps were also completed, wherever
possible, in a single day to reduce sample degradation by repeated freeze-thawing.
2.3.2 Animals
Gastro-intestinal tissue from Angora cross 'Scottish cashmere' goats aged six
months to four years were used for all GMCP purifications. The majority were from
Sourhope farm, Kelso, Roxburghshire, Scotland. Following natural exposure to
nematodes at pasture, they had been housed and challenged according to an
anthelmintic disrupted challenge model (ADCM) commonly used in challenge studies
conducted at Moredun Research Institute (MRI) (Smith et al., 1983 and 1985; Coop,
Huntley and Smith, 1995; Huntley et al., 1995; Patterson, 1996). This regime involved
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treating the animals with anthelmintic (fenbendazole (Panacur) 10 mg/kg) or
ivermectin (Ivermectin (Ivomec injectable) 400pg /kg) and housing them before
administering a 'trickle challenge' infection consisting of 2000 T. circumcincta L3 and
1000 T. vitrinus L3 five times weekly for 4 to 8 weeks. The goats were then treated
with anthelmintic again before being given a secondary challenge with 50,000 T.
circumcincta L3 seven days later. Ten days after this second challenge, they were
killed and the tissues harvested.
2.3.3 Tissue collection andpreparation
Tissue collection
Animals were killed either by captive bolt stunning and exsanguination or by
intravenous injection of 20mls pentobarbitone solution (Euthatal, Rhone Merieux
Ltd.). Immediately post mortem, the abomasum and a section ofjejunum
(approximately 50 cm long and taken distal to a point starting 1 metre below the
pylorus), were removed, everted and washed briefly in tap water to remove any
residual intestinal contents. (In one experiment, tissues from other sites were also
removed, see Chapter 4). The tissues were placed in labelled plastic bags and
transported, on ice, to the MRI where they were stored at -70°C prior to processing.
ELISA homogenate preparation
Tissues for ELISA analysis (see 2.12 below) were trimmed to portions
weighing approximately lg and transferred to pre-weighed sterile universals. The
universals were also transported to MRI on ice where they were weighed again to
ascertain the actual tissue weight before adding ten volumes of 20mM*Tris HC1 +
1.5M NaCl pH 7.5. The samples were homogenised in a Polytron homegeniser (Cave,
North Humberside, England) and the homogenate stored at -20 °C until analysis.
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Tissue homogenate preparation for protease purification
5-7 g aliquots of tissue for GMCP purification were thawed and homogenised
in 3 volumes of 20mM tris HC1 pH 7.5 and centrifuged at 600 x g for 20 minutes in a
Beckman J2-21 centrifuge. The supernatant was removed and the pellet resuspended
in 2 volumes of 1,0M NaCl 20mMTris HC1+0.1% Brij 35 pH 7.5 (Brij 35, Sigma Cat.
no. 430 AG-6, was added to all subsequent buffers to prevent adherence ofGMCP to
vessel surfaces) before centrifuging at 4 °C for 1 hour at 20,000 x g. The resulting
supernatant, termed the 1.0M NaCl tissue extract, was collected and further clarified
by centrifuging at 4 °C for another hour at 20,000 x g.
2.3.4 Active protease monitoring in samples
Tissue homogenates and samples taken throughout the purification process
were tested for their proteolytic activity using synthetic, chromogenic substrates.
Carboxybenzoyl-L-tyrosine nitrophenol ester (Cbz-L-Tyr-NPE) (Sigma Cat. No. C
3637) was used in the initial stages of the project, but subsequently, carboxybenzoyl-
L-lysine thiobenzyl ester (BLT) (Sigma Cat. No. C 3647) was used due to its more
rapid rate of hydrolysis in the presence ofGMCP. Samples (2pl) to be tested were
added to 46 pi ofO.lMtris HC1 pH 7.8 containing 2pl of 5mM Cbz-L-Tyr-NPE
dissolved in dimethyl sulfoxide (DMSO) (Sigma Cat. No. D 5879 ) or 44pl of 0.1M
Tris HC1 pH 7.8 containing 5mM BLT stock solution + 5mM dithionitrobenzoic acid
(DTNB) (Appendix A) in DMSO. Positive samples produced a yellow colour within
five minutes at room temperature.
2.3.5 Fast Protein Liquid Chromatography (FPLC) separation of tissue
homogenate samples
Sample purification was achieved by sequential affinity and cation exchange
chromatography using columns attached to a Pharmacia Bio-tech FPLC system. This
consisted of two P-500 pumps (Pharmacia Bio-tech, Uppsala Cat. No. 18-1003-65)
termed A and B which controlled the relative amounts of initial sample buffer (buffer
A) and elution buffer (buffer B) passing through the column. Fall through and eluted
samples from the columns were collected into an automated rotary fraction collector
(Pharmacia Bio-tech, Uppsala Cat. No. 18-1000-77) maintained at 4 °C by the
circulation of refrigerated H2O. The total protein concentrations of these samples
were measured at 280nm using a UV-1 monitor (Pharmacia Bio-tech, Uppsala Cat.
No. 18-1003-66) connected to a REC 101 paper chart recorder (Pharmacia Bio-tech,
Uppsala Cat. No. 18-1001-42). Homogenate (lOmls) was initially diluted 1:3 in 20
mM tris HC1 + 0.1% Brij 35 pH 7.5 and the total volume applied to a column packed,
according to manufacturer's instructions, with 25mls CM-sepharose CL-6B gel
(Pharmacia Bio-tech, Uppsala Cat. No. 17-0720-01). Bound sample was eluted with
a 0-1,0M NaCl gradient in 20mM trisHCl 0.1% Brij and the resulting fractions tested
for substrate activity. Positive fractions were pooled and diluted 1:3 in 20mM trisHCl
0.1% Brij 35 pH 7.5 prior to loading onto a pre-packed 2ml monoS HR 5/5 cation
exchange column (Pharmacia Bio-tech, Uppsala Cat. No. 17-0547-01). Bound sample
was eluted with a stepped 0-0.5 M NaCL 20mMtrisHCl pH 7.5 0.1% Brij gradient.
Peak fractions which caused the most rapid substrate hydrolysis were collected and
pooled, prior to concentrating to a volume of less than 1ml in Centricon-10 (Amicon
Ltd., Stonehouse, UK) small volume centrifugal concentrator tubes. Samples were
taken from each purification step and stored at -70 °c prior to testing by SMCP
ELISA for protease content and a commercial bichinoic acid (BCA) assay (Pierce
corporation, USA Cat No. 23225) for total protein content.
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2.3.6 Silver stained sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE)
This was carried out using a modification ofLaemmli's technique (Laemmli
1970). Resolving gels (12% or 7.5%) were made up as outlined in Appendix A and
immediately cast into BioRad Mini-Protean II SDS-PAGE gel apparatus (BioRad
systems Cat. No. 165-2940 ). 1ml of 70% ethanol in double distilled (dd) H2O was
layered on top of the gel mixture and the gels left to set for 20 minutes at room
temperature. Meanwhile, a 4% stacking gel mixture was also made up (Appendix A)
. Once the resolving gel portion had set, the 70% ethanol was poured off and the
stacking gel layered onto the resolving gel. Sample well combs with space for 10 or
15 samples per gel were inserted into the stacking gel, which was left to set for a
further 10 minutes at room temperature.
Samples for SDS-PAGE were diluted in either reducing or non-reducing (see
2.3.7) sample buffer (Appendix A) prior to loading. Samples dissolved in reducing
sample buffer were heated to 100 °C in a water bath for 3 minutes to denature the
sample proteins. The presence of glycerol and bromophenol blue in the sample buffers
facilitated sample loading onto the gels and also allowed the position of the sample to
be monitored throughout the procedure. Following immersion of the gel tank in 500
mis of tank running buffer (Appendix A), 5-7 pi of BioRad reference protein standards
(BioRad systems Cat. No. 161-0304) consisting ofEscherichia coli galactosidase
(116,000 kD); phosphorylase b (97.4 kD); bovine serum albumin (66.2 kD); chicken
egg ovalbumin (42.7 kD), carbonic anhydrase (31.0 kD) and soyabean trypsin inhibitor
(21.5 kD) were used as molecular weight standards.These were diluted in the same
sample buffer as the unknown samples and loaded into the furthest left sample well,
followed by 10-20 pi aliquots of the unknown samples in the subsequent wells. Gels
were run at 200 volts for 45-50 minutes, or until the bromophenol blue dye front had
reached the bottom of the gel.
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Protein bands in samples, thus separated by SDS-PAGE were visualised by
dismantling the apparatus and staining the gels with silver nitrate using the following
protocol modified from Morrissey (1981):
1. 30 minutes fixation in 50% methanol and 10% acetic acid
2. 30 minutes fixation in 5% methanol and 7% acetic acid
3. Three 5 minute washes in ddH/^O to rehydrate the gel
4. 20 minutes wash in 5pg/ml dithiothreitol in ddH/jO to completely reduce the
electrophoresed proteins
5. 30 minutes wash in 0.1% silver nitrate
6. Rinse briefly in ddH/^O
7. Develop in 3% sodium carbonate (Na2C03) containing 50pl 37%
paraformaldehyde per lOOmls solution until adequate staining is obtained.
8. Stop the development by adding 5mls 2.3M citric acid and agitating the gel for 5
minutes.
2.3.7 Azocasein substrate gels
Non-reduced protein samples were loaded onto 12% resolving SDS-PAGE
gels incorporating 20mg of azocasein substrate (Sigma Cat. No. A 2765)
(AAppendixA). The gels were prepared and run out as described above. The gels were
given two 45 minute washes in PBS + 2.5% Triton X-100 (Sigma Cat. No. x 100) to
remove the SDS from the gel matrix. They were then given three 5 minute washes in
PBS before being incubated overnight at 37 °C in phosphate buffered saline (PBS) +
0.01% sodium azide (NaN3). Staining for 30 minutes in 0.5% Coomassie Blue
(Appendix A) was followed by three 10 minute washes in destainer solution (Appendix
A) to remove the excess Coomassie Blue. Areas of proteolytic activity could be seen
as clear bands against a blue background, due to enzymatic cleavage of the casein
component of the substrate.
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2.4 Production of antibodies to GMCP
2.4.1 Rabbitpolyclonal antibodyproduction
Immunisation
Polyclonal antibodies were raised by inoculating New Zealand White (NZW)
rabbits, with aliquots of purified GMCP emulsified 1:1 with Freund's adjuvant. Each
animal received a total volume of 0.5mls per injection, which was administered
subcutaneously as a divided dose on the left and right flanks. The immunisation
protocol consisted of a primary injection of approximately lOpg GMCP in Freund's
complete adjuvant (Sigma Cat. No. F-5881), followed by at least two booster
injections of approximately lOpg GMCP in Freund's incomplete adjuvant (Sigma Cat.
No. F-5506) at two to three week intervals thereafter. Test bleed sera were taken from
the caudal marginal ear vein 10 days after the final booster and tested for activity
against purified GMCP dot blotted onto nitrocellulose.
Harvesting of sera
Sera positive for activity against GMCP was collected by exsanguination by
cardiac puncture under terminal intra-venous anaesthesia (Sagatal, Rhone Merieux
Ltd.). Harvested blood was allowed to clot in sterile universal tubes for 4 hours at
room temperature before spinning at 600 x g for 10 minutes. The resulting serum
supernatant was collected and divided into 1ml or 5ml aliquots for storage at -70 °C.
Protein A purification of serum IgG
The IgG-containing fraction of the rabbit serum was purified by column
chromatography using a 5ml Protein A sepharose CL-4B column (Pharmacia Bio-tech,
Uppsala Cat. No. 17-0780-01) attached to the FPLC apparatus described above.
Aliquots of serum (2mls) were diluted 1:5 in 20mM*fris/HCl + 0.5M NaCl pH 7.5 and
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loaded onto the column, the fall through fraction being collected for subsequent
testing. The bound IgG fraction was eluted with lOmls of 0.1M citrate pH 2.2 and
immediately neutralised to pH 7.5 by adding lMlris buffer to the fraction containing
the eluted protein peak. Both the fall through and eluted samples were tested by dot
blotting against purified GMCP, and immunohistochemistry on goat jejunal tissue
sections (see below), to ensure that the eluted fraction contained all the antibody
specific for GMCP. The total protein content of the eluted sample was determined by
BCA assay (Pierce corporation, USA Cat. No. 23225) and adjusted to lmg/ml before
being divided into 50pi aliquots for storage at -20 °C.
2.4.2 Mouse monoclonal antibodyproduction
Immunisation
Male and female Balb/c mice were immunised subcutaneously on three
occasions, three weeks apart, with 100 pi sterile PBS containing approximately 5pg
purified GMCP and 20pg QuilA (Superfos Biosector Batch No. C77-67) adjuvant per
injection. Tail bleeds were taken ten days after the last injection and tested for activity
against purified GMCP by dot blotting. Animals containing anti-sera positive for
GMCP were immediately given a final intra-peritoneal booster injection of the same
mixture. Three days later, they were killed by cervical dislocation and their spleens
removed under aseptic conditions for splenic lymphocyte harvesting.
Splenic lymphocyte harvesting
Harvested mouse spleens were placed in sterile petri dishes in RPMI 1640
medium + 10% FCS + P/S (Appendix A) (Kennet, Denis, Tung and Klinman, 1978).
Several holes were made in the splenic capsular tissue with a 26g needle before the
spleen was gently injected with 5mls medium to displace the parenchymal cells into the
surrounding dish. The resulting cell suspension was centrifuged at 200 x g for five
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minutes and the supernatant removed. The cell pellet was gently resuspended, washed
twice in serum free RPMI 1640 + P/S and adjusted to 1-2 xlO^ cells/ml.
Hybridoma fusion protocol
The method was a modification of that used by Claflin and Williams (1978). 1
x 10? or more NS0/1 murine myeloma cells (ECACC No. 85110503) were grown in
225 cm^ canted neck tissue culture flasks (Corning Cat. No. 25110-75) in serumless
RPMI 1640 medium + P/S (Appendix A) from liquid nitrogen stored stocks for three
to five days prior to carrying out the fusion protocol (Galfre and Milstein, 1981).
These mutant myeloma cells are defective for hypoxanthine guanine phosphoribosyl
transferase (HGPRT) which prevents their growth in selection medium containing the
antifolate drug aminopterin. After fusion with murine spleen cells containing HGPRT,
the salvage pathway for the synthesis of purine and thymidylate is enabled in the
hybridoma cells. This results in the growth of immortalized hybrids which can
successfully synthesise nucleotides derived from purine and thymidylate. In contrast,
residual unfiised Y3 and non-immortalized spleen cells are either killed by the
continued presence of aminopterin or die naturally during the subsequent two weeks
culture in serum-free medium. The Y3 and splenic lymphocyte cells were mixed to
give a 1:5 cell ratio and centrifuged at 200 x g for 5 minutes. The supernatant was
removed and the cell pellet tapped loose before resuspension in 0.5ml 35% Hybri-
max® poly-ethylene glycol (PEG) (Sigma Cat. No. P 7181). The suspension was
centrifuged at 100 x g for three minutes. Eight minutes after the addition of the PEG,
5 mis serum free RPMI 1640 + P/S was added slowly over two minutes without
disturbing the pellet. The cells were then gently resuspended by swirling over a further
three to four minutes, taking care not to dislodge the whole pellet at once. The
suspension was centrifuged at 200 x g for five minutes, the supernatant removed and
5mls RPMI 1640 + oxaloacetic acid (OAA) + pyruvate (PYR) + insulin (INS) +
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hypoxanthine, aminopterin, thymidine (HAT) + 3-[N-morpholino]propanesulphonic
acid (MOPs) + 10% foetal calf serum (FCS) (plating medium, Appendix A) was
added slowly without disturbing the pellet. Seven minutes later, the pellet was gently
resuspended and the resulting suspension made up to 60 mis with more plating
medium. The final suspension containing the hybridoma cells was plated out in lOOpl
aliquots onto six sterile 96 well plates (Corning, USA Cat. No. 3595) before
incubating at 37 °C in a tissue culture incubator (ICN Flow automatic CO2 Incubator
Model 160, ICN Pharmaceuticals) in a humidified atmosphere of 5% CO2 in air.
Production of stable antibody producing clones
The hybridoma cells were fed every two to three days by removing the medium
along with any dead and unfused cells and replacing with lOOpl fresh RPMI 1640 +
OAA + PYR + INS + HAT + MOPS + 10% FCS. After seven days, the plates were
screened for the presence of hybrid colonies, which could be identified under a Leica
DM 1L inverted microscope (Leica microscopy Cat. No. 520802/152192) as round
colonies of bright, rapidly dividing cells. The location and number of colonies in each
well was recorded and their growth monitored daily until the cells covered
approximately 1/3 of the well surface area. Supernatants from these wells were
assayed for the presence of antibody to GMCP by tissue immunohistochemistry (see
2.8.7 below), and positive antibody-secreting hybrids were resuspended by aspiration,
for sub-cloning into fresh 96 well plates. The GMCP antibody-positive hybrid cells
were sub-cloned by limiting double dilutions of the cell suspensions in RPMI 1640 +
OAA + PYR + INS + MOPS + 10% FCS (without the addition ofHAT), to ensure
that individual cell colonies in the sub-cloned plates were derived from single parent
clones (Goding 1983). Supernatants from all wells containing single colonies were
again tested, by immunohistochemistry, for the presence of antibody to GMCP and,
following the second sub-cloning, positive hybrids plated out into sterile 12 well plates
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(Costar Cat. No. 3523) and fed with RJPMI 1640 + OAA + PYR + INS + MOPS +
10% FCS. These cells were grown to confluency and split into further wells to
produce sufficient cell stocks for storage in liquid nitrogen as well as injection into
Balb/c mice for production of ascitic fluid.
Liquid nitrogen storage of antibody producing clones
Cells for storage in liquid nitrogen were harvested from the 12 well culture
plates by aspiration and centrifiiged at 200 x g. The supernatant was removed and the
cells resuspended in 1-2 mis 'freezing down' medium containing 50% FCS, 40% RPMI
1640 + P/S and 10% dimethyl sulphoxide (Hybri-max® DMSO, Sigma Cat. No. D
2650) before storing in 1ml freezing vials (Sigma Cat. No. V 4381) for slow freezing
in a nalgene container ('Mr. Frosty' Sigma Cat. No. C 1562 ) overnight at -70 °C.
Once frozen, the tubes were transferred to dewars containing liquid nitrogen for long
term storage. Tubes containing cell aliquots removed from liquid nitrogen storage
were rapidly thawed in a water bath at 37 °C and their contents diluted 1: 20 in RPMI
1640 + OAA + PYR + INS + MOPS + 10% FCS. The cells were washed twice in the
same medium before setting up at 2 x lO^/ml in flasks or plates.
Ascites production
Five days after priming with a subcutaneous injection of lOOpl pristane
(0.79g/ml 2,6,10,14-tetramethyl-pentadecane, Sigma, Cat. No. T-7640), Balb/c mice
were injected intra-peritoneally with 5 x 10^ cells in 0.5 mis PBS and monitored daily
for the development of ascites. This usually occured approximately ten to twenty one
days after injection. Ascitic animals were killed by cervical dislocation and the ascitic
fluid harvested (generally 1-5mis per animal) under aseptic conditions using a 16g
needle attached to a 5ml syringe. The ascitic fluid was centrifuged at 600 x g for ten
minutes and the supernatant stored in 1 ml aliquots at -20 °C
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Protein G purification
Ascites fluid Ig purification was carried out as for the polyclonal rabbit anti-sera
to GMCP using Protein G-sepharose (Pharmacia Biotech Cat No. 17-0618-02) in
place of protein A-sepharose. Both fall through and eluted fractions were tested for
positive staining of tissue sections to ensure that antibody binding to the column had
occurred. A BCA assay (Pierce corporation, USA Cat. No. 23225) was carried out to
quantify the protein content of the eluted antibody which was adjusted to 100 pg/ml in
20mM Tris/HCl pH7.5.
Biotinylation protocol
Protein A eluted monoclonal antibody was dialysed against 0.1M NaHCC>3, pH
8.4, overnight at 4 °C and the protein concentration adjusted to lmg/ml.
N-hydroxysuccinimidobiotin (Sigma Cat. No. H 1759) was dissolved in DMSO
(Sigma Cat. No. D 5879) at lmg/ml and 120pl of the biotin ester was added to each
ml of monoclonal antibody solution (Goding, 1983). This mixture was incubated at
room temperature for 4 hours then dialysed against PBS + 0.01% NaN3 overnight at
4 °C. The biotinylated antibody solution was diluted 1:1 in glycerol as a
cryoprotectant and stored at -20 °C.
2.5 Dot blotting and Western blotting on nitrocellulose
2.5.1 Dot blotting
Samples (2gl) containing GMCP, SMCP or IgE (see 2.13, below) were
blotted, by pipetting, onto a nitrocellulose (NC) membrane (Bio-blot, Costar, Cat No.
8801) and allowed to dry for fifteen minutes at room temperature. The NC membrane
was blocked for thirty minutes in two changes of PBS + 0.5M NaCl + 0.5% Tween80
(Appendix A), which was also used as a reagent diluent and wash buffer for all
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subsequent steps. The blot was incubated with primary antibody diluted 1:200 or
1:500 for 1 hour at room temperature and given three five minute washes, before
incubating for a further hour with the appropriate peroxidase-linked conjugate
antibody or biotinylated secondary antibody diluted 1:500. Blots probed with a
biotinylated secondary antibody were washed as above and treated for a further thirty
minutes with peroxidase-linked streptavidin (Streptavidin-POD; Boerhinger Mannheim
Cat. No. 1 089 153 ) diluted 1:2000. Antibody binding to the protein sample was
visualised by washing the blots and staining for five minutes with 3,3'-
diaminobenzidene in H2O2 ( Sigma Fast™ DAB tablets; Sigma Cat. No. D 4293).
Controls consisted of blotted samples incubated with either normal serum or a non-
cross reactive monoclonal antibody diluted 1:200 or 1:500 in place of primary
polyclonal or monoclonal antibodies respectively.
2.5.2 Western blotting
This was performed using a three-buffer modification of the Khyse-Anderson
semi-dry technique for protein transfer onto nitrocellulose membranes (Towbin &
Gordon, 1984). SDS-PAGE was carried out on 12% gels loaded with reduced
samples as described previously. Gel sized double layers of filter paper (3M paper;
Whatmans Cat No. 3030917) were soaked in anode buffer 1, anode buffer 2 and
cathode buffer (Appendix A). Gel sized sections ofNC membrane (Bio-blot NC,
Costar, Cat. No. 8801) were cut out and soaked in anode buffer 2. The SDS-PAGE
gels were placed on top of the NC membranes, anode buffer 2 and cathode buffer
soaked 3M papers in a blotting apparatus (Sigma Cat. No. B 2529), as shown in Fig.
2.1. The positions of the gels and sample lanes were marked on the NC membrane
before covering with the anode buffer soaked 3M papers. The apparatus was closed
with the anode plate and attached to a constant current power supply. A transfer
current of 70mA per gel was applied to the apparatus for ninety minutes before
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dismantling and removing the blotted NC membrane. The molecular weight standard
lanes were cut from the remainder of the blot and stained for one minute in a 0.1%
solution of amido black (Sigma Cat. No. A 8181) before washing in double distilled
(dd) H2O for thirty minutes to remove excess stain. Sample-containing lanes for
immunostaining were cut out as necessary and treated with the appropriate antibodies
as outlined previously for dot blots.
ANODE
CATHODE
Fig. 2.1 Diagram of assembled Western blot apparatus.
1) 3M papers soaked in anode buffer 1.
2) Nitrocellulose membrane soaked in anode buffer 2.
3) 3M papers soaked in anode buffer 2.
4) 3M papers soaked in cathode buffer. Sample proteins were transferred to
the NC membrane using a current of 70mA per gel for ninety minutes
2.6 Characterisation of GMCP
2.6.1 Synthetic substrate assays and inhibitor assays
Synthetic substrate assays were based on the method described in 2.3.4 for
monitoring GMCP purification. For substrate assays, GMCP was compared with
SMCP, bovine a-chymotrypsin (Sigma Cat. No. C-7762) and bovine pancreatic
trypsin (Sigma Cat. No. T-8918). Stock enzyme solutions were diluted in 0. lMTris
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HC1 + 0.1% Brij 35 pH 7.5 to provide the same concentrations for each preparation (1
- 1.5 pg/ml). Substrate stocks were obtained from Sigma and made up to 5mM
solutions in DMSO. (See Appendix A for details of the substrates used). Each
substrate was freshly prepared prior to each test. For BLT, where DTNB was the
chromogen, the components were made up separately and mixed just prior to adding
to the reaction mixture. To 40pl ofO.lMlris HC1 + 0.1% Brij 35 pH 7.5 in a
microtitre plate well (Dynatech, Cat No. Ml 29A) was added 5 pi of enzyme followed
by 5 pi of substrate solution. For the thiobenzyl ester and nitrophenol ester substrates,
the reaction was allowed to proceed for five minutes at room temperature, whilst the
nitro-anilide substrates were incubated for two hours in a warm air oven at 37 °C (A.
Pemberton, personal communication). All reactions were terminated by adding lOOpl
100% methanol. The degree of colour change was measured at 492nm on a Titertek
MC scanner and the readings corrected for colour changes in parallel negative control
wells containing buffer and substrate only.
Enzyme kinetic studies to evaluate the Michaelis-Menten constant (Km) for
GMCP and SMCP in the presence of BLT were also carried out using a Beckman
DU-650 spectrophotometer. The enzyme assays were set up as previously described
for the microtitre plate assays in 100 pi capacity quartz glass cells (Beckman
microcells). Each reaction was carried out with reducing concentrations of substrate
added to each reaction mixture in the presence of 1 pg/ml GMCP. Freshly prepared
aliquots of substrate were double diluted in DMSO (Sigma Cat. No. D 5879 ) to
provide a stock concentration range of 1.56-50 mM Aliquots (2pl) of these stock
solutions were added to the enzyme assay mixture to provide a final reaction
concentration range of 0.125-2mM . The reactions were monitored for between sixty
seconds and three minutes at 405nm, and the rate of substrate hydrolysis at each
substrate concentration averaged over a minimum of three reactions. The Km values
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for the substrates were calculated from the initial rates of substrate hydrolysis, using
onboard enzyme mechanism analysis software supplied with the spectrophotometer.
For inhibitor assays, samples of GMCP and SMCP (1.5 pg/ml) were incubated
for one hour at room temperature with the following small molecular weight inhibitors
(final reaction concentration shown in brackets); 1,10 phenanthrolline (50mM, Sigma
Cat. No. P-9375), pepstatin (5mM, Sigma Cat. No. P-4265), 1-trans-
epoxysuccinylleucylamido-(4-guanido)-butane (E64) (0.05mM, Sigma Cat No. E-
3132), phenylmethylsulfonylfluoride (Pms-F) (5mM, Sigma Cat No. P-7626). In
addition, samples were incubated with goat serum and sheep serum respectively (1:
200 dilution in 0.1M tris HC1). The samples were assayed for residual proteolytic
activity against BLT as described above. The results were expressed as percentage
inhibition compared to positive control samples of enzyme pre-incubated in 20 mMfris
buffer pH 7.5 only.
2.6.2 Amino acid sequencing of immunoaffinity purified GMCP
Protein A purified rabbit IgG antibodies to GMCP (5mg) were coupled to
lml cyanogen bromide activated sepharose 4B (CNBr-sepharose) (Pharmacia Bio¬
tech, Uppsala Cat. No 17-0430-01) according to the manufacturer's instructions. This
was used to construct an immunoaffinity column for the extraction of GMCP from a
20mM"fris HC1 + 1 5M NaCl extracted jejunal homogenate sample. Samples (5g) of
tissue were extracted in three volumes of 20mlVrfrisHCl +1.5M NaCl+0.1% Brij 35
pH 7.5 and centrifuged as described in 2.3 .3. The extract was then incubated for forty
five minutes at room temperature with 2mM Pefabloctm (Boerhinger Mannheim Cat.
No. 1 429 868) broad spectrum protease inhibitor to minimise proteolytic breakdown
of the column bound IgG. Small (l-3ml) aliquots of the resultant sample were diluted
1:3 in 20 mMTris/HCl+0.1% Brij 35 pH 7.5 and applied to the column sequentially.
Bound sample was eluted as for the protein A column described previously (2.4.1).The
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eluted protein samples were pooled and concentrated under vacuum in a dialysis
thimble (Sartorius Cat. No. 250-11) immersed in 20 mMTris/HCl+0.1% Brij 35 pH
7.5 at 4 °C, then reduced and run on 12% SDS-PAGE gels. The gels were blotted
onto an Immobilon-P membrane (Millipore Cat. No.P 0807) pre-soaked in 100%
methanol using the three buffer method outlined above. Blotted proteins were stained
with 0.5% Coomassie Blue (Appendix A) for five minutes before destaining with two
or three rapid washes in 100% methanol to reveal blue coloured protein bands. The
blots were allowed to dry at room temperature before cutting out bands with a
molecular weight corresponding to GMCP. These were sent to the Microchemical
Facility, Babraham Research Institute, Cambridge, England for NH2-terminal amino
acid sequence analysis.
2.7 Cloning of cDNA sequences for GMCP
2.7.1 Total RNA extraction from goat BMMC
Aliquots (5 x 10^ cells) of goat bone marrow derived mast cells (BMMC) cells
grown in recombinant ovine interleukin-3 and recombinant ovine stem cell factor (see
below), were collected on days 2, 5 and 7 of the cultures. They were spun at 200 x g
for five minutes lysed in 1ml Tri-reagent (Sigma Cat. No. T 9424) and then stored at
-70 °C. The total RNA was obtained by sequentially extracting the cell lysate in
chloroform and isopropanol. The isopropanol fraction containing precipitated RNA
was centrifuged at 13000 rpm for five minutes and the pellet washed in 75% ethanol.
The sample was re-centrifuged and the RNA pellet allowed to air dry before dissolving
in 50pl DNase/RNase free, sterile ddF^O (Sigma Cat. No. W 1754).
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2.7.2 Messenger RNA (mRNA) selection from total RNA
This was carried out using a commercial kit (Quickprep Micro mRNA
Purification Kit; Pharmacia Bio-tech, Uppsala Cat. No. 27-9255-01) consisting of
microspin® columns packed with oligo(dT)-cellulose. The solubilised total RNA
preparations were passed through the columns which selectively bound the 3' poly-
adenosine (poly-dA) tail specific to mRNA, allowing it to be eluted free from
contamination with ribosomal RNA and genomic DNA.
2.7.3 Formaldehyde gelsfor RNA detection
1% agarose gels containing formaldehyde, for the detection of total and mRNA
extracted from BMMC, were made up as described in Appendix A. RNA samples or
RNA markers (O.lmg/ml) (Boerhinger Mannheim Cat. No. 1 062 611) (6 pi) were
added to 12.5pl formamide (Sigma Cat. No.F 7508), 2.5pl 10 x MOPS (Sigma Cat.
No.M 5162) and 4pl 37% formaldehyde. The mixture was incubated for ten minutes at
65 °C then 2.5pl Northern running dye (Appendix A) and 0.5pl of 0.5mg/ml ethidium
bromide (Sigma Cat. No. E 1385) added. The gels were loaded with 20pl of sample
per well. Separated bands were visualised on a dual intensity ultra-violet (UV)
transilluminator (Hoefer Scientific Instruments).
2.7.4 Reverse transcriptase reaction protocol
cDNA templates for sequencing the central and 3' fragments of GMCP were
constructed by priming the purified RNA with either a random hexamer primer or a
specially synthesised poly-thymidine primer kindly provided by Dr. D. Knox. This
latter primer is specific for mRNA 3' poly-dA nucleotide sequences. In contrast,
cDNA templates for the 5' GMCP fragment were primed with an ovine P7 primer (see
chapter 5, Fig. 5.1) to ensure maximal quantities of 5' specific cDNA in the final
reaction mixture. Both templates were then constructed by incubating the RNA and
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the template primers with 20 units of cloned M-MuLV (murine leukaemia virus)
reverse transcriptase enzyme (Boerhinger Mannheim Cat. No. 1 062 603) in the
presence of a 2mM solution of mixed nucleotides (dNTPs) at 42 °C for sixty minutes.
2.7.4 Primary and secondary polymerase chain reaction (PCR) amplification
using nestedprimersfor GMCP and SMCP
Primer oligonucleotides specific for GMCP and SMCP cDNA sequences were
commercially synthesised (Cruachem, Glasgow). Amplification of GMCP cDNA
required the use of nested or semi-nested primers (Sambrook, Fritsch & Maniatis
1989), for 30 cycle primary and secondary polymerase chain reactions (PCR) which
were carried out on an Astec pc-700 thermocycler in the presence of 1.0 unit of
Thermus aquaticus BM, recombinant, E.coli Taq DNA polymerase (Boerhinger
Mannheim Cat. No. 1 647 679) (see Appendix A for PCR reagent volumes and the
amplification programme). The Taq polymerase was added at 72 °C as a 'hot start'
following an initial 10 minute cDNA strand denaturing step at 94 °C.
2.7.6 Agarose gelsfor PCR product detection
Agarose gels (0.8%) for the detection ofPCR amplified cDNA were made up
as described in Appendix A. 10 pi ofPCR product or 1 kilobase pair (kb) DNA
standard ladder (O.lmg/ml) (Boerhinger Mannheim Cat. No. 236 233) was combined
with 2 pi agarose gel dye (Appendix A) and the total volume loaded onto the gel.
Following electrophoresis, separated bands were viewed on a dual intensity UV
transilluminator (Hoefer Scientific).
2.7. 7 Southern blottingprotocol
Agarose gels containing PCR product cDNA were denatured, neutralised
(AppendixA) and southern blotted overnight onto Hybond N+ nylon membranes
(Amersham International, Cat. No. RPN 303B) according to the manufacturer's
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instructions. This allowed subsequent probing with digoxigenin-labelled
oligonucleotide primer sequences specific for the required amplified cDNA fragments.
2.7.8 Digoxigenin-labelling (dig-labelling) ofoligonucleotide probes
Mast cell protease-specific oligonucleotide sequence probes were labelled with
a digoxigenin ddUTP molecule according to the manufacturer's instructions using a
DIG-oligonucleotide 3'-End labelling Kit (Boerhinger Mannheim Cat. No. 1 362 372).
20pl of labelled probe was diluted in lOmls Rapid-hyb™ (Amersham International
Cat. No. RPN 1636 ) and stored at -20 °C between uses.
2.7.9 Probe hybridization protocol (see Appendix A for buffer details)
Blotted Hybond N+ membranes were rinsed in 6 x saline sodium citrate (SSC),
dried for thirty minutes and fixed by cross-linking with two 1200J pulses of ultra
violet light (Hoefer UV cross-linker, Hoefer scientific). Lanes containing the DNA
molecular weight markers were removed and stained with Genogold® (British Biocell
Cat. No. Gen 500) according to the manufacturer's instructions. The remaining
portions of the blots were incubated for forty five minutes at 40 °C in a hybridisation
oven (Techne Hybridiser HB-1D) in lOmls Pre-hybridisation buffer (Rapid-hyb™
Amersham International Cat. No.RPN 1636), followed by 3 hours incubation at 40 °C
with the dig-labelled oligonucleotide probe. The probed blot was washed for ten
minutes in 2 x SSC buffer and thirty minutes in 1 x SSC buffer before rinsing with
maleic acid buffer + 0.3% tween 20 and blocking for a further thirty minutes at room
temperature in 1% blocking reagent (Boerhinger Mannheim Cat. No. 1 096 176)
dissolved in 20 mis maleic acid buffer + 0.3% tween 20. Blots were then conjugated
for thirty minutes at room temperature with 1 gl commercially obtained alkaline
phosphatase linked sheep Fab' fragments to digoxigenin (Anti-dig-AP; Boerhinger
Mannheim Cat. No. 1 093 274). Following two further fifteen minute washes in maleic
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acid + 0.3% Tween 20 and a rinse in buffer 3, the blots were incubated for five
minutes with 0.1% CDP-slar™ chemiluminescent substrate (Boerhinger Mannheim
Cat. No. 1 685 627) dissolved in buffer 3. The blots were finally transferred to a
radiographic film cassette containing Hyperfilm™-ECL high performance
luminescence film (Amersham International, Cat. No. RPN 2103) and exposed for five
minutes. Dark bands on the processed radiographic films indicated where dig-labelled
probe hybridisation had occurred with the cDNA in the PCR amplified samples. The
blots could also be stripped of the probes to allow re-hybridization with another probe
or the same probe using different hybridization conditions (see below). This was
achieved by giving the blots two fifteen minute washes at 40 °C in 0.2M NaOH +
0.1% SDS followed by three five minute washes at 40 °C in 2 xSSC + 0.1% SDS. The
blots were then re-exposed for 30 minutes to ensure that all dig-labelled probe had
been removed.
2.7.10 High and low stringency hybridization conditionsfor whole enzyme
cDNA probing
In addition to using oligonucleotide cDNA probes which were generally 25-30
base pairs (bp) in length, the latter stages of the sequencing study also involved
hybridizing blotted samples with much larger (> 500 bp) whole enzyme cDNA probes.
Moreover, the hybridizations had to be carried out at differing temperatures and
washing stringencies to allow selective binding of the probes to blotted samples which
demonstrated only the highest degrees of identity with the probe. For 'low stringency'
hybridizations which allowed less specific probe binding, the probe hybridization step
was carried out at 50 °C for three hours followed by a ten minutes 2 x SSC and thirty
minute 0.5 x SSC wash. For 'high stringency' hybridizations which allowed more
selective probe binding, the hybridization step was carried out at 65 °C for three hours
followed by a ten minute 2 x SSC and thirty minute 0.2 x SSC wash.
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2.7.11 Cloning ofmast cellprotease-specific cDNA fragments
Secondary PCR products positive for mast cell protease cDNA were inserted
between the P lac promoter and lacZa (p-galactosidase) gene of an Invitrogen 3.9kb
pCR™2.1 plasmid vector which also contained genes for ampicillin and kanamycin
resistance (Fig. 2.2). The ligation reaction was carried out overnight at 15 °C
according to the manufacturer's instructions (TA cloning kit; Invitrogen Cat. No.
2331). The ligated plasmids were transformed into 'One Shot' competent Invitrogen E.
coli cells (TA cloning kit; Invitrogen Cat. No. 2331 ) which were then plated out onto
Luria Broth (LB) agar plates containing 50pg/ml kanamycin (Sigma Cat. No. K 0879)
and lOpg/ml x-galactopyranoside (Appendix A). The plates were incubated overnight
at 37 °C and stored for at least two hours at 4 °C. They were then screened for the
presence ofwhite colonies which indicated the presence of transformed E. coli
containing ligated plasmids, due to the disruption of the plasmid derived p-
galactosidase expression. These colonies were picked off the plates and inoculated into
sterile universals containing LB media and 1 pg/ml ampicillin (Appendix A) for further
selection and cloning overnight at 37 °C.
70
Insertion point for PCR product
(§)
Fig. 2.2 Map of the Invitrogen pCR II plasmid showing the genes for ampicillin and
kanamycin resistance as well as the insertion point for PCR products between the Plac
promoter and the lacZa gene
2.7.12 PlasmidDNA purification
Overnight selected E. coli suspension (3mis) was harvested from the LB media
(R)universals and processed using a commercial kit (Qiaprep Mini-prep plasmid DNA
purification system; Qiagen Cat. No. 27104 ) according to the manufacturer's
instructions.
2.7.13 Restriction enzyme digestion of the plasmid inserts
Aliquots (I pi) of the purified plasmid DNA preparations were incubated for
one hour at 37 °C with 0.01 pg /ml EcoRI (Boerhinger Mannheim Cat. No. 703 737),
O.Olpg/ml NotI (Boerhinger Mannheim Cat. No. 1 014 706), or no restriction enzyme
(uncut). pCR™2.1 incorporates two cleavage sites for EcoRI positioned at either end
of the ligated DNA insert and a single NotI site positioned 3' to the DNA insert.
Incubation with these enzymes therefore resulted in either the complete removal of the
DNA insert from the plasmid (EcoRI) or linearisation of the plasmid (NotI). The
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restriction enzyme digestion products were separated on an agarose gel and blotted
with a mast cell protease-specific dig-labelled probe as outlined above.
2.7.14 DNA sequence analysis ofplasmid inserts
Plasmid preparations containing probe positive inserts were checked for their
DNA content and purity on a Beckman DU-650 spectrophotometer by measuring the
OD260nm an^ OD260nm/'O^)280nm ratio for samples diluted 1:50 in ddHgO. 20pl
sample aliquots containing > 200pg/ml DNA with an OD260nrr/OD280nm va'ue >
1.5 were sent to the Department ofBiological Sciences, Durham University, England
for sequence analysis. Samples were sequenced in both the forward and reverse
directions and the results compared, to minimise the possibility of sequencing errors
due to non-identified nucleotides.
2.8 Histochemical and immunohistochemical staining of tissues and cytosmears
2.8.1 Tissue fixation, embedding and cutting
Tissues were routinely fixed for six hours in 4% paraformaldehyde in PBS or
modified Bouin's fixative (Appendix A) at room temperature (Newlands, Huntley and
Miller 1984). Thereafter, they were transferred to 70% ethanol and stored at 4 °C
until they were embedded in paraffin wax. Serial 4pm sections were cut from the
embedded tissue blocks using a microtome and attached to 0.1% poly-l-lysine (Sigma
Cat. No. P 8920) treated glass slides by heating for two hours at 60 °C in an oven.
2.8.2 Cytosmear preparations
Cytosmear preparations of goat BMMC and isolated goat MMC and GL were
made using a Shandon Cytospin 2 cytocentrifuge (Shandon Southern Products Ltd.).
Aliquots (200pl) of cell suspension containing 2 x 10^ to 1 x 10^ cells/ml were
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centrifuged for five minutes at 800 rpm. Cytosmears were air dried for fixation or
staining. Cytosmears for immunohistochemical staining were fixed in 4%
paraformaldehyde in PBS for one hour at 40 °C, rinsed in tap water and stored in 70%
ethanol at 4 °C prior to use.
2.8.3 Toluidine blue stainingfor mast cells
This was modified from the original technique of Enerback (1966a). Slides
containing the paraffin embedded tissue sections were dewaxed by incubating in two
changes of xylene for ten minutes and passing through a graded alcohol series
(Appendix A). The slides were then placed in 0.5% toluidine blue pH 0.5 (Appendix
A) overnight. Stained slides were washed for ten minutes in running tap water before
dehydrating through a graded alcohol series (Appendix A) and mounting in poly-vinyl
pyrrolidone (PVP) (Tissuetek II, Naperville, USA).
2.8.4 Carbol chromotrope staining of tissuesfor GL and eosinophils
Dewaxed tissue sections were pre-stained for one minute in haematoxylin
(Appendix A) and washed for ten minutes in running tap water. They were then
stained for one hour in Lendrum's carbol chromotrope (Lendrum 1944) (AppendixA)
at room temperature before washing for ten minutes in running tap water, dehydrating
and mounting in PVP.
2.8.3 Carhnxybenwyl-L-lysine thiobemyl (BLT-) esterase staining of tissues
This was carried out using a modification of the technique of Kramer, Fruth,
Simon and Simon (1989) for the detection of T cell-derived serine protease -1
granzymes. Dewaxed sections were incubated for fifteen minutes at 37 °C in a
solution of carboxybenzoyl-L-lysine thiobenzyl ester and fast blue BB salt pH 8.2
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(Appendix A). They were washed for five minutes in running water and mounted in
Apathy's water soluble mountant (Raymond-Lamb, London, Cat. No. AE004-A).
2.8.6 Leishman's staining of cytosmears
Air-dried, unfixed cytosmears were laid out on a staining rack and flooded with
1 ml Leishman's staining solution (Appendix A) for two minutes. 1ml of tap water was
then added and the mixture left for a further five minutes. After rinsing thoroughly in
tap water, the slides were air dried and mounted in PVP.
2.8.7 Immunohistochemistry protocolfor detecting mast cellproteases in
tissue sections and cytosmears
Dewaxed tissue sections and fixed cytosmears stored in 70% ethanol were
treated with 100% methanol + 0.5% H2O2 (Appendix A) for thirty minutes at room
temperature to block endogenous peroxidase activity before washing for fifteen
minutes in three changes ofPBS . All slides were washed for ten minutes in two
changes ofPBS and blocked for thirty minutes at room temperature with 4% bovine
serum albumin dissolved in PBS (BSA/PBS). They were then incubated overnight in a
humidity chamber at 4 °C with primary antibody diluted in 4% BSA/PBS (1:200 for
polyclonal rabbit anti-GMCP IgG or 1:500 for polyclonal rabbit anti-SMCP and
polyclonal rabbit anti-human tryptase) or neat hybridoma cell supernatant. After
washing for 15 minutes in three changes of PBS they were incubated for 1 hour at
room temperature with a horseradish peroxidase (HRPO) or biotin conjugated
secondary antibody diluted 1:500 in 4%BSA/PBS. Staining procedures involving the
use of a biotinylated secondary antibody required a further PBS wash and incubation
step for another thirty minutes at room temperature with streptavidin peroxidase (S-
POD) (Boerhinger Mannheim Cat. No. 1089 153) diluted 1: 4000 in 4% BSA/PBS.
Peroxidase-binding to mast cell proteases was visualised by washing the slides for a
further ten minutes in PBS and reacting with 3'3'-diaminobenzidene and H2O2 (DAB)
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substrate solution (Sigma Fast™ DAB tablets; Sigma Cat. No. D 4293) for five
minutes at room temperature. Finally, the slides were counterstained for one minute in
haematoxylin (Appendix A) and washed for five minutes in running tap water before
dehydrating and mounting in PVP.
2.8.8 Dual immunofluorescence protocolfor detecting mast cellproteases in
tissue sections.
This was carried out on modified Bouin fixed sections using a similar protocol
to that described for peroxidase staining of 4% paraformaldehyde/PBS fixed tissues
with the following modifications. Following treatment for endogenous peroxidases, the
sections were washed in PBS for ten minutes and blocked with DAB + H202 (Sigma
Fast™ DAB tablets; Sigma Cat. No. D 4293) for five minutes to reduce auto-
fluorescence. They were initially incubated with mouse monoclonal antibodies to
GMCP diluted 1:200, followed by a sheep anti-mouse Ig antibody conjugated to
fluoroscein isothiocyanate (sheep anti-mouse Ig FITC, Moredun batch no. 99/91)
diluted 1: 50 in 4% BSA/PBS. They were then incubated with rabbit polyclonal
antibody to SMCP diluted 1:500 followed by a goat anti-rabbit IgG antibody
conjugated to tetra-rhodamine isothiocyanate (goat anti-rabbit IgG TRITC, Dakopatt,
Denmark Cat. No. R 0156) again diluted 1: 50 in 4% BSA/PBS. After washing for
fifteen minutes in three changes ofPBS, the slides were mounted, without
dehydrating, in Citifluor® non-fluorescent mountant (Citifluor Ltd., London ) for
viewing on an Ortholux II U.V microscope (Leitz, Germany) fitted with
interchangeable purple and green excitation filters for viewing the FITC and TRITC
staining cells respectively. Control sections were incubated with normal rabbit serum
diluted 1:500 in place of anti-SMCP and murine ascites fluid diluted 1:500 containing
an unrelated monoclonal antibody (VPM-12) to the NS2-3 (non-structural) pestivirus
polypeptide present in Border Disease Virus (Entrican, Dand and Nettleton 1995)
developed at MRI and kindly provided by Dr. G. Entrican and Mr. D. Deane. Control
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sections treated with DAB alone were also examined for the presence of
autofluorescence.
2.8.9 Countingprotocolsfor tissue sections and cytosmears
Stained cells in the tissue sections were counted under a x 10 eye-piece
containing a calibrated graticule and x 40 objective lens viewing an area of 0.08 mm^.
In the abomasal sections, counts were made systematically from the mucosal surface to
the muscularis layer on a minimum of 25 graticule fields per tissue segment (Fig. 2.3a)
and expressed as the mean number ofmast cells per 0.2mm^. Counts in the jejunal
tissues were made on a minimum of 20 villus crypt units (VCU) (Fig 2.3b) and
expressed as the mean numbers ofmast cells per VCU. For both tissues, duplicate
counts were made on a minimum of two separate tissue segments trimmed from
separate areas of the fixed tissue. When counting cytosmears, a minimum of400 cells
were randomly counted per slide with the final result expressed as the percentage of
mast cells relative to the total cell population present in the cytosmear.
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Abomasal Mucosa
Lamina Propria
Fig. 2.3a Counting protocol for abomasal tissues showing approximate graticule area













Villus Crypt Unit (VCU)
Fig. 2.3b Counting protocol for jejunal tissues showing one villus crypt unit (VCU)
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2.9 Isolation of goat BMMC and GL
2.9.1 Trickle infection ofanimals
Animals used for the isolation ofMMC and GL were all more than three years
old and had been previously exposed to natural infection whilst maintained on pasture.
Three animals were given weekly doses of 2000 T.vitrinus and 2000 T. circumcincta
L3 (kindly provided by Dr. F. Jackson) per os for 8 weeks, and euthanased 10 days
after the final dose. These animals were also used to provide tissues for the GMCP
tissue distribution experiment described inChapter 4.
2.9.2 Isolation ofMMC and GL
This procedure was carried out according to the method of Jones, Huntley and
Emery (1992). Immediately post mortem, 50cm sections ofjejunum were harvested
from an area commencing 1 metre distal to the pylorus, opened longitudinally, rinsed
and stored in PBS. In the laboratory, the jejunal segments were transferred to lOOmls
isotonic Hanks balanced salt solution (HBSS) (Gibco BRL, Life technologies Ltd. Cat
No. 041-04020/1M) pre-warmed to 37 °C, and 40mg Dispase II neutral protease
(Boerhinger Mannheim Cat. No. 165 189) was added. The mixture was incubated for
sixty minutes at 37 °C with agitation on a rotary shaker. The enzyme reaction was
inhibited by the addition of 2mls foetal calf serum (FCS) (Advanced Protein Products
Ltd. Cat. No. AS-302-50) and 2000 iu heparin (tissue culture grade 1 A, Sigma Cat.
No. H3149) to reduce cell aggregation. The remnants of the jejunal tissues were then
removed and the remaining cell suspension was washed twice by centrifuging for five
minutes at 200 x g and re-suspended in HBSS + 2% FCS + P/S + heparin (Appendix
A; tissue culture media). A viable cell count was performed by diluting the cells 1:10
in 0.1% nigrosin/eosin dye and counting duplicate samples on a Cristalite™ modified
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Neubauer haematocytometer (Hawksley, England). Sufficient cells were removed to
provide 4x10^ cells for each gradient as well as cytosmears for Leishman and
antibody staining. Discontinuous Percoll™ (Pharmacia Cat. No. 17-0891-01) density
gradients were constructed in clear polypropylene tubes as outlined in Appendix A.
Cells removed for gradient purification were centriffiged and re-suspended in sufficient
55% isotonic Percoll (IP) to provide 2mls suspension for each gradient. The
suspension was carefully layered on top of the 65% IP portion of the gradients which
were then centrifuged at 600 x g for 30 minutes in a swing-out rotor with no brake
(Beckman, model TJ-6 centrifuge) at 4 °C.
Following centrifugation, cells at the 65% / 80% inter-phase were harvested,
pooled and diluted with at least 4 volumes ofHBSS + 2% FCS + P/S + heparin. The
purified cells were washed twice and re-suspended in lOmls Earles solution + 2% FCS
(Appendix A) for a viability cell count and cytosmear samples. Cells deemed to be
sufficiently pure by Leishman staining (60-70% MMC and GL) were then used for
release studies and electron microscopy.
2.9.3 Cellfixationfor electron microscopy
Harvested isolated MMC/GL or BMMC (see below) were transferred to
eppendorffs and centrifuged at 200 x g for five minutes at 1200 rpm in a
microcentrifuge (Costar Model 10, Sigma Cat. No. M3033), to produce a pellet
containing 1x10^ cells. The supernatant was removed and the cell pellet resuspended
in 1ml of freshly made up fixative containing 3% gluteraldehyde and 0.1M sodium
cacodylate. The cells were fixed for 24 hours at 4 °C before delivering to Mr. S.
Mitchell at the Electron Microscope Unit of the Royal (Dick) School ofVeterinary
Studies for processing. Following post-fixation in 1% osmium tetroxide in 0.1M
sodium cacodylate, the cells were embedded in Araldite™ overnight before cutting and
mounting onto 200 mesh copper grids. The grids, containing approximately 5-20
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cells per square, were then viewed using a Phillips 400® transmission electron
microscope and the best cells selected for photographing.
2.10 In vitro growth of goat bone marrow mast cells
After the harvesting of the sternal bone marrow (see 2.10.1), all procedures
were carried out under aseptic conditions in a tissue culture hood (ICN Flow Gelaire®
Class IIBSB48, ICN Pharmaceuticals Ltd.) using sterile media and equipment.
2.10.1 Harvesting ofsternal bone marrow cells
This procedure was carried out using a modification of the technique ofHaig
et al. (1988) for the collection of ovine sternal bone marrow. Animals were killed by
exsanguination after captive bolt stunning. Immediately post mortem the sternum was
removed and split longitudinally from the xiphoid cartilage to the manubrium with a
surgical saw. The marrow was extracted by squeezing the sternum in a vice and
collecting the exudate from the cut surface with a sterile scalpel blade. The extracted
marrow was resuspended in 20 ml of sterile Hanks balanced salt solution (HBSS)
containing 5% foetal calf serum (FCS), 100 U/ml penicillin, 50 pg/ml streptomycin
(P/S) and 20 U/ml heparin (Appendix A) for transport to MRI. In the laboratory, the
cell suspension was removed from below the fat layer, filtered through two thicknesses
of sterile lens tissue to remove fat and debris and washed twice in fresh HBSS + 5%
FCS + P/S + heparin by centrifugation at 200 x g in a Beckman Model TJ-6
centrifuge at 4 °C for five minutes before re-suspending each preparation in 24ml of
the same medium. 4ml aliquots of the washed cell suspension were carefully overlaid
onto 6 mis of Lymphopreptm (Bayer, GmBH) for centrifugation at 400 x g for thirty
minutes at room temperature The resulting inter-phase cells were harvested, pooled
and diluted in at least four volumes of HBSS + 5%FCS + P/S + heparin and washed
three times as above, to remove any residual Lymphoprep. After the final wash, the
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cells were resuspended in 20 mis of sterile Iscoves's modified Dulbecco's medium
(IMDM) containing 5 x 10"^M 2-mercaptoethanol (2-ME), 10% FCS and P/S
(Appendix A). A viable cell count was performed before adjusting the cell density to 2
or 3 x 105 cells/ml in IMDM + 2-ME +10%FCS + P/S.
2.10.2 Feeding and incubation of cultures
The adjusted cell suspensions were aliquoted into either 24 well plates (24 well
culture cluster, Costar Cat. No. 3524) or 75 - 225 cm^ canted neck tissue culture
flasks (Corning Cat. No. 25110-75). The recombinant cytokines, ovine interleukin-3
(rOvIL-3; Moredun batch no.lH2 3/2/10/TF/1/C/9/2) and/or ovine stem cell factor
(rOvSCF; Moredun batch no.3/2/7/2/TF/2/A/3/12/3) were added in the appropriate
combination and concentration for the current experiment (Chapter 7) then the cells
incubated in an atmosphere of 5% CO2 in air at 37 °C in a tissue culture incubator
(ICN Flow automatic CO2 Incubator Model 160, ICN Pharmaceuticals). Cultures in
24 well plates were fed with fresh cytokine(s) every 48 - 72 hours by removing 500pl
of cell-free medium from each well and replacing it with 500pl of IMDM + 10%FCS
+ P/S + 2-ME incorporating the appropriate dilution of cytokine. Flask cultures were
also fed at the same time interval by adding the appropriate volume of cytokine
supernatant to give the correct final dilution. Every seven days, the cells were
centrifuged at 200 x g for five minutes and resuspended in fresh IMDM + 2-ME
+ 10%FCS + P/S. Throughout the culture period, the cells were monitored daily under
aLeica DM IE inverted microscope (Leica microscopy Cat. No. 520802/152192) and




After gentle aspiration with a sterile wide bore Pasteur pipette, 250pl of cell
suspension from each well was removed for viable cell count and cytosmear
preparations. The remaining cell suspension volume was measured before being
transferred to 1.5ml eppendorff tubes and centrifuged at 200 x g for 5 minutes at 1200
rpm in a microcentrifuge (Costar, Model 10, Sigma Cat. No. M3033 ). The resulting
supernatant was carefully removed and stored along with the cell pellet at -20 °C
pending further analysis. The results of the cell count were corrected for viability and
total cell suspension volume, with the final results expressed as total cell numbers per
well x 10^.
Tissue culture flasks
After gentle agitation, 500 -1 OOOpil aliquots of cell suspension were removed
for a cell count and cytosmear preparations. Sufficient cell suspension was then
removed to provide a cell pellet containing 1x10^' cells which was collected and
stored as described above.
2.10.4 Extraction ofcell pelletsfor mediator assays
This technique was modified from that ofHuntley (1991) for the extraction of
ovine BMMC cell pellets. Granule-associated mediators were solubilised from the
harvested cell pellets by lysing the cells in 200pl of 20mMTris + 1.5M NaCl pH 7.5
(extraction buffer, Appendix A) . The suspension was sonicated for sixty seconds in a
Polaron sonicator (Polaron Ltd. England) and rapidly freeze-thawed three times. The
resulting extract was centrifuged at 10, 000 rpm for five minutes in a microcentrifuge
(Costar, model 10) to remove residual cell debris.
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2.11 Secretogogue and worm antigen-mediated release of goat bone marrow
mast cells (BMMC) and mucosal mast cells (MMC)
2.11.1 Secretogogue-mediated cell release protocol
Aliquots of purified MMC and cultured BMMC harvested between days 16
and 22 of culture were washed twice by centrifiiging at 200 x g and re-suspending in 1
x Earle's medium containing Mg^+ and Ca^+ without phenol red + 2% FCS
(Appendix A). A cell count was performed and the cell suspension adjusted to 0.5-1 x
107 viable cells per ml. Aliquots (100 pi) of the cell suspension each containing 0.5-1
x 10^ cells, were transferred to 1.5ml eppendorff tubes containing lOOpl of the
appropriate secretogogue diluted in 1 x Earles medium + 2% FCS to twice the final
reaction concentration. The cell suspension/secretogogue mixture was then incubated
at 37 °C in a shaker water bath (Grant Instruments model No. 55-40D, Cambridge)
for sixty minutes. At the end of the incubation period, the samples were centrifuged
for three minutes at 200 x g and the supernatants carefully collected for storage at -20
°C. All samples were tested in duplicate with matched negative controls incubated
with 1 x Earles + 2% FCS alone in place of diluted secretogogue. Positive controls to
measure total cell mediator content consisted of duplicate 100 pi cell suspension
aliquots harvested prior to the incubation step by centrifugation at 200 x g without the
addition of secretogogue or diluent. The resulting pellets were lysed as described
previously for harvested BMMC and the extracts stored at -20 °C.
2.11.2 Lymph and serum sensitisalion ofgoat BMMC
Abomasal afferent gastric lymph and serum samples were kindly provided by
Dr. F. Jackson and Dr D M. Patterson. They were were tested for the presence of IgE
by dot blotting and western blotting reduced samples using a rat monoclonal antibody
supernate to a fragment of recombinant ovine IgE (1E7, anti-ovine s-chain; Kooyman,
van Kooten, Huntley, Mackellar, Cornelissen and Schallig, 1997) as described below
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(2.13). Samples containing the highest concentrations of IgE, along with heat-
mactivated controls which had been incubated at 56 °C for two hours, were used to
sensitise caprine BMMC for FceRI mediated granule release in the presence of
Telodorsagia circumcincta and Haemonchus contortus nematode antigen
preparations. BMMC harvested between days 16 and 22 were washed twice in 1 x
Earle's medium without FCS, re-suspended in 2mls of lymph or serum diluted 1:4 in 1
x Earles, and incubated for forty five minutes at 37 °C in a shaker water bath. After
washing three times in 1 x Earles, sufficient cells were removed for the antigen release
studies and the remainder retained for cytosmear preparations or placed on ice for
immunofluorescent surface-bound immunoglobulin staining.
2.11.3 Immunofluorescent staining ofgoatMMC and sensitisedgoat BMMCfor
surface immunoglobulin
Aliquots of isolated MMC, serum sensitised BMMC and heat-inactivated
serum sensitised BMMC, containing 5 x 10^ cells in 1 x Earles were maintained on ice
(cells were maintained on ice throughout the procedure to minimise capping and
internalisation of surface bound immunoglobulin). Murine ascites fluid containing
monoclonal antibody to ovine immunoglobulin light chain (Bird, Jones, Allen,
Donachie, Huntley, McConnell and Hopkins, 1995) (VPM-8, kindly provided by Mr.
D. Deane) was added to produce a final antibody dilution of 1: 500. The cells were
mixed by inverting 6 times before incubating for 30 minutes with occasional agitation.
The cells were then washed three times in ice-cold 1 x Earles before adding affinity-
purified polyclonal sheep anti-mouse IgG FITC (Dakopatt, Denmark Cat. No. F 0261)
to produce a final antibody concentration of 1:50. The cells were again mixed and
incubated for a further sixty minutes before washing three times in ice-cold lx Earles.
Cytosmear preparations were made of the stained cells and the slides mounted in
citiofluor® for viewing under an ortholux II U.V. microscope (Leitz, Germany) as
described above for immunofluorescent antibody stained tissue sections. Controls
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consisted of replacing VPM-8 primary antibody with a murine monoclonal antibody
directed against Border Disease virus non-structural proteins (VPM-12) and, in the
case ofBMMC, by staining for surface immunoglobulin on cells sensitised with IgE
positive goat serum which had been heat inactivated at 56 °C for 2 hours.
2.11.4 Worm antigen preparations
These were kindly provided by Dr. D. Knox and Dr. J. Huntley, having been
prepared from nematodes provided by Dr. F Jackson. Six preparations were routinely
used for testing; these consisted of T. circumcincta L3, L3 PBS soluble whole worm
homogenate antigen (WWA) and excretory/secretory antigen (ES) proteins, and H.
contortus L5 WWA and ES proteins. Unfortunately, due to limited stocks, equivalent
H. contortus L3 preparations were unavailable. Briefly, WWA proteins were prepared
by homogenising either 5000/ml L3 or 60-100/ml adult parasites in PBS with sterile
quartz sand (Sigma Cat. No. S 9887) in a hand held glass homogeniser (Pyrex). The
homogenised samples were then centrifuged at 600 x g for five minutes and the
supernatant harvested. Supernatant batches were tested for their protein content by
measuring 1.3 x their OD260nm on a Beckman DU-650 spectrophotometer then
aliquoted and stored at -20 °C. For ES proteins, the same numbers of L3 or adults
were maintained, with constant gentle agitation, for sixteen hours at 37 °C in sterile
RPMI 1640 medium. Parasite viability at the end of the culture period was confirmed
on the basis of structural integrity and motility. The culture supernatant was
concentrated twenty fold using Centricon-10 filters (Amicon Ltd., Stonehouse, U.K.)
and centrifugation at 1500 x g (4 °C) for one hour in a MSE Mistral 6L centrifuge.
The protein content of the concentrated samples was assessed as for the WWA
preparations for aliquoting and storing at -20 °C. Freshly thawed aliquots were used
for each experiment.
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2.11.5 Worm antigen-mediated release protocol
This was carried out as for the secretogogue mediated release protocol
described above, however the BMMC were initially sensitised with IgE-positive or
heat inactivated goat lymph and serum from animals challenged with T. circumcincta.
All worm antigen preparations were tested at a final reaction concentration of 50pg/ml
and incubated with the cells for 30 minutes at 37 °C. The final results were corrected
for background spontaneous release by subtracting the percentage mediator release in
supernatants from paired control samples undergoing sensitisation only without
exposure to the nematode antigen preparations.
2.11.6 Calculation ofpercentage mediator release from stimulatedBMMC andMMC
After testing the released cell supernatant samples for GMCP, P-
hexosaminidase and aryl-sulphatase content as described below, the % secretogogue
or nematode antigen mediated release from the cells was calculated as follows:
([mediator] in supernatant-[mediator] in diluent only control -[mediator] in the releasing agent)
% release = x 100
[mediator] in the harvested cell pellet
2.12 Enzyme assays for goat bone marrow mast cells
2.12.1 SMCP and GMCP enzyme linked immunosorbent assays (ELISAs)
ELlSAs for SMCP and GMCP utilised the double antibody sandwich design
for the detection of SMCP developed by Huntley et al.( 1987). Both assays consisted
of homologous polyclonal capture antibodies and homologous rodent or murine
monoclonal detection antibodies which had been conjugated to biotin (Fig 2.4). All
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antibodies used in the SMCP ELISAs had been developed previously by Dr. J. Huntley
and A. MacKellar, whilst the purified SMCP required for the assay standards was
provided by Dr A. Pemberton. All reagents used for the GMCP ELISAs were
developed specifically for this study using the techniques outlined above.
Substrate
Fig 2.4 Double-antibody sandwich design for SMCP and GMCP ELISAs.
Polyclonal antibody stocks were diluted to 1 pg/ml (SMCP affinity purified
rabbit polyclonal antibody to SMCP, Batch No. A 95/1) or 10pg/ml (Protein A
purified rabbit polyclonal IgG antibody to GMCP, Batch No. 177/95) in carbonate
coating buffer pH 9.6 (Appendix A). 96 well microtitre ELISA plates (M129B,
Dynatech Laboratories Ltd) were coated with 50pl per well of the diluted antibody
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and incubated overnight at 4 °C. The plates were washed six times with PBS/0.05%
Tween 20 (ELISA wash buffer, Appendix A) and loaded with duplicate 50pl aliquots
of purified SMCP/GMCP standards (0.5, 1.0, 2.0, 4.0, 6.0, 8.0, 10.0, 12.0 ng/ml) or
samples diluted in PBS/0.05% Tween 20. The samples were assayed at a range of
dilutions (1:10 to 1: 10 000 for tissue homogenates and undiluted to 1 : 50 for cell
release supernatants), to ensure that at least one of the final sample optical density
(OD) readings would lie within the standard curve OD range. The plates were
incubated for sixty minutes at room temperature and washed six times with wash
buffer before incubating for one hour with 50pl per well of biotinylated rat monoclonal
antibody to SMCP (Batch No. 165/95) diluted 1:500 in PBS + 0.5% Tween 80 +
0.5M NaCl (AppendixA), or biotinylated murine monoclonal antibody to GMCP
diluted 1: 200 in PBS + 0.5% Tween 80 + 0.5M NaCl. The plates were again washed
six times and incubated for thirty minutes with 50pl per well of streptavidin
peroxidase (Boerhinger Mannheim Cat. No. 1 089 153) diluted 1: 4000 in PBS +
0.5% Tween 80 + 0.5M NaCl. Following a further six washes, the colour reaction was
developed by the addition of 50pl per well of orthophenylendiamine (OPD) substrate
(Voller, Bidwell and Bartlett, 1979) in urea H2O2 buffer (SigmaFast™ OPD tablet
sets, Sigma Cat No. P 9187). The colour reaction was terminated by the addition of
25pl 2.5M H2SO4 (Appendix A) and the plates read at OD492nm in a Titertek®
Multiskan MC Reader (Titretek® Flow Laboratories).
A standard curve based on the OD values given by the SMCP or GMCP standards was
plotted using Dynatech data analysis software (Dynatech Laboratories Ltd), and the




Activity of the granule-associated acid hydrolase, P-hexosaminidase, was
measured by hydrolysis of the substrate p-nitrophenyl-N-acetyl-P-D-glucosaminide
(Sigma Cat. No. N9376); 1 unit of enzyme cleaving 1 pinole of substrate per hour at
37 °C (Schwartz, Austen and Wasserman, 1979). Duplicate 25pl samples of cell pellet
extract or supernate were added to 50pl aliquots of 5mM substrate diluted in citrate
buffer pH 4.5 (Appendix A) in a 96 well microtitre ELISA plate (M129A, Dynatech
Laboratories Ltd). The mixture was incubated at 37 °C for forty five minutes then the
reaction terminated with the addition of 100pi ice cold glycine NaOH buffer pH 10.7
(Appendix A).The resulting colour change was read at OD405nm on a Titertek®
Multiskan MC Reader (Titretek® Flow Laboratories) with the mean OD result being
converted into approximate units of P-hexosaminidase activity using the equation:
P-Hexosaminidase activity (units) =
OD405nn/(°-8 x 18.8 x 103) x (TRV/TSV) x 1.2735
(TRV = the total reaction volume and TSV = the total sample volume)
2.12.3 Aryl-sulphatase Assays
Aryl-sulphatase activity was measured by assessing the lytic activity of cell
pellet extracts and supernatants against 6.255mM p-nitrocatechol sulphate (Sigma Cat.
No. N 7251). Duplicate 20pl samples were added to 80pl of substrate dissolved in
0.2M sodium acetate pH 5.7 (Appendix A) in 96 well microtitre plates (Ml29A,
Dynatech Laboratories Ltd) and incubated at 37 °C for sixty minutes before stopping
the reaction with lOOpl of 5M NaOH (Appendix A). Mean sample ODs were
determined at 492 nm on a Titertek® Multiskan MC Reader (Titretek® Flow
Laboratories) and compared with a linear 1.92-250 pg/ml standard curve of
sulphatase-V (Sigma Cat. No. S 8629) diluted in 0.2M sodium acetate pH 5.7. The
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standard curve was plotted using Dynatech data analysis software and concentration of
aryl-sulphatase in the unknown samples calculated from the resulting linear equation.
2.13 Ovine IgE assays
A dot blot assay system using a a rodent monoclonal antibody supernatant to a
recombinant fragment of ovine IgE s chain (1E7 antibody (Kooyman et al., 1997)
kindly provided by Dr. H. Schallig, University ofUtrecht and Dr. J. Huntley ) was
used to quantify the IgE concentration in serum and gastric lymph samples from goats
undergoing parasitic challenge. The dot blot protocol was the same as that outlined
above (2.5.1), apart from the sample preparation which required samples to be
reduced by diluting 1:4 in reducing sample buffer (Appendix A) and heating to 100 °C
for five minutes prior to blotting onto the NC membrane. This step was necessary to
enable IgE detection by 1E7, suggesting that the monclonal antibody binds to a
determinant normally hidden within the tertiary structure of native IgE (J. Huntley,
personal communication). The samples were probed with the 1E7 antibody diluted 1 :
20 in PBS + 0.5% Tween 80 + 0.5M NaCl followed by a biotinylated rabbit anti rat
IgG antibody conjugate (Dakopatt, Denmark Cat. No. E 0468) diluted 1: 500 in PBS
+ 0.5% Tween 80 + 0.5M NaCl. The average ODs of the DAB stained positive sample
dots were determined by scanning the blots on a BioRad gel scanner (BioRad model
No. 600) linked to a computer running BioRad 'Molecular Analyst' densitometry
software (BioRad, Ohio, USA). The OD results for the unknown samples were then
compared with a 0.875 - 7 pg/ml linear standard curve constructed from the
recombinant ovine IgE s chain protein used to produce the 1E7 monoclonal antibody
(recIgEl-2, kindly provided by Dr. H.D.F. Schallig). The standard curve protein
samples were double diluted in reducing sample buffer and heated to 100 °C for five
minutes before blotting onto the NC membrane adjacent to the test samples. Final
results for the unknown samples were expressed as pg total IgE per ml of serum.
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Controls consisted of reduced serum samples taken from specific pathogen free (SPF)
lambs as well as kids which had been maintained under worm-free conditions.
2.14 Data Analysis and Presentation
2.14.1 Statistical analyses
These were carried out using Excel™ version 5.0 (Microsoft Corporation, USA) for
the calculation of group mean values, the standard deviation (SD) and linear regression
analyses in Chapters 3,4 and 6, as well as all parametric analyses of grouped data in
Chapters 3, 4, 7 and 8 using Student's two sample T-test. Minitab version 9.2
statistical software was used to analyse the distribution of logjo (* +1) transformed
parasitological data (faecal egg counts and worm burdens) as well as untransformed
cell count and serological data obtained from individuals in the experiment described in
Chapter 6. The significance of grouped results in this experiment was tested using the
non-parametric Mann-Whitney U test.
2.14.2 GMCPI and II cDNA and nominal amino acid sequence analyses
This was carried out by Telnet access via the Joint Academic Network
(JANET) to the Seqnet computer based at Daresbury, England. Analyses were carried
out using the Wisconsin Package® Version 8 (Genetics Computer Group, Madison,
Wisconsin, USA)
2.14.3 Thesis presentation
This thesis was prepared using Microsoft Word™ version 2.0 (Microsoft
Corporation, USA). Data charts were constructed using Excel™ version 5.0
(Microsoft Corporation, USA) and Microcal Origin™ scientific graphics package
version 4.0 (Microcal Software, USA). Line diagrams were created using
Corel Draw™ version 4.0 (Corel Corporation, Canada).
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CHAPTER 3
THE ISOLATION AND PURIFICATION OF GOAT MAST CELL
PROTEASE
3.1 Introduction
The aim of this chapter is to describe the isolation of a mast cell-specific
protease from goat intestine, and to describe the development of immunospecific
techniques for detecting this enzyme in host tissues. This will enable initial investigations
to be made regarding the localisation, concentrations and catalytic properties of such an
enzyme. Such findings will also allow more detailed assessments to be made of the
comparative MMC responses shown by goats and sheep as a result of infection with
gastro-intestinal nematodes. In addition, analysis of the substrate specificity of isolated
GMCP will show whether it belongs to the newly emerging class of dual specific
intestinal proteases recently isolated from other ruminants, including for example, bovine
duodenase (Zamolodchikova et al., 1995a and b) and SMCP (Pemberton et al., 1997a
and b).
3.2 Materials and methods
3.2. J Animals
Thirty commercially reared Scottish cashmere goats (17 female, 13 male) aged between
six months and four years were used. All had been exposed previously to repeated
natural and artificial infections of T. circumcincta and T. vitrinus as outlined for the
ADCM described in Chapter 2, section 3.2 (2.3.2)
3.2.2 Abomasal andjejunal tissue surveysfor mast cellprotease content
Samples (lg) of abomasal and jejunal tissues from each animal were
homogenised for ELISA analysis as described in 2.3.3. Utilising the antigenic cross
reactivity between SMCP and the presumptive GMCP (Huntley et a/., 1995), these
samples were assayed for potential GMCP content by SMCP ELISA as described
previously (Huntley et al., 1987), using the protocol outlined in 2.12.1. Tissues
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containing the highest protease concentration were prepared for protease purification as
described in 2.3.3.
3.2.3 Histochemical and immunohistochemical staining ofmast cells and GL.
Sections (4pm) were prepared from 4% paraformaldehyde/PBS fixed abomasal
and jejunal tissue from 6 does and 6 bucks randomly selected from the original group of
30 animals as well as 3 kids that were less than one year old which had been housed
under worm-free conditions since birth (worm naive kids). In addition, 4 pm sections
were also cut from 4% paraformaldehyde/PBS fixed, archived abomasal tissues taken
from seven month old lambs which had been involved in an experiment one year
previously (Coop et al., 1995). During the experiment, these animals had undergone an
ADCM regime similar to that described for the goats in 2.3.2. Tissues from three
previously worm naive lambs which had received a single 50, 000 71 circumcincta L3
challenge ten days before sacrifice (primary challenge lambs) were also included for
comparison. Sections for histochemical analysis of MMC and GL were stained using
toluidine blue and carbol chromotrope as described in 2.8.3 and 2.8.4, whilst sections for
immunohistochemistry were incubated with polyclonal antibodies to GMCP and SMCP
as described in 2.8.7. BLT-esterase staining and dual immunofluorescence studies
incorporating murine monoclonal antibody to GMCP, and rabbit polyclonal antibody to
SMCP, were also carried out on modified Bouin fixed goat tissues as described in 2.8.5
and 2.8.8
All other techniques employed for purification and characterization of GMCP, as
well as the raising of antibodies and the construction of an ELISA for GMCP, were as
described in the relevant sections in Chapter 2.
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3.3 Results
3.3.1 ELISA survey ofcollected tissues
The mean (± SD) results obtained from the tissues of 30 goats tested with the
SMCP ELISA were 0.945 ± 0.14pg/g for abomasal tissues and 2.37 ± 0.2pg/g for
jejunal tissues. In the male goats there was significantly more protease present in the
abomasal tissues (1.33 ± 0.24 pg/g) than in the females (0.64 ± 0.14 pg/g) (p < 0.05)
although there was no significant difference between the sexes in the jejunal tissues (2.14
± 0.47 pg/g and 2.67 ± 0.4 pg/g respectively). Overall, the goat jejunal tissues contained
significantly higher amounts of protease (p<0.001) when compared to the abomasal
tissues from either sex. As a result, the majority ofGMCP purifications were carried out
using jejunal tissue extracts.
3.3.2 Histochemical andBLTstaining offixed tissues
Fig. 3.1a and b and show cells staining positive with BLT substrate in modified Bouin
fixed goat jejunal, and abomasal tissues. Fig. 3.1c and d show cells stained with toluidine
blue in modified Bouin fixed abomasal, and 4% paraformaldehyde/PBS fixed jejunal
tissues respectively. Fig. 3. le also shows GL and eosinophils stained with carbol
chromotrope in jejunal tissues fixed with 4% paraformaldehyde/PBS. Three of the cells
in the abomasal section (Fig 3.1b) are identical to cells staining positive for toluidine blue
in a paired serial section of the same tissue (Fig. 3.1c). BLT positive cells were also
present in the sub-epithelial tissues of the jejunum (Fig. 3.1a) demonstrating an
anatomical distribution similar to that seen in equivalent 4% paraformaldehyde/PBS
tissues stained with toluidine blue (Fig. 3. Id). Faint BLT-positive intra-epithelial cells
can also be seen in the jejunal tissues (Fig. 3.1a) which share a similar morphology and
distribution to GL stained with carbol chromotrope on equivalent 4% paraformaldehyde
fixed tissues (Fig. 3 .1e).
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Fig. 3 1a Goat jejunal villus crypt stained with BLT, Note the faint positive staining
intra-epithelial cells (arrow) and the sub-epithelial position of the other positive cells.
Modified Bouin fixed tissue (x 400)
Fig. 3 .1b Goat abomasal tissue stained with BLT, Note the triad of positive staining
cells. Compare with the toluidine blue positive cells from the paired serial section in
3.1c. Modified Bouin fixed tissue (x 400).
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Fig. 3 .1c Goat abomasal tissue stained with toluidine blue. Compare the positive cells
with the BLT stained cells in 3.1b. Modified Bouin fixed tissue (x 400).
Fig. 3 . Id Goat jejunal villi stained with toluidine blue. Note the subepithelial position of






? . . k _ a*
«>* .
, ' < «, ■* ' ' 1'















, *i i iMpSl•» ' * , Kt*
.«. * » -
» * J * *
* 1 v i
' *
- J * .
«T « »
k% ' ^ k-
*
s • % 4
f "
• g> , *









i. *£ ' V
. ff „7»- ■
*
* *
♦ * * * » % «. *
•
. „ ** »
I *
» *»■ *
* A • */" '










' 4 > ♦
•A*,'.. \
\t'fc - ,
*- * *»** *
j « » -*i *"
♦ . -■4 1 v
Fig. 3.1e Goat jejunal villus crypt stained with carbol chromotrope. Note the pink
staining intra-epithelial GL, compare their position and morphology with the faint
staining BLT positive cell in 3 .1a Note also the small, granular, darker staining
eosinophils within the submucosal tissues (arrows) 4% Paraformaldehyde fixed tissue
(x 250).
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3.2.3 FPLC and immunoaffinity purification ofGMCP
Table 3.1. shows the BLT substrate activity, SMCP EL1SA and total protein
content results for each stage of a typical separation starting with a 1 OM NaCl extract
from 5g ofjejunal tissue. Figure 3.2 shows typical elution OD profiles, measured at
280nm, for samples exiting CM-sepharose and MonoS FPLC columns after the









1.5 M NaCl Homogenate for ELISA ND ND 6.17**
'
'
<■ : ; ::; • V'"' v
*
•
- t / v ■ f
1.0 M NaCl Tissue extract 0.13 2.54 3.8
CM Sepharose Eluate 0.99 0.33 2.27
MonoS Eluate 18.66 ND*** 1.51
% Yield of GMCP from homogenate 24.55
Table 3.1 BLT substrate activity, total protein content and SMCP ELISA determination
for each step of a typical purification of 5g of goat jejunal tissue.ND = Not Done
* AO D. = Change in sample optical density at 405nm after 5 minutes incubation at room
temperature.**Result for 5g of jejunal tissue calculated from the SMCP ELISA result
obtained from an equivalent lg tissue aliquot homogenised in high (1.5M) NaCl
buffer.*** = total protein content of sample below the assay sensitivity threshold of
12|ig/ml.
Protein content and enzyme activity monitoring of the purification process (Fig.
3 .2a and b) demonstrated that active fractions bound to the CM-sepharose column and
could be eluted off in a broad peak at 0.4M NaCl (Fig. 3 .2a). These eluted samples were
diluted three volumes of 20mM Tris/HCl pH 7.5 and applied to the Mono S column,
where the application of a stepped 0-0.5M NaCl buffer gradient produced a series of
small peaks. Maximal substrate activity after five minutes incubation at room
temperature occurred in peak fractions eluted at approximately 0.3-0.4 M NaCl
(Fig. 3 .2b). The proteolytic activity of the eluted sample as measured
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Fig. 3 .2a Schematic diagram of the OD280nm elution profile obtained from the CM-sepharose
column after applying a 0-1.OM NaCl gradient
column after applying a 0-0.5M stepwise NaCl gradient
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by the rate of reaction against BLT per mg of total sample protein (AOD/mg/ml)
increased from 0 .13 to 18 .66 indicating increasing protease purity at each stage of the
procedure (Table 3.1).
The final presumptive GMCP content of samples obtained, as assayed by
SMCP ELISA, ranged from 1.02 pg to 7.635 pg depending on the initial GMCP content
of the tissue used. This gave an estimated overall yield ofGMCP recovered from the
tissues of20-30% (Table 3.1).
Immunoaffinity purification was initially much more successful, and achieved a
greater than 80% recovery of the total tissue GMCP content (Fig. 3.3b lane 3).
However, a significant reduction in column purification efficiency was demonstrated
after only 2 or 3 purification runs. This may have been due to the presence of residual
active proteases in the homogenate sample despite pre-incubation with Pefabloctm
inhibitor or due to high affinity interactions between the protease and polyclonal anti-
GMCP column antibody. Since the construction of each column required relatively large
amounts of polyclonal antibody (5 mg of IgG per 1 ml ofCNBr sepharose), which was
of limited supply, this method of enzyme purification was used to provide samples for
NH2-terminal amino acid sequence analysis only.
3.2.4 Silver stain SDS-PAGE & Azocasein SDS-PAGE
SDS-PAGE of samples eluted from the ftfonoS column produced a separate
band of approximately 29kD (Fig.3 .3a, lane 5). This was identical in weight to SMCP
(Fig 3 .3a lane 6) and corresponded to a band of proteolytic activity found on the
azocasein containing gels (Fig 3.4 lane 3). The SMCP sample shown on the silver
101
stained SDS-PAGE gels appears as a doublet (Fig.3.3a lane 6 and Fig.3.3b lane 2)
which may also be present in the immunoaffinity purified GMCP sample (Fig. 3.3b lane
3). Flowever, in the case of SMCP, this is thought to be due to variable glycosylation of
the enzyme since both bands share identical chromatographic and biochemical properties
(A.Pemberton, personal communication) and can also be seen on Western blots probed
with antibody to SMCP (not shown) and GMCP (Fig.3.5 lane 5; see 3.2.7 below). Non-
reduced samples of isolated MMC/GL lysed in 20mMtiris HC1 + 1.5 M NaCl (see
Chapter 8) were separated on azocasein substrate gels alongside samples taken from the
GMCP purification stages and purified SMCP (Fig. 3.4). The purified GMCP and
SMCP samples demonstrated bands of proteolytic activity at 29kD (Fig. 3.4 lanes 3 and
5) which also coincided with the greatest activity in the isolated MMC extracts (Fig. 3.4
lane 4).
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kD 1 2 3 4 5 6
Fig.3.2a Silver stained SDS-PAGE gel of GMCP purification. Lane 1, reduced Biorad
low molecular weight standards (relative molecular weights shown in kilodaltons (kD));
lane 2, jejunal tissue homogenised in 1.5M NaCl for SMCP ELISA analysis; lane 3,
1.0 M NaCl jejunal tissue extract; lane 4, CM-sepharose eluate; lane 5, /flonoS
purified GMCP (5pg/ml); lane 6, purified SMCP (34pg/ml).
kD 1 2 3
Fig. 3.2b Silver stained SDS-PAGE gel of immunoaffinity purified GMCP. Lane l,
reduced Biorad low molecular weight standards (relative molecular weights shown in
kilodaltons (kD)); lane 2, purified SMCP (15 pg/m!) (note doublet) ; lane 3








Fig. 3.3. Azocasein SDS-PAGE gel of GMCP purification, isolated MMC and in vitro
derived BMMC. (relative molecular weights were defined by running non-reduced
Biorad low molecular weight standards (not shown). Lane 1, l.OMNaCl jejunal tissue
extract; lane 2, CM-sepharose eluate; lane 3, hlonoS purified GMCP (5 pg/ml); lane 4,




Fig. 3.4 Western Blot probed with rabbit polyclonal antibody raised against GMCP.
Lane 1, Biorad reduced molecular weight standards; lane 2, mono S purified GMCP (7
pg/ml); lane 3, 1.5M NaCl extracted day 16 BMMC grown in rOvIL-3 and rOvSCF( 1
x 1 C)6 cells), lane 4, 1,5M NaCl extracted isolated goat MMC (1 x 10^ cells): lane 5.
purified SMCP (15pg/ml). Repeat samples run in lanes 6,7,8 & 9; these samples were
probed with normal rabbit serum diluted 1: 500 as a negative control.
10^
GMCP SMC-P Chym Tryp
□ LYS-TBE STYR-NPE □ TRY-NPE □ PHE-NPE
M LYS-NPE u ALA-NPE a ARG-NAN uTi"R-NAN
Fig.3.6 Comparative mean (±SD) substrate profile ODs for GMCP, SMCP,
chymoptrypsin & trypsin activity. Results measured by dA at 492nm after 5 minutes
incubation at room temperature for thiobenzyl ester and nitrophenol ester substrates or 2
hours incubation at 37 °C for nitroanilide substrates. Substrates tested: LYS-TBE
(BLT) = carboxybenzoyl-L-Lysine thiobenzyl ester; TYR-NPE = carboxybenzoyl -L-
Tyrosine nitrophenol ester; TRY-NPE = carboxybcnz.nyl-: .-Tryptophan nitrophenol
ester; PHE-NPE = carboxybenzoyl-L- Phenylalanine nitrophenol ester; ALA-NPE =
carboxybenzoyl-L-Alanine nitrphenol ester; ARG-NAN = carboxybenzoyl-L-Argnine
nitroanilide; TYR-NAN = carboxybenzoyl L-Tyrosine nitroanilide Results represent the















Pepstatin lOOmM 5 82 79
E64 (thiol inhibitor) ImM 0.05 100 100
Pms-F (serine inhibitor) lOOmM 5 3 2
Serum (1:200) 1 0
Table 3.2 Mean % residual activity ofGMCP and SMCP against BLT after 60 minutes
incubation at room temperature with a selection of synthetic inhibitors and serum.
3.2.5 Comparative substrate & inhibitorprofiles ofGMCP & SMCP
Samples of purified GMCP were tested against synthetic substrates and inhibitor
substances. These studies, run in parallel with equivalent samples of SMCP, bovine a-
chymoptrypsin & trypsin (Fig.3.6 and Table 3.2) showed that GMCP has catalytic and
inhibition properties that are almost identical to SMCP.
GMCP, SMCP and chymotrypsin all cleaved the chymotrypsin-associated
substrate Cbz-L-Tyr NPE, whilst GMCP and SMCP also cleaved the trypsin-like
substrate BLT which was also catalysed by trypsin but not chymotrypsin A (Fig.3.5). In
addition, mean Km values calculated for both GMCP and SMCP in the presence of a
range of concentrations ofBLT (0.125-2 mM) gave the values 44 pM and 40.6 pM
respectively which is in agreement with previous findings for SMCP (Pemberton et al.,
1997a). Inhibitor results (Table 3 .2) showed that GMCP and SMCP were both
completely inhibited by the serine esterase inhibitor PMS-F but were unaffected by the
specific thiol proteinase inhibitor E-64. In addition, both enzymes were moderately
inhibited (approximately 70-80%) by the chelating agent 1,10 phenanthrolline and by
pepstatin but were again completely inactivated following incubation with goat serum or
sheep serum respectively.
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Fig. 3.7 Optimal pH titration for GMCP as measured by activity against BLT. Results
shown are the mean values from samples tested in duplicate.
GMCP was found to have a broad pH optimum for activity against BLT with
peak activity estimated to be around pH 7.8 (Fig. 3.7). This agrees with earlier results for
SMCP against Cbz-L-Tyr NPE (Knox et al., 1986).
3.2.7 Western Blot Analysis ofGMCP & SMCP
Blotted samples of presumptive GMCP and SMCP probed with protein A
purified polyclonal rabbit IgG anti-GMCP (adjusted to lmg/ml and diluted to 1: 200 in
PBS + 0.05% Tween 80 + 0.5 M NaCl) reacted with both GMCP and SMCP samples
(Fig. 3.5 lanes 2 and 5) producing a thick single band for GMCP and a double band for
SMCP at approximately 29kD. Extracts from day 16 goat bone marrow-derived mast
cells (BMMC), cultured in rOvIL-3 and rOvSCF along with isolated goat MMC, also
showed a single reactive band of similar weight (Fig. 3 .5 lanes 3 and 4; see also Chapter
8) indicating that GMCP is present in both these cell types.
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3.2.8 Amino acid sequence analysis ofGMCP
GMCP samples purified from 1.5M NaCl extracted homogenate samples on an
anti-GMCP IgG column produced the highest yields of presumptive GMCP (>80% of
the original tissue content). NH2-terminal amino acid sequence analysis demonstrated a
minimum 83% sequence homology with SMCP and bovine duodenase for the first 18
residues. The sample also showed a high degree of homology with other isolated rodent
and murine mast cell proteases (Table 3.3).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
GMCP* I I G G ? E A K P ? S ? P Y M A F L
SMCP* I I G G H E A K P H S R P Y M A F L
RMCPI I I G G V E S R P H s R P Y M A H L
RMCPII I I G G V E S i P H s R P Y M A H L
MMCPI I i G G V E A R P H s R P Y M A H L
MMCP2 I I G G V E A K P H s R P Y M A Y L
MMCP3 I I G G V E S R P H s R P Y M A T L
MMCP4 I I G G V E S R P H s R P Y M A H L
MMCP5 I I G G T E C I P H s R P Y M A Y L
MMCP6 I V G G H E A S E S K W P W Q V S L
MMCP7 I V G G Q E A H G N K W P W Q V S L
Bov Duodenase* I I G G H E A K P H S R P Y M A F L
Table 3.3 Comparative NTTj-terminal amino acid sequence data from isolated mast cell
proteases in the goat, sheep, rat, mouse (sheep, rat and mouse data from Miller et al.,
1995) and bovine duodenase (data from Zamolodchikova et al., 1995b). Amino acids
shown in standard single letter notation. ? = undetermined residue * GMCP, SMCP and
bovine duodenase share a minimum 83% homology over the first 18 residues.
3.2.9 Immunohistochemical analysis ofMMC and GL in tissues
Table 3.4a show counts obtained from serial sections of abomasal tissues from the
ADCM challenged adult goats (does and bucks), worm naive kids, ADCM challenged
lambs and, single primary challenged lambs. Table 3 .4b shows counts obtained from
serial sections of jejunal tissues from the ADCM challenged adult goats and worm naive
kids. The cells were stained with 0.5% toluidine blue and carbol chromotrope for MMC
and GL respectively as well as polyclonal rabbit anti-GMCP and polyclonal rabbit anti-
SMCP antibody. Cells staining positive with the anti-GMCP antibody shared the same
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anatomical distribution, within the lamina propria of the mucosa, as the toluidine blue
stained cells, whilst morphologically they also exhibited a focal pattern of staining
consistent with the presence of cytoplasmic granules (Figs. 3.1c and d; 3.?a and b). In
addition, a number of intra-epithelial cells also stained positively (Fig. 3,^a and b)
although more faintly than the cells within the submucosa. These fainter staining cells











Does (6) 10.0 (±4.7) 12.6 (±10.1) 22.6(±12.6) 7.3 (±3.7) 8.9 (±3.7)
Bucks (6) 7.2 (±1.7) 9.1 (±4.0) 16.3 (±4.9) 5.2 (±3.0) 5.5 (±2.5)
Kids (3) 1.8 (±0.6)a 0.3 (±0.3)a 2.1 (±1.3)a 1.1 (±1.0)a 1.3 (±2.3)a




2.5 (±1.3)a 1.8 (±1.7) 4.3 (±1.6)a 3.3 (±0.9)a 3.9 (±l.l)a
Table 3.4a Mean (± SD) cell counts for abomasal tissues from goats and lambs.
Represented as numbers of cells per 0.2mm2 Total MMC/GL represents the sum of the
results obtained for the toluidine blue (MMC) and carbol chromotrope (GL) stained
sections. * primary challenged lambs who received a single 50,000 T. circumcincta
challenge ten days prior to slaughter. Superscripts show values that are significantly
different (p < 0.05). a = values significantly less than corresponding ADCM challenged
animals of the same species; b = values significantly higher than those obtained for the










Does (6) 13.8 (±2.0) 9.4 f±5.5f 23.2 (±1.1) 15.6 (±2.0") 14.9 (±1.61
Bucks (6) 16 (±0.9) 8.7 (±2.01 24.7 (±4.9) 15.8 (±3.5) 17.2 (±1.6)
Kids (3) 14.6 (±2.4) 0.6 f±0.5 fa 15.3 f±2.4fa 7.6 (±2.9)a 6.3 f±3.4fa
Table 3 .4b Mean (±SD) cell counts for jejunal tissues from goats only represented as
numbers of cells per VCU. Total MMC/GL represents the sum of the results obtained for
the toluidine blue (MMC) and carbol chromotrope (GL) stained sections. Superscripts
show values that are significantly different (p < 0.05). a = values significantly less than
corresponding ADCM challenged does and bucks.
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Fig 3.8a Goat abomasal tissue incubated with polyclonal anti-GMCP. Note the granular
cytoplasmic morphology of the MMC and the fainter staining GL.4% Paraformaldehyde
fixed tissue (x 400).
1
Fig 3 .8b Goat jejunal villus crypt incubated with polyclonal anti-GMCP. Note the fainter
staining intra-epithelial cells (arrow), compare with the GL shown in Fig. 3.1e. 4%
Paraformaldehyde fixed tissue (x 400).
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Fig 3 .8c Goat abomasal tissue incubated with normal rabbit IgG. 4% Paraformaldehyde
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Fig 3 .8d Goat jejunal villi incubated with normal rabbit IgG 4% Paraformaldehyde fixed
tissue (x 100)
ill
Abomasal cell counts (Table 3.4a) demonstrated that, with the exception of
carbol chromotrope stained cells in the lambs, ADCM challenged animals from both
species showed significant increases in the numbers of cells stained by all methods when
compared to worm naive kids or primary challenged lambs. The ADCM challenged
lambs also contained significantly higher numbers of toluidine blue, anti-GMCP and anti-
SMCP staining cells than the ADCM challenged goats (p < 0.05). However, both the
does and bucks contained higher mean numbers of carbol chromotrope staining cells,
which meant that there were no significant differences in terms of the 'total mast cell
count' (ie the combined toluidine blue (MMC) and carbol chromotrope (GL) stained cell
counts) between the ADCM challenged lambs and goats. In the jejunum (Table 3.4b),
there were significantly greater numbers of carbol chromotrope, anti GMCP and anti-
SMCP positive cells in the does and bucks compared to the kids, although there were no
significant differences observed in the toluidine blue cell counts. Regression analyses
comparing abomasal toluidine blue cell counts with abomasal GMCP-positive cell counts
from all animals demonstrated a high degree of correlation (R^ = 0.95, p < 0.0001)
whilst a less strong, but still significant relationship, was also demonstrated between
abomasal total cell counts (MMC/GL) and anti-GMCP cell counts (R^ = 0.75, p<
0.0001). In addition, the relationships between the numbers of anti-GMCP positive and
anti-SMCP positive cells in the abomasal tissues from both species and the goat jejunal
tissues were also highly correlated (R~ = 0.98, p < 0.0001 and R- = 0.81, p < 0.001
respectively)
3.2. JO Production ofmonoclonal antibodies to GMCP
The hybridoma cells originally produced 5 clones whose supernatants stained cells on
tissue sections that corresponded in distribution and morphology to cells stained with
toluidine blue or incubated with polyclonal anti-GMCP. The parent hybridoma colonies
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were allowed to grow to confluency, before being harvested and stored in liquid
nitrogen. Cells from two of the positive colonies (3E3 and 5C1) were subcloned twice
and the resulting supernatants from single cell-derived clones retested on tissue sections.
On the basis of the intensity, morphology and anatomical location of cells stained, one
subclone (3E3/E3/E4), was cultured to produce sufficient cells for ascites production as
outlined in 2.4.2. Harvested ascites fluid was tested on tissue sections before purifying on
a protein G column and biotinylating as outlined in 2.4.2
3.2.11 Dual immunofluorescence using monoclonal anti-GMCP andpolyclonal anti-
SMCP
Figures 3.9a and b show FITC positive cells stained with monoclonal anti-GMCP
and TRITC positive cells stained with polyclonal anti-SMCP respectively. This
demonstrates the cross reactivity shown by the two antibodies as they stain the same
MMC populations within the lamina propria. This same pattern of staining was also seen
in the abomasum. Control slides, where monoclonal anti-GMCP and polyclonal anti-
SMCP were replaced with a non-related murine monoclonal antibody to border disease
virus (VPM-12) and normal rabbit serum respectively were negative (Figs. 3.9 c and d).
Unfortunately, GL auto-fluoresced on the negative control slides despite attempts to
block this by preparing the tissues in modified Bouin's fixative and pre-treating the slides
with DAB (Figs. 3.9 c and d). It was therefore impossible to determine, by dual





Fig. 3 8 Dual immunofluorescence staining ofMMC in goat jejunal tissues, a) Cells
staining positive in a jejunal villus tip with mouse monoclonal anti-GMCP and FITC
conjugated anti-mouse IgG. b) Same cells staining positive with rabbit polyclonal anti-
SMCP and TRITC conjugated anti-rabbit IgG c) and d) jejunal tissues incubated with
VPM-12 (c) and normal rabbit IgG (d) respectively, Note the lack ofMMC staining and
the auto-fluorescence of intra-epithelial GL. Modified Bouin fixed tissue (a and b x 400;
c and d x 250)
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3.2.12 GMCP ELISA
Fig 3.10 shows the results of an experiment to determine the optimal concentration for
polyclonal capture antibody to GMCP. Duplicate rows on ELISA plates were coated
with polyclonal IgG anti-GMCP at 16 pg/ml, 8 pg/ml, 4pg/ml and 2 pg/ml in CO3 buffer
as outlined in 2.12.1. Each set of coated wells was then incubated with GMCP samples
diluted in PBS + 0.5M NaCl to provide a concentration range from 5ng/ml to 70 ng/ml.
GMCP binding to the capture antibody was detected using biotinylated monoclonal anti-
GMCP as described in 2.12.1. The results demonstrate a significant reduction in O.D.,
indicating a loss in sensitivity, when polyclonal IgG anti-GMCP is used at less than
8pg/ml. However, the sensitivity was not significantly enhanced by coating at 16pg/ml,
therefore, plates were routinely coated with polyclonal antibody at lOpg/ml. Fig. 3.11
shows the mean OD results from a standard curve titration for purified GMCP on plates
that had been coated with polyclonal anti-GMCP at lOpg/ml. The most linear part of the
curve was found to lie between approximately 1 ng/ml and 15 ng/ml. A standard curve
range of 0.5 to 12 ng/ml similar to that described previously by Huntley et al. (1987) for
an SMCP ELISA, was employed in subsequent assays. Fig. 3.12 demonstrates the cross
reactivity shown by the anti-GMCP antibodies used in the GMCP ELISA, when testing
samples containing known stock concentrations of purified GMCP or SMCP. Samples
were diluted in PBS + 0.02% Tween20 to produce a 0.5-12 ng/ml range of
concentrations. No significant differences (p > 0.05) were observed in the mean OD
492nm results obtained from either species at each concentration, demonstrating total







Fig. 3.10 The effects of concentration of coating polyclonal rabbit anti-GMCP on the
sensitivity of a double antibody sandwich ELISA for GMCP. Biotinylated monoclonal
anti-GMCP antibody was used at 1:200 dilution of stock. The colour reaction was
allowed to develop for 30 minutes before terminating with 2.5M H2SO4 and measuring
the blank corrected OD 492nm. Each point represents the mean of duplicate tests.
0.9 1.1 1.3 1.5
Log concentration of GMCP (ng)
0 2 4 6 8 10 12 14
G MCP ng/ml
Fig 3.11 Standard curve titration for purified GMCP in the GMCP ELISA. The graph
shows a range of dilutions of GMCP from 0.5ng/ml to 15ng/ml. The most linear part of
the curve used for measuring GMCP concentrations lies between 0.5ng/ml and 12 ng/ml
(as determined by Dynatech data analysis software). Each data point represents the mean
























Fig. 3.12 Comparative OD 492nm results obtained for a 0.5 - 12ng/ml dilution range of
stock GMCP and SMCP samples. No significant differences were observed in the
absorbances measured for each sample. Each data point represents the mean (± SD) of 4
tests
3.4 Discussion
This chapter describes, for the first time, the isolation and purification to
homogeneity of a goat mast cell protease (GMCP). The enzyme was purified from
samples of goat jejunum that contained the highest levels of putative GMCP as
determined by an ELISA for SMCP. Following preliminary investigations to determine
the concentration ofNaCl required to achieve maximal tissue protease extraction, GMCP
was extracted from homogenised tissues by solubilising it in a high salt (1 0M NaCl)
buffer. This possibly acts to release GMCP from the granule glycosaminoglycan matrix
to which it is ionically bound when the mast cell is in a quiescent state (Schwartz and
Austen, 1984). The requirement for NaCl in the extraction buffer was in common with
other relatively insoluble mast cell proteases such as SMCP and RMCP I, both ofwhich
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which need high salt extraction buffers for purification (Huntley et al., 1986; Yurt &
Austen, 1977). Subsequent cation exchange chromatography steps further
categorised the enzyme as a basic protein, whilst SDS-PAGE analysis showed that it had
a molecular weight of approximately 29kD, which was in common with SMCP. Pierce
protein quantification and SMCP ELISA analysis of each purification step indicated that
only low pg level quantities of protease were present in the goat tissues and FPLC
column eluates. These findings agree with earlier results for GMCP quantification in
tissues as previously determined using the ELISA for SMCP (Huntley et al., 1995).
The mast cell origin ofGMCP can be deduced on the basis of five separate
findings. Firstly, tissue staining with the substrate used to monitor the purification of
GMCP (BLT) was localised to cells also staining positive with toluidine blue, which is
specific for mast cell protoglycans (Enerback, 1966a). Secondly, azocasein substrate
gels loaded with samples of purified GMCP produced a band of proteolytic activity at 29
kD, which was also seen in samples of cell extracts from density gradient purified goat
jejunal cells that were enriched for MMC and GL (see Chapter 8). Thirdly, Western blot
analysis of purified GMCP samples, isolated MMC/GL extracts and in vitro derived bone
marrow mast cell (BMMC) extracts all exhibited a protein bands at 29-3OkD when
probed with polyclonal rabbit IgG anti-GMCP. In addition, samples of purified SMCP
also stained with this antibody indicating the presence of cross reactivity between the
two proteases. Fourthly, cell counts for goat and sheep tissue sections stained with
polyclonal rabbit IgG anti-GMCP correlated with counts from the same sections stained
with toluidine blue for MMC, whilst both populations of stained cells were found to be
localised to the lamina propria and exhibited similar staining morphology. Finally, a high
degree of homology between NH2-terminal amino acid sequences obtained for
immunoaffinity purified GMCP and SMCP (Pemberton et al., 1997a) provided, together
with the above evidence, confirmation that GMCP represents a caprine mast cell-specific
protease.
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The presence of BLT and polyclonal anti-GMCP staining cells which were
localised in the epithelium of the jejunum as well as the abomasum provided evidence
that goat GL may be derived from MMC. These cells also demonstrated a similar
morphology and tissue distribution to GL stained with carbol chromotrope. The fact that
the cells were particularly faint staining may have resulted from them having already
degranulated and released the majority of their protease content. This in turn, may have
accounted for poorer correlations obtained when total MMC/GL cell counts from
toluidine blue and carbol chromotrope stained abomasal tissues were compared with the
results from equivalent tissues stained with anti-GMCP. An alternative rationale is that
caprine GL represent a heterogeneous population in which protease is absent in some
cells, or that they contain protease which is antigenically distinct from GMCP.
Three further significant results were obtained from the histochemical and
immunohistochemical analyses of the sheep and goat tissues. Firstly, the numbers of
mast cells increased significantly in all animals exposed to the ADCM challenge
indicating that intestinal mastocytosis occurs in both species following nematode
challenge. Secondly, whilst the ADCM challenged lambs generated significantly more
MMC than the goats, the numbers of total mast cells (MMC and GL) were not
significantly different due to proportionately greater increases in GL numbers in the
ADCM challenged goats. Earlier findings (Huntley et al., 1995), demonstrated greater
numbers ofGL in the gastro-intestinal tissues of goats when comparing ADCM
challenged does and ewes, whilst significantly higher total worm burdens were also
recovered from the does at post mortem. Parasite numbers were not recorded in the
current experiment, however these previous findings, along with the evidence that at
least some caprine GLs are related to MMC suggests that there may be greater or more
prolonged antigenic stimulus for increased GL formation from MMC in goats. Finally,
there was also an extremely high correlation between the cells of similar morphology and
tissue location staining positive with anti-GMCP and anti-SMCP in both species. This
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indicates that a high degree of cross reactivity occurs between the antibodies to both
proteases suggesting that both enzymes are closely related in terms of immunogenicity,
structure and, possibly, biochemical function.
Results from biochemical characterisation studies including semi-quantitative
substrate and inhibitor assays demonstrated that both GMCP as well as SMCP, as their
'chymase' nomenclature would suggest (Miller et al., 1995), possess catalytic activity
against some chymotrypsin-associated substrates. This included Cbz-L-Tyr NPE
which contains an aromatic PI residues at its catalytic site (see general introduction).
However, somewhat unusually, GMCP and SMCP also demonstrated a partial 'trypsin-
like' reactivity restricted towards BLT, which contains a lysine P1 residues at its
catalytic site. Indeed, the catalytic activity against this particular substrate was so rapid
that it was subsequently chosen for routinely monitoring GMCP activity during FPLC
purification. GMCP, like SMCP, was also relatively unaffected by the specific thiol-
proteinase inhibitor E-64 whereas it is fully susceptible to PMS-F indicating that both
enzymes are serine esterases. Moreover, both GMCP and SMCP were completely
inhibited after incubating in normal goat or sheep serum indicating that they are both
susceptible to serum derived protease inhibitors (serpins) present in vivo. These may
include alpha-1-proteinase (alpha-1-antichymotrypsin) and alpha-2-macroglobulin
inhibitors which have been demonstrated in sheep serum (A. Pemberton personal
communication, Pemberton et al., 1997b) and/or the recently characterised goat serine
protease inhibitors, elastasin and contrapsin which have been shown to be similar to
human alpha-1-antichymotrypsin (Potempa, Enghild and Travis, 1995). In previous
studies, both SMCP and bovine duodenase have also been shown to be susceptible to
soyabean trypsin inhibitor (Pemberton et al. 1997b, Zamolodchikova et al., 1995a)
further emphasising their 'trypsin-like' biochemical properties. Catalytic activity against
BLT was also noted in samples of purified MMC/GL that had been lysed in a 1 5M NaCl
buffer at pH 7.5. This, along with the results from the BLT staining of tissues discussed
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above, implies that GMCP is stored in an active form within the cell, whilst the granular
pattern of staining present in tissue MMCs probed with antibody to GMCP (Fig. 3.7 a
and b) appears to localise the enzyme to the cytoplasmic granules. Overall, these results
indicate that GMCP, in common with SMCP is present in MMC where it is found as a
biochemically active, granule-associated, serine protease exhibiting both chymotrypsin-
like and partial trypsin-like substrate specificity. This property of dual substrate
specificity is a relatively novel finding, associated with certain human and ruminant serine
proteases and has recently been ascribed to human cathepsin G (Hof et al., 1996),
SMCP (Pemberton et al., 1997a) and bovine duodenase (Zamolodchikova et al., 1995a).
NH2-terminal amino acid sequence results for the first 18 residues of an
immunoaffinity purified sample ofGMCP demonstrated a minimum 83% homology with
SMCP and bovine duodenase and 33%-66% homology with other previously sequenced
rodent and murine mast cell proteases. Work is currently underway to determine the
complete amino acid sequence for this protease through cDNA sequence analysis
obtained from in vitro derived BMMC mRNA (see Chapter 5). When complete, it is
likely that the well conserved serine esterase-associated catalytic triad ofHis-57, Asp-
102 and Ser 195 common to chymotrypsin A and other completely sequenced mucosal
mast cell chymases such as MMCP 1 & MMCP 2 (Huang, Blom and Hellman 1993;
Serafin, Reynolds, Rogelj, Lane, Conder, Johnson, Austen and Stevens, 1990) and
RMCP I (Le trong, Parmelee, Walsh, Neurath and Woodbury, 1987) will also be found.
Sequence analyses may also provide more information on the presence of potential
glycosylation sites which may account for doublet bands seen in some preparations of
SMCP and immunoaffinity-purified GMCP isolated from tissues (Fig. 3.2a and b), as
well as the presence of certain charged amino acid residues within the active site which
could account for the presence of dual specificity (Hof et al., 1996).
Attempts at constructing an ELISA with polyclonal and monoclonal antibodies to
GMCP were also successful, with optimal concentrations of polyclonal capture antibody
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enabling the assay to detect as little as lng/ml ofGMCP. Given the high degree of cross-
reactivity shown by polyclonal and monoclonal anti-GMCP and polyclonal anti-SMCP
antibodies (Figs. 3.5 and 3.9), it is perhaps not surprising to find that there were no
significant differences in the ability of the GMCP ELISA to detect either GMCP or
SMCP. Ffowever, this work validates previous results obtained using SMCP antibodies
for the detection ofGMCP in goat tissues (Huntley et ai, 1995).
Having isolated and characterized GMCP, further studies were performed to
analyse its distribution in mast cell populations, its molecular characteristics through




THE DISTRIBUTION OF GOAT MAST CELLS, GLOBULE
LEUKOCYTES AND GOAT MAST CELL PROTEASE.
4.1 Introduction
Currently, very little is known about the distribution ofmast cells or globule
leukocytes in goat tissues. Histochemical studies carried out by Rahko (1972a and b)
demonstrated the presence ofmast cells and GL in the bile ducts ofgoats during
natural infections of fascioliasis, whilst Huntley et al. (1995) also demonstrated their
presence in the abomasa and jejuna of does infected with T. circumcincta and T.
vitrinus. However, histochemical studies on the distribution of these cells throughout
the rest of the gastro-intestinal tract as well as in other tissues have yet to be carried
out. Moreover, as outlined in the general introduction, mast cells from a number of
species including rodents, mice, humans and most recently sheep, have been shown to
possess phenotypic heterogeneity in terms of their tissue location, histochemical,
biochemical and functional properties (reviewed Galli, 1990 and Huntley, 1992).
In this respect, studies investigating the expression of antigenically distinct
neutral granule proteases in mast cell populations has led to the identification of
MMC and CTMC subsets in the rat (Gibson and Miller, 1986; Gibson et al., 1987;
Huntley, Mackellar, Newlands, Irvine and Miller, 1990), mouse (Miller, Huntley,
Newlands, Mackellar, Irvine, Haig, Macdonald, Lammas, Wakelin and Woodbury,
1989) and man (Schwartz, 1989). In the rat, RMCP II predominates in intestinal
MMC, whilst RMCP I is primarily located in CTMC found in sites other than mucosal
tissues. In mice, MMCP 1 is only expressed in MMC, whilst MMCP 4 is principally
found in CTMC (Reynolds et al., 1990). In humans, there are at least two mast cells
subsets, one that contains a tryptase and a chymase (MC^C), an(j one that contains
only tryptase (MC^). Most tissues appear to contain a mixture of both phenotypes,
although MC^C cells are predominantly found in the skin and small intestinal
submucosa whereas MC^s are chiefly found in the lung and small intestinal mucosa
(Schwartz, 1989). Recent work by Sture et al. (1995) demonstrated heterogeneity
amongst sheep mast cells on the basis of their SMCP content. Two populations of
125
sheep mast cells were defined, those in gastrointestinal and other tissues where the
majority ofmast cells stained positive for SMCP (equivalent to an MMC subset) and
those present in the skin (a putative CTMC subset) that was deficient in SMCP.
The work presented in Chapter 3 demonstrated the isolation, purification and
characterization of a mast cell-specific protease from goat tissues (GMCP) that is
analogous to SMCP. The development of polyclonal antibodies to GMCP now
provides an opportunity to examine the distribution ofmast cells and GL within goat
tissues. This will be achieved using both histochemical techniques to stain mast cells
and GL as well as immunohistochemistry which may provide evidence for phenotypic
heterogeneity in terms of the distribution ofGMCP. In addition, the development of
an ELISA for GMCP will allow assessments to be made on the concentration of
GMCP in various tissues. Finally, the kind gift of a polyclonal rabbit antibody to
human mast cell tryptase (from Professor K. F. Austen via Professor H. R. P. Miller),
which has been shown to cross react with a putative tryptase enzyme in sheep mast
cells (H. R. P. Miller, personal communication), will also allow preliminary
investigations into the presence or absence of a putative goat mast cell tryptase. The
distribution of tryptase positive cells will be examined in relation to the distribution of
GMCP-positive cells to determine whether a situation analogous to MC^ and MC^C
cell heterogeneity described in humans, also occurs in the goat.
126
4.2 Materials and methods
4.2.1 Animals
Three adult (three to four year old) female Scottish cashmere goats were used
for the study. They had undergone exposure to nematode infections at pasture before
being housed approximately six months prior to the start of the experiment. In order
to stimulate an intestinal mast cell response, they were dosed with 2000 T.
circumcincta L3 and 2000 71 vitrinus L3 weeklyper os as described in Chapter 2.9.1.
4.2.2 Processing of tissues
The animals were killed as described in Chapter 2.3.3 before identifying and
harvesting the following tissues from similar locations in each animal: abomasum
(abomasal fold), duodenum, jejunum, ileum, colon, mesenteric lymph node, trachea,
lung (right caudal lobe), bronchial lymph node, spleen, liver (ventral margin of the left
lobe), skin (glabrous skin from ventral abdomen) and heart (left ventricle). Harvested
tissues were fixed in 4% paraformaldehyde/PBS or weighed, homogenised and stored
at -20 °C for ELISA analysis as described in Chapter 2.8.1 and 2.3.3 respectively. 4
pm serial sections were prepared for histochemical and immunohistochemical staining
as described in Chapter 2.8.1
4.2.3 Staining and enumeration ofcells in tissue sections.
Sequential sections were cut and stained with toluidine blue pH 0.5 (Enerback,
1966; see 2.8.3) for mast cells (MC), carbol chromotrope for GL (Lendrum, 1944;
see Chapter 2.8.4), polyclonal rabbit IgG containing antibody to GMCP or affinity
purified polyclonal rabbit antibody to human tryptase (Chapters 3 & 2.8.7). Negative
controls for the immuno-localisation incorporated normal rabbit serum diluted 1:500
in place of the primary antibody. Cell counts were carried out on paired segments of
tissue from related areas on sequential sections as described in Chapter 2.8.9. Counts
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from intestinal tissues distal to the abomasum were quoted as numbers of positive
cells per VCU whilst counts from all other tissues were quoted as numbers of positive
cells per 0.2mm2.
4.2.4 ELISAfor GMCP
Tissue homogenates prepared in a 1,5M NaCl 20mMTris buffer as described
in Chapter 2.3.3 were tested on a double antibody sandwich ELISA for GMCP as
described in Chapter 3. using the protocol outlined in Chapter 2.12.1. Final results
were quoted as pg GMCP/g wet weight tissue.
4.3 Results
The mean (+SD) results for the toluidine blue, carbol chromotrope, anti-
GMCP and anti- human tryptase cell counts along with their respective tissue GMCP
concentrations are shown in Table 4.1. Overall, toluidine blue, anti-GMCP and anti-
human tryptase staining cells as well as detecTable levels ofGMCP were identified in
every tissue tested except the trachea. In this tissue, mast cells were not found on any
of the sections examined. Histochemical staining with carbol chromotrope identified
GL in gastro-intestinal tissues only, where they were found in all areas except the
colon. As previously (Chapter 3), both intestinal mast cells and GL stained positive
using antibody to GMCP (as well as antibody to human tryptase, Fig. 4.3). Therefore,
for comparative purposes the results for toluidine blue stained MMC and carbol
chromotrope stained GL in gastro-intestinal tissues were combined to give a 'total
mast cell' count. In the gastro-intestinal tissues the highest total mast cell counts were
obtained for the jejunal tissues (26.2 cells/VCU) which also corresponded with the
highest counts for tissues stained with anti-GMCP (18.9 ± 0.3 cells/VCU). Apart
from the intestine, the highest mast cell counts obtained for toluidine blue stained











Anti-human pg GMCP per





Abomasum 6.7 (±2.7) 2.9 (±2.5) 2.8 (±2.1) 6 (±2.1) 0.2 (±0.09)
Duodenum 14.6 (±2.5) 7.6 (±1.8) 18.3 (±5.0) 7.7 (±2.2)a>b 8.2 (±1.3)
Jejunum 16.1 ( ±0.9) 10.1 (±1.8) 18.9 (±0.4) 8.7 (±3.4)a=b 7.8 (±1.4)
Ileum 10 ( ±1.4) 1.7 (±1.8) 9.8 (±1.3) 7.3 (±0.8) 0.6 (±0.08)
Colon 4.4 ( ±1.5) 0 4.1 (±2.6) 5 (±0.6) 0.1 (±0.02)
Mesenteric 13.5 (
lymph node
±3.5) 0 9.9 (±2.68) 11.2 (±3.0) 3.8 (±3.0)
Respiratory
tissues
T rachea 0 0 0.1 (±0.1) 0 0
Lung 18.1 ( ±5.4) 0 0.9 (±0.6)a 2.2 (±1.2)a 0.05 (±0.02)
Bronchial 16.5 (
lymph node
±3.0) 0 2.9 (±1.2)a'b 10.5 (±2.3) 0.3 (±0.1)
Other
tissues
Skin 12.6 ( ±2.7) 0 0.3 (±0.2)a-b 10.2 (±3.3) 0.04 (±0.03)
Liver 6.5 (±1.6) 0 0.1 (±0. l)a 0.8 (±0.5)a 3.29 (±1.2)
Spleen 4.8 (±0.8) 0 2.3 (±1.5) 2.3 (±0.8) 0.09 (±0.08)
Heart 1.8 (±0.5) 0 1.6 (±1.2) 0 6 (±0.4)a 0.05 (±0.04)
Table 4.1 Mean (±SD) results for tissue cell counts and tissue GMCP concentrations.
Figures for intestinal tissue cell counts are expressed as per VCU Figures for all other
tissues are expressed as per 0.2mm2. Figures for GMCP ELISA are expressed as pg/g
wet weight tissue. Superscripts denote significance, a = significantly fewer positive
cells than the equivalent toluidine blue or total mast cell counts; b = significantly fewer
positive cells than the equivalent anti-GMCP or anti-tryptase stained tissues. See text
for p values
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There were fewer GMCP-positive cells in comparison to toluidine blue stained
cells in the bronchial lymph node (p < 0.005, Fig. 4.4a and b), liver (p < 0.005), skin
(p < 0.005; Fig 4.4d and e) and lung (p <0.01) whilst, there were fewer anti-tryptase
positive cells compared to total mast cells or toluidine blue stained cells in the
duodenum (p < 0.05), jejunum (p < 0.05), liver (p < 0.005), heart (p < 0.05) and lung
(p < 0.005). Comparisons between tissues stained with anti-GMCP and anti-tryptase
also demonstrated significant differences in the numbers of positive cells in the
duodenum (p < 0.05), jejunum (p < 0.01), bronchial lymph node ( p < 0.01; Fig 4.4 b
and c) and skin (p <0.01; Fig. 4.4e and f) but not the lung or liver (p > 0.05). No
statistically significant differences between the numbers of cells staining
histochemically or immunohistochemically were observed in the other individual
tissues examined.
Figure 4.1 shows that there was a strong positive correlation (R^ = 0.90, p <
0.0001) between toluidine blue positive mast cell numbers and GMCP-positive cell
counts from the gastro-intestinal tissues. This was slightly stronger than the
correlation obtained between the total mast cell counts and the GMCP-positive cell
counts (R.2 = 0.88, p < 0.0001) (not shown). The relationship was maintained when
comparing toluidine blue positive mast cell numbers with anti-GMCP cell counts for
all tissues except the respiratory tissues, liver and skin (R^ = 0.77, p < 0.0001; Fig
4.2), but fell markedly (R^= 0.27, p < 0.001; Fig. 4.2), when counts from these
tissues were included in the regression calculation.
In terms of tissue protease concentrations, both the duodenum and jejunum
contained significantly more GMCP (8.2 + 0.8 and 7.8 ± 0.8 pg/g p < 0.05; Table
4.1) than any other tissue except the mesenteric lymph node (3.8 ± 1.7 pg/g). Apart
from gastro-intestinal tissues, the liver also contained relatively large amounts of
GMCP (3.29 ±0.7 pg/g).
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Fig. 4.1 Comparison of the numbers of toluidine blue stained mast cells and GMCP-
positive mast cells in the gastrointestinal tract (abomasum, duodenum, jejunum, ileum
and colon). Each point represents the counts for sequential sections from an individual
tissue (R2 = 0.90, p < 0.0001)
No. Toluidene blue-positive mast cells
Fig. 4.2 Comparison of the numbers of toluidine blue stained mast cells and GMCP-
positive mast cells in all tissues. Each point represents the counts for sequential
sections from an individual tissue. The solid points (•) represent the counts for all
tissues except the respiratory tissues, liver and skin (R^ = 0.77, p < 0.0001). The
clear points (°) represent the counts from the respiratory tissues, liver and skin. When
these tissues are included in the regression calculation, the correlation co-efficient
drops to R2 = 0.27; p < 0.001 (line not shown).
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Figure 4.3a Anti-human tryptase positive cells in a goat jejunal villus. Note the similar
anatomical distribution and morphology to cells reacting with polyclonal anti-GMCP
in Chapter 3 (Fig 3 .8b). Note also the presence of a positive staining intra-epithelial
GL Tissue fixed in 4% paraformaldehyde (x 400).
Figure 4.3b Negative control section incorporating normal rabbit serum diluted 1.500
in place of the anti-tryptase primary antibody. Tissue fixed in 4% paraformaldehyde (x
400).
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Figure 4.4 (following pages) Goat bronchial lymph node (a, b and c) and dermis (d, e
and f) stained with toluidine blue (a and d); anti-GMCP (b and e) and anti-human
tryptase (c and f). Note the lack of cells staining positive in tissues incubated with
anti-GMCP (arrows); compare with the numbers of faintly positive cells in tissues
stained with toluidine blue (arrows) and and the numbers of strongly positive cells in
tissues incubated with anti-human tryptase. Negative controls for the immuno-
localised tissues incorporating normal rabbit serum diluted 1:500 in place of the
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Mast cells were detected with toluidine blue, polyclonal anti-GMCP antibody
and anti-human tryptase antibody in all tissues examined except the trachea. In
addition, GL could be detected histochemically in the gastro-intestinal tissues from the
abomasum to the ileum with the highest numbers ofGL relative to the total mast cell
counts found in the abomasum, duodenum and jejunum. It is interesting to note, that
these areas would have been exposed to the highest numbers of T. circumcincta and
T. vitrinus during the challenge period prior to slaughter. Direct exposure to
nematodes, may therefore influence the prevalence of this particular cell type in these
tissues. Immunohistochemical staining also demonstrated that many GL contained
GMCP and/or a putative goat tryptase enzyme, further suggesting that the cells are
closely related to and derived from the same cell lineage as MMC (see also Chapter 3
and Chapter 8). Regression analysis demonstrated that the numbers ofGMCP-
positive cells correlated best with cell counts from histochemically stained tissues
from the gastro-intestinal tract, although the relationship was slightly better for the
toluidine blue counts for MMC (R^ = 0.90) than the combined toluidine blue and
carbol chromotrope (total mast cell) counts for both MMC and GL ( R^ = 0.88). This
indicates that not all GL contained GMCP, although, as outlined in Chapter 3, many
GL stained relatively faintly with anti-GMCP (Fig. 3.8 a and b). This possibly
reflected their low mediator content, which would be expected for MMCs that had
already degranulated (Huntley et al. 1984a). As a result, some poorly staining cells
may have been missed when counting cells on sections stained with anti-GMCP.
In the lung and the liver, despite the presence of relatively high concentrations
ofGMCP, significantly more MMC were detected with toluidine blue than with anti-
GMCP or anti-tryptase. The reasons behind this remain unclear, although it may
indicate the presence ofmast cells containing neither GMCP or tryptase, or a very
sparse population of cells containing extremely high concentrations ofGMCP per cell.
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However, a more likely explanation is that the 4% paraformaldehyde /PBS fixative
used to prepare the tissues blocked antibody binding in these sections. This problem
has also been encountered with ovine lung parenchyma fixed in 10% formalin (D.
Collie, personal communication). In this case, the tissue sections required treatment
with 0.1% porcine trypsin prior to staining positively with the same batch of
polyclonal anti-human tryptase. Given the prominence of tryptase reactivity in the
goat bronchial lymph node tissues (Fig. 4.4c), it is possible that the goat lung
parenchyma also contains substantial populations of tryptase staining cells. Further
work is therefore required to optimize the fixation and/or staining conditions for
antibody binding in these tissues.
The highest concentrations ofGMCP were found in the duodenal and jejunal
tissues. This is in agreement with the abomasal and jejunal tissue surveys carried out
in Chapter 3. These tissues also had a higher concentration ofGMCP calculated on a
per GMCP-positive cell per VCU basis (0.44 and 0.41 pg/g/cell/VCU) than the ileum
and colon (0.061 and 0.024 pg/g/cell/VCU). Unfortunately, due to the different
counting method required for enumerating cells in the abomasum (cells/0.2mm^
instead of cells/VCU), these values could not be related directly to the protease
concentrations per cell per counting area in this tissue. Since the animals were infected
with a mixed population of abomasal and small intestinal worms, the higher values for
the upper small intestine may indicate increased upregulation and/or storage of GMCP
in individual MMCs in response to nematode exposure. However, in the absence of
worm-free control animals for comparison, this may also indicate that the mast cells in
this area merely contain intrinsically higher levels of protease than mast cells from
other areas of the intestine.
The linear regression results comparing counts for toluidine blue and GMCP-
positive cells from different tissue sites indicate that GMCP is present in a high
proportion of toluidine blue-positive cells in all tissues except the respiratory tissues,
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liver and skin. The finding that relatively low numbers of cells stained for GMCP in
the skin and liver was in agreement with the previous findings of Sture et al. (1996)
for the distribution of SMCP in sheep. The current study also suggests that goat mast
cells in the bronchial lymph node and possibly the lung are relatively deficient in
GMCP, although as discussed above, immunoreactivity in the liver and lung may be
poor due to problems with tissue fixation.
Although weak staining for GMCP was observed in the skin and bronchial
lymph node, this was not demonstrated when the equivalent tissues were stained with
anti-human tryptase antibody indicating that, in these tissues, the method of fixation
was unlikely to be a problem. Here, significantly more cells with an equivalent
morphology and anatomical position to the toluidine blue stained cells were positive
after incubation with anti-tryptase than with anti-GMCP antibody (Fig 4.4 a-f).
Accurate interpretation of results obtained using heterologous antibody is difficult,
but the ability to stain the majority ofmast cells in these tissues may indicate
heterogeneity in terms of the distribution of GMCP and a putative goat mast cell
tryptase. If so, these findings show that toluidine blue-positive cells in majority the of
tissues examined contain chymase and/or tryptase. However, in the bronchial lymph
nodes, skin and possibly the lung and liver, the majority of cells appear to contain
tryptase with a minority of cells containing GMCP. In contrast, in the remaining
tissues, including those in the gastro-intestinal tract, the majority of the cells appear
to contain both GMCP and tryptase. At present, it is not possible to determine how
GMCP and the putative goat mast cell tryptase enzyme are distibuted amongst mast
cell populations in individual tissues. However, dual immunofluoresence studies could
investigate this by using mouse monoclonal antibody to GMCP (Chapter 3) and the
rabbit anti-human tryptase antibody. Future efforts should also be directed at the
further characterisation of the putative goat mast cell tryptase enzyme. Such studies
will be required to more fully define the enzyme's role in vivo, as well as enable the
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THE CLONING AND SEQUENCING OF cDNA FOR GMCP
5.1 Introduction
Revolutionary techniques in molecular biology have enabled researchers to
characterise proteins through the interpretation and manipulation of genetic
information that co-ordinates and encodes their synthesis. This has produced major
insights into the regulatory, structural and functional properties of biological
compounds in ways that are not feasible using conventional purification and
biochemical techniques alone. The genomic and complementary DNA (cDNA)
sequences for a number ofmast cell neutral granule proteases have already been
determined in a number of species (Table 5.1, page 146). These studies have proved
particularly useful, allowing predictions to be made regarding molecular size, net
charge, presence of potential glycosylation-sites and tertiary structure. This last point
is particularly important with regard to enzymes, since in conjunction with computer
modelling and crystallisation studies, such information allows detailed analyses of the
enzyme's active site.
Active site conformation has important implications for defining the enzyme's
catalytic activity and substrate specificity, which may be attributed to the shape and/or
presence of certain charged amino acid residues within the substrate binding pocket.
In this instance, it will be particularly relevant to examine this feature ofGMCP and
SMCP, since they have both been shown to exhibit an unusual dual substrate
specificity (Chapter 3; Pemberton et al., 1997a). Further information on the structural
requirements for potential substrates may also help to define the role of these
proteases in vivo.
In addition to predicting amino acid sequences, labelled cDNA probes may
also be used to detect the presence ofmRNA for proteases within tissues under
investigation. In studies involving mast cell proteases, reverse transcriptase-
polymerase chain reactions (RT-PCR) analysis may prove advantageous, enabling
measurements to be made on the comparative levels of protease mRNA synthesis in
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tissues rather than direct enzyme concentrations in tissues, serum or lymph by
ELISA. This may circumvent the problem of obtaining artificially low ELlSA results
for mast cell proteases due to the presence of protease inhibitors (Huntley, 1991) or
possible differences in the kinetics of protease synthesis, storage and release from
MMC in both species (see Chapter 6).
Molecular probe techniques have also been used on rodent and murine RNA
samples obtained in vivo from tissues as well as in vitro from BMMC and tranformed
cell lines. They have been able detect the presence of transcripts for proteases that are
either only transiently expressed during cell maturation or are not normally expressed
as a protein product. These include the mouse tryptase enzyme MMCP-7 which was
initially found only in early murine BMMC cultures (McNeil, Reynolds, Schiller,
Ghildyal, Gurley and Stevens, 1992) and MMCP-L (a mouse mast cell like protease)
which has yet to be detected as a protein despite having a high predicted amino-acid
homology with other murine mast cell chymases (Serafin et a!., 1991). The finding
that mast cells contain carefully regulated genomic information for synthesising a wide
variety of proteases has stimulated recent studies examining the mechanisms
controlling protease expression in vivo and in vitro (reviewed Springman and Serafin,
1995). These have been undertaken to examine the processes involved in producing
phenotypic heterogeneity amongst mast cells in vivo, where the differences in
protease expression of are an important distinguishing characteristic for certain mast
cell subsets (reviewed, Huntley, 1992). Most results have now implicated cytokines,
particularly those produced locally within the peripheral tissues, as being important
for regulating protease transcription in mast cells undergoing the final stages of
differentiation. However, the precise intra-cellular pathways and genomic regulatory
elements involved are still largely unknown (reviewed Springman and Serafin, 1995).
As yet, only one mast cell chymase has been isolated from the sheep (Huntley et al.,
1986) and the goat (Chapter 3) although immunohistochemical studies heve
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demonstrated that heterogeneity in terms of mast cell protease content occurs in
sheep (Sture el al. 1995) and the goat (Chapter 4). Therefore, it will be interesting to
see if molecular analysis of sheep and goat mast cell DNA libraries also uncovers the
presence of a family of genes coding for further proteases.
A further advantage of isolating genomic or cDNA for proteins expressed in
low concentrations in vivo, is the ability to insert this DNA sequence into a bacterial
or mammalian expression system, enabling the protein to be expressed in larger
quantities in vitro. This approach may be relevant in the case ofGMCP which is
present in low concentrations in gastro-intestinal tissues in vivo (Chapter 3), making it
difficult to obtain sufficient amounts for ELISA and biochemical characterisation
studies. For the latter, the use of a mammalian expression system would probably be
desirable to reproduce post-translational processing modifications that may occur as
the translated protein acquires the correctly folded tertiary structure exhibited by the
mature, active enzyme in vivo.
In summary, it can be seen that there are distinct advantages to be gained by
unravelling the cDNA structure for GMCP. The aim of this Chapter is to achieve this
by isolating RNA from caprine BMMC that have been grown in vitro using rOvIL-3
and rOvSCF. These cytokines have been shown to produce populations of ovine and
caprine mast cells from bone marrow progenitor cells (Sture, 1996, Chapter 7).
BMMC were chosen as a source material for two reasons; firstly, the presence of
immature mast cells can be demonstrated as early as day 2 in the cultures and they
increase rapidly in number to make up approximately 80% of the total cell population
by day 16 (Chapter 7) and, secondly, these cells also express GMCP by day 2
(Chapter 7). The use of these cells should therefore maximise the chance of
extracting GMCP specific mRNA from the cell pellet preparations.
The majority of the work described in this Chapter was performed at the
Royal (Dick) School of Veterinary Studies (RDSVS), in the laboratories of Professor
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Hugh Miller. Many of the primers and probes used for amplifying and blotting of the
goat RNA and DNA samples were very kindly provided by Dr. S. Macaleese who was
simultaneously working on sequencing the cDNA for SMCP. The results obtained
here will therefore compare the sequences obtained for GMCP with those obtained
for SMCP. This will provide further comparative data on the molecular characteristics
ofmast cell proteases present in these two species.
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Mast Cell Proteases References
Chymases
Mouse mast cell protease-1 (MMCP-1) Huang, Blom and Hellman, 1991*
Mouse mast cell protease-2 (MMCP-2) Serafin, Reynolds, Rogelj, Lane, Conder, Johnson,
Austen and Stevens, 1990
Mouse mast cell protease-4 (MMCP-4) Serafin, Sullivan, Conder, Ebrahimi, Marcham,
Johnson,Austen, and Reynolds, 1991*
Mouse mast cell protease-5 (MMCP-5) McNeil, Austen, Somerville, Gurish and Stevens,
1991*
Mouse mast cell protease-L (MMCP-L) Serafin, Reynolds, Rogelj, Lane, Conder, Johnson,
Austen and Stevens, 1990
Human chymase Caughey, Zerweck, and Vanderslice, 1991*
Rat mast cell protease II (RMCP II) Sarid, Benfey and Leder, 1989*
Dog chymase Caughey, Raymond and Vanderslice, 1990*
Trvptases
Mouse mast cell protease-6 (MMCP-6) Reynolds, Gurley, Austen and Serafin, 1991
Mouse mast cell protease-7 (MMCP-7) McNeil, Reynolds, Schiller, Ghildyal, Gurley, Austen
and Stevens, 1992
Human tryptase-a Miller, Westin and Schwartz, 1989
Human tryptase-p Vanderslice, Craik, Nadel and Caughey, 1989
Human tryptases I, II and III Vanderslice, Ballinger, Tarn, Goldstein, Craik and
Caughey, 1990
Dog tryptase Vandcrslice, Craik, Nadel and Caughey, 1989
Table 5.1 References for selected mast cell serine esterase enzymes from a variety of
species whose genomic or cDNA sequences have now been determined. *chymase
sequence data used for the initial construction of SMCP primers based upon areas of
consensus between the species
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5.2 .Mapping of oligonucleotide sequences used for priming and blotting
Figure 5.1 represents an entire cDNA sequence obtained for SMC? cDNA
showing the positions of oligonucleotide sequences (coloured letters) used as primers
for amplifying the goat cDNA templates, as well as for hybridising to check the
specificity of the resulting PCR products Primers PI. P2, P3 and P4 were initially
synthesised by J. Handley at the RDSVS, based upon areas of consensus in previously
published cDNA sequences for rodent (RMCP II). murine (MMCPs 1. 4 and 5),
canine and human mast cell chymases (Sarid et a/., 1989, Huang el al.. 1991; Serafin
el al1991; McNeil el al., 1991, Caughey el al. 1990 and Caughey el al. 1991)
(Table 5,1). In addition, a number of degenerate primers (not shown) were also
synthesised from the NHo-terminal amino acid sequences published for isolated
SMCP (Pemberton el al 1997a) and bovine duodenase (Zamolodchikova el al.
1995b). All subsequent primers were synthesised on the basis of results obtained from
sequencing cloned SMCP and GMCP cDNA fragments. Also depicted in Fig. 5.1 are
the positions of the start and stop codons. indicating the start of the signal peptide
sequence and the end of the mature protein sequence. The position of nucleotides
encoding the pro-peptide G-E residues associated with an inactivated form of the
enzyme which exists prior to activation and storage within the mast cell granule
(LJrata, Karnik, Graham and Husaiti, 1993) are also shown. This dipeptide is
positioned immediately before the start of the mature enzyme peptide sequence which
possesses the classical 1-1-G-G tetra-peptide sequence found in the majority of
chymase enzymes (Springman and Serafin, 1995).
§ ' Pi
CX.CCCCTCGCCAGCCTCTCTGAGAAG .1 .i
CCCGGGACX fcGXCf.GAGAGACTCTT C GTAGCAGt ;AGGAGAGGGCGACCACGAGGAOS
iKMC.'P/SMCT* I pr x trier,
ATCATCGGGGGCCAYGAGC
CTCTOCTGCAGAGCC.C.AGGCT • A J WVr™'GG,%G,""rCAO iGAfACrC.AAGCCACAC.
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Fig. 5.1 Complete cDNA sequence for SIV!CP 11 showing the positions of the primers used
for amplifying and probing the GMCP DNA fragments. The positions of the start and stop
codons are shown in red, along with the nucleotide sequence present at the start of the
inactivated SMCP pro-enzvme and the 3' polyA tail. Also shown are the positions of 2
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Fig. 5.2 Fragment assembly of GMCPII sequence data showing the positions of the
amplified GMCP II cDNA fragments relative to one another. Sequences compared
with a GMCPII clone (consensus) containing the entire GMCP II cDNA sequence.
5.3 Sequencing strategy
This was designed to follow closely the successful strategy used previously for
the isolation of a cDNA sequence for SMCP (S.M.Macaleese, personal
communication), and initially involved sequencing the GMCP cDNA as 3 separate
fragments. The first fragment, termed the central fragment, was isolated to give a
sequence for the region lying between the P3 and P9 primers. This was followed by a
3' fragment covering the region between P8 and RACEdT primers and finally a 5'
fragment covering the areas between PI5 primer and the signal peptide sequence
(Figs. 5.1 and 5.2). Once the sequences of these 3 fragments were checked for
homology with sequences obtained for SMCP, primers specific for the 5' and 3' ends
were constructed to allow the production of amplified clones containing the entire
GMCP sequence. This complete sequence was then used to confirm the position and
content of the initially obtained sequence fragments (Fig 5.2), as well as to provide a
whole enzyme cDNA probe for further cDNA hybridisation or tissue mRNA
hybridisation (Northern blotting) studies.
5.4 Results
5.4.1 Isolation ofRNA
Caprine bone marrow cells for mRNA extraction were harvested from cultures
fed with optimal concentrations of recombinant ovine interleukin-3 (rOvIL-3) only, or
rOvIL-3 and recombinant ovine stem cell factor (rOvSCF), as outlined in Chapter 7.
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Cells (5 x 106), were removed from each culture on day 2, day 5 and day 7 and
lysed in 1ml Tri-reagent (Sigma Cat. No. T 9424) before storing at -70 °C. The
samples were subsequently processed to extract the total RNA as outlined in Chapter
2.7.1. Samples from the isolated preparations were separated on a formaldehyde gel
to check the integrity of the RNA (Fig. 5 .3). Cells grown in rOvIL-3 alone and
harvested at day 7 contained significantly more total RNA than the other samples
(Fig. 5.3; lane 3). Therefore, this sample was chosen for construction of a cDNA
library by following the reverse transcription (RT) protocol for the central and 3'
GMCP fragments using a random hexamer primer as outlined in 2.7.4. All
subsequent polymerase chain reaction (PCR) amplification steps were carried out as
described in Chapter 2.7.5.
123456789
Fig. 5.3 Formaldehyde gel of total RNA preparations from goat BMMC Lanes 1 and
6 RNA standards. Lanes 2, 3 and 4; day2, day7 and day 12 BMMC grown in rOvIL-
3 only. Lanes 7, 8 and 9; day 2, day7 and day 12 BMMC grown in rOvIL-3 and
rOvSCF.
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5.4.2 Cloning the centralfragment ofGMCP DNA
Products from the RT reaction were initially amplified in the presence of ovine
PI and P5 primers. However when these were separated on a 0.8% agarose gel bands
were not evident in any of the samples. The primary PCR products were therefore re-
amplified using P3 and P9 which both lie internal to PI and P5 (Fig. 5.1). This time, a
1.5 kilobase pair (kb) band was present (Fig 5.4 lanes 2 - 4), indicating that a second
amplification step had been required to increase the DNA concentration of the
primary PCR products to levels sufficient for visual detection. An agarose gel
containing samples of this secondary PCR product was Southern blotted and probed
with a digoxigenin labelled P4 (P4-dig) probe (Fig. 5.1), to test whether the fragment
contained the correct sequence for a mast cell protease. The blotted sample gave a
positive 1.5kb band (Fig 5.5 lane 2) and aliquots of the secondary PCR product were
ligated into an Invitrogen 3.9kb pCR™2.1 plasmid before transforming into E. coli
for cloning as outlined in Chapter 2.7.11. After purification and restriction enzyme
digestion of the cloned plasmid DNA (see 2.7.12 and 2.7.13), the digested samples
were separated on a 0.8% agarose gel, Southern blotted and again re-probed with P4-
dig to check that the cloned plasmids contained the correct DNA inserts. The EcoRI
digest product representing the PCR product removed from the plasmid gave positive
1.5 kb bands for 3 clones. DNA quantification was performed on these samples (see
2.7.14), and an aliquot was sent for sequencing.
The size of the cloned band (1,5kb) was approximately 3 times larger than that
predicted from the equivalent 445 bp P3 to P9 fragment isolated from SMCP (Fig.
5 .1) indicating that the clone was probably the amplified product of either
unprocessed mRNA or genomic DNA, and not cDNA. This was confirmed when the
forward and reverse analysis of the GMCP clone demonstrated the presence of two
introns in the cloned fragment at the sites shown on Fig. 5.1. The first intron was so
large, that its entire sequence was not determined and therefore it's size remains
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unknown. However, the second intron found in the sequence from the reverse primer
was shorter, containing only 375 bp before the coding region of the neighbouring
exon could again be detected.
The potential presence of contaminating heteronuclear DNA in the cell total
RNA preparations and the subsequent RT reaction products indicated that, in order
generate a cDNA sequence for GMCP, the mRNA component would have to be
purified from the total RNA. This was achieved by fractionating total RNA samples
on a commercial oligodT cellulose column (see Chapter 2.7.2), which selectively
binds the 3' polyA sequences present in mRNA. The integrity of the eluted mRNA
fraction was checked on a formaldehyde gel, before repeating the RT reaction using a
RACEdT primer in place of the previously used random hexamer primer. This primer
also selectively binds to polyA mRNA sequences, ensuring that they undergo
preferential reverse-transcription to produce maximal amounts of cDNA, with
minimal genomic DNA contamination. These mRNA selected RT products were
amplified twice using the ovine PI and P9 primers used above, followed by two new
primers constructed from the first goat DNA sequence results termed GP1 and GP2,
which are found internal to P3 and P9 (Fig. 5.1). After the second amplification, a 400
bp band could be detected on a 0.8% agarose gel (Fig. 5.4 lane 7), indicating that it
was the correct size for the required cDNA sequence based upon predictions from the
previously obtained SMCP sequence (Fig. 5.1). This was confirmed by Southern
blotting and probing with P4-Dig, which also produced a strong band at 400 bp (Fig.
5.5 lane 4). The amplified sample was ligated into the Invitrogen 3.9kb pCR™2.1
plasmid and cloned as described previously. Following restriction enzyme digestion of
the plasmid DNA, blotted samples were again probed with P4-dig to confirm the
presence of the required 400 bp cDNA inserts and positive samples were sent for
sequencing. The results confirmed the presence of a 398 bp fragment without the
intron sequences found in the previous samples. This fragment was aligned with the
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previously obtained equivalent SMCP cDNA sequence using the GCG sequence
analysis software (Chapter 2.14.2) and demonstrated a 94.3 % homology between the
two sequences.
1 2 3 4 5 6 7
1 kb -
Fig. 5.4 0.8% agarose gel of PCR amplification products for the central fragment of
GMCP II. Lane 1; DNA standards. Lanes 2,3 and 4; second PCR amplification from
the total RNA RT reaction product showing the 1.5kb central fragment. Lane 6; first
PCR from the mRNA selected RT reaction product. Lane 7; second PCR






Fig. 5.5 Southern blot of the 1.5kb and mRNA selected PCR products for GMCP II
probed withP4-dig. Lane 1; DNA standards. Lane 2; 1.5kb central fragment. Lane 3;
primary amplification of mRNA selected RT product using PI and P9. Lane 4;
secondary amplification of the PI and P9 amplification products using GP1 and GP2
showing a 400bp cDNA fragment which was cloned and sequenced.
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5.4.3 Cloning of the 3'fragment ofGMCP cDNA
The mRNA selected RT products prepared above, were amplified twice using
PI 1 and RACEdT followed by P8 and RACEdT (Fig 5.1). This was designed to
amplify selectively the 3' region of the GMCP cDNA present in the RT product.
Following primary amplification, faint smeared bands were present on a 0.8%
agarose gel. However, after re-amplification with P8 and RACEdT a strong band of
approximately 400bp was observed which also reacted positively following Southern
blotting and probing with a digoxigenin-labelled P9 probe (P9-dig). The sample was
ligated and cloned as previously, and the resulting restriction enzyme digests of the
purified plasmid DNA again blotted and re-probed with P9-dig to check for positive
insertions ofGMCP 3' cDNA (Fig. 5.6). Samples with positive inserts sent for
sequencing were returned as a 440bp sequence which, on alignment, overlapped






Fig. 5.6 Southern blot of restriction enzyme digests of cloned and plasmid ligated 3'
GMCP II cDNA fragments probed with P9-dig. Lane 1; DNA standards. Lanes 2, 5
and 8; undigested plasmid. Lanes 3, 6 and 9; NotI linearised plasmids. Lanes 4, 7 and
10; EcoRI digested plasmids showing the free 400bp 3' cDNA inserts.
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5.4.4 Cloning of the 5'fragment ofGMCP cDNA
PCR amplification of the 5' segment of cDNA was hampered by the lack of
primers specific for the 5' non-coding signal peptide sequences which lie upstream of
the regions that encode the mature enzyme. A number of primers have already been
synthesised on the basis ofNH^-terminal amino acid sequences obtained from samples
of isolated SMCP and bovine duodenase. However, these were unable to amplify
fragments from the ovine cDNA libraries, possibly as a result of their inherent
degeneracy (S. Macaleese, personal communication). In any case, the use of primers
based on the NH2-terminal mature protein sequences alone would not allow the
production of amplified clones containing signal peptide sequences which may be of
importance in dictating the final cellular destination of the translated enzyme.
This problem was overcome by artificially tailing of the 5' ends of the mRNA
selected RT preparations with polyA sequences, before amplifying them in a similar
way to the naturally polyA-tailed 3' cDNA sequences. The poly A tailing reaction was
carried out out using a commercial 5'/3' RACE (Rapid Amplification of cDNA Ends)
kit (Boerhinger Cat. No. 1 734 792), according to the manufacturer's instructions.
The kit involves an additional cDNA purification step for the RT products before
tailing the 5' ends of the resulting cDNA fragments with polyA sequences using
terminal transferase. The tailed sequences were then amplified twice using a special
oligodT anchor primer provided in the kit, which is functionally identical to the
RACEdT primer used previously for RT reactions and the 3' fragment amplifications.
In the first amplification, P14 was used with the oligo dT anchor primer, resulting in
the production of a faint 225kb band. The sample was re-amplified using PI 5 and
oligo dT which produced a thick smear of bands with the strongest lying in the 100-
200kb range. The gel was blotted and probed with digoxigenin labelled P12 (P12-dig)
which produced thick bands for both the primary and secondary amplification
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products at approximately 225kb and 200kb respectively. The secondary amplification
product was ligated, cloned and sequenced as previously, returning a 185bp fragment
that demonstrated a 91.1% identity with the SMCP cDNA sequence (Fig. 5.7).
5.4.5 The production ofafull length cDNA clonefor GMCP
After the sequence results obtained from the GMCP cDNA fragments, it was
necessary to produce a full length GMCP cDNA clone to confirm the relative
positions of the GMCP cDNA fragments as well as their nucleotide sequences. This
was achieved using a combination of a P19 primer developed from a 5' signal
sequence obtained for SMCP, along with P20 and P22 primers which are specific for
the areas that incorporate and lie external to the SMCP cDNA stop codon (Fig. 5.1).
The mRNA selected RT products were amplified initially with P19 and P22 followed
by PI 9 and P20. The second PCR amplification produced a band of approximately
700bp which was ligated and cloned as described previously. Clones were selected by
probing Southern blots ofEcoRI digested plasmid DNA with P12-dig before sending
for sequencing. The sequence results showed that the cDNA insert contained 714 bp,
which was 37 bp less than the equivalent SMCP cDNA sequence. When the
sequences were aligned with the concatenated GMCP cDNA fragments, it could be
seen that this deficit was due to a loss of nucleotides between C^7 and T-^ (Fig.
5.7). Despite this, the cloned fragment still showed a 92 % identity with the SMCP
cDNA and an 87 % identity with the concatenated GMCP cDNA fragments. The
identity between the full length GMCP cDNA clone and the combined GMCP cDNA
fragments was lower than that shown between the full length GMCP cDNA and the
SMCP cDNA sequences, due to marked differences in the signal peptide coding
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Fig. 5.7 Comparison of the 5' nucleotide sequences for the full length GMCP II
(GMCP2) clone, SMCP II (smcp2) and the 5' GMCP II cDNA fragment (gmcp2con)
The position of the start codon is shown in red. The markedly different signal peptide
sequence obtained as a result of the amplification with the oligodT primer is shown in
bold type. Note also the missing nucleotides in the GMCP II sequence shown as red
dots.
5.4,6 Protein translations ofthe (iMCP and SMCP cl)NA sequences
The nucleotide sequences obtained for SMCP cDNA. the whole GMCP
cDNA clone and the GMCP cDNA fragments were translated in the 5' to 3' direction
for the three possible forward reading frames. In all three sequences, a G-E pro¬
peptide followed by the f-I-G-G tetra-peptide was noted for one of the reading
frames. This reading frame was also in phase with the ATG start codons present in the
SMCP cDNA and whole GMCP cDNA sequences (Fig 5.7), indicating that the
resulting translation was correct for the signal peptide sequence as well as the pro-
and mature enzyme amino acid sequences. The protein translations were aligned to
one another and it was found that the GMCP full length clone exhibited 97% and
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96.7% identity with the SMCP cDNA and the combined GMCP fragment cDNA
translations respectively (Fig. 5.8). However, when these sequences were compared
with the NH2-terminal amino acid sequences for isolated SMCP (Pemberton et al.,
1997a), isolated GMCP (Chapter 3) and the complete amino acid sequence for
isolated bovine duodenase (Zamolodchikova et al. 1995b) it was found that they
exhibited much less homology. This included an overall identity of only 53 %
occurring between the whole deduced GMCP peptide sequence, and the whole
isolated bovine duodenase peptide sequence (Fig. 5.8).
This indicated that the cDNA sequences isolated for SMCP and GMCP may
code for separate, albeit related, proteins to those isolated from ruminant intestinal
mast cells in vivo. On the basis of this, these potentially novel proteases were
designated as SMCP II and GMCP II and an alternative strategy was initiated to
isolate and clone cDNA sequences coding for their isolated intestinal equivalents now
termed SMCP I and GMCP I.
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qffivp2 GEIIGCTEY-K PHSRPiM ACGGFLIRRP FVLTAAHCAG
smt'p2 GEIIGGTE3K PHSRPYMAYL EISTSQtiKQV ACGGFLIRRD FVLTAAHCAG
grncplcon GEIIGGTESK PHSOPYMAYL EIVTSREKQV ACGGFLIRRD FVLTAAHCAG
Boy ciuocJ 11GGHEAK PlfBRPYHAFL LFKT3. 5KSH ICGGFLVREL. FVLTAAHCLG
Xsoi. SMCP 11GGHEAK PH3RPYMAFL QFKISGK3YR FG


































































































Fig. 5.8 Deduced amino acid sequences from the SMCP II (smcp2) and GMCP II
(gmcp2 and gmcp2con) cDNA sequences compared with NH2-terminal amino acid
sequences obtained from isolated SMCP (Isol SMCP) and GMCP (Isol GMCP) as
well as the whole amino acid sequence for isolated bovine duodenase (Bov Duod) (all
shown in standard single letter notation). Note the high degree of identity between the
deduced amino acid sequences for SMCP and GMCP and their poorer identity with
the amino acid sequences from the isolated proteases. ? = undetermined residue; * =
stop codon site.; green residues = potential glycosylation sites. The catalytic triad of
His, Asp and Ser residues are shown in blue whilst the S ] active site residues are
shown in red. The standard chymotrypsinogen numbered positions of these residues
are shown above in red. Note also the position of P2 which shows consensus with
GMCP II, SMCP II and bovine duodenase.
5.4. 7 Isolation and cloning ofa cDNA sequence for GMCP I
This was achieved using codon usage information from the SMCP II and
GMCP II nucleotide sequences to synthesise a primer specific for the homologous
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residues in the isolated NH^-terminal sequences for GMCP I and SMCP I as well as
by examining the ability of a full length GMCP II probe to hybridise with the
resulting blotted PCR products under different conditions of stringency. The NH2-
terminus primer (P26, Fig. 5.1) was synthesised to match the nucleotides coding for
the I-I-G-G region ofGMCP II, but in place of the nucleotides coding for the
subsequent T residue, a degenerate codon for the H residue found in the isolated
SMCP I and bovine duodenase NH2-terminus sequences was inserted (Fig 5.9). This
was followed by a codon for the E residue that matched the codons found in the
GMCP II and SMCP II sequences and finally two thirds of a codon for the
subsequent A residue found in GMCP I, SMCP I and duodenase, thus avoiding the
degenerate 3rd position which could have contained any of the four possible
nucleotides.
GMCP II cDNA sequence ATC ATC GGG GGC ACA GAG AGC
Deduced GMCP II amino acid sequence I I G G T E S
Isolated SMCP amino acid sequence I I G G H E A
Isolated GMCP amino acid sequence I I G G 7 E A
Bovine duodenase amino acid sequence I I G G H E A
NH2-terminus primer (P26) ATC ATC GGG GGC CAY GAG GC*
Fig. 5.9 Construction of the P26 primer for selectively amplifying cDNA that codes
for the NH2-terminal amino acids of SMCP I and GMCP I. Primer sequence
information is gained largely from the GMCP II and SMCP II nucleotide sequences
but a degenerate codon for the H residue is placed after the codon for the second G
residue. Here, the primer mixture contains an equal number of T and C nucleotides at
the third position (represented here as a Y) since either combination can code for H.
The last nucleotide has also been left out of the final codon (*) since it could contain
any of the four possible nucleotides at this position and still code for an A residue.
The P26 primer was used in combination with P2 which is specific for an area
of sequence showing 100% amino acid identity between GMCP II and bovine
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duodenase (Fig. 5.1 and Fig. 5.8). Following primary amplification of the same
mRNA selected RT products used to isolate GMCP II, a sample of the resulting PCR
product was separated on a 0.8% agarose gel where it produced a strong band at
approximately 550bp. The gel, which also contained secondary PCR products for
GMCP II amplified using primers for the full length cDNA (P 19 to P20), as well as a
truncated product using P25 (specific for the N-terminus ofGMCP II, see Fig. 5.1) to
P2 was blotted as previously. The blot was hybridized with a digoxigenin labelled
probe made from full length (PI9 to P20) cDNA for GMCP II (GMCP II-dig) under
conditions of low and high temperature and washing stringency (see 2.7.10). This
acts to alter the binding or annealing capacity of the GMCP II-dig probe to the blotted
cDNA, thus highlighting differences in the sequence identity of cDNA sequences
coding for related proteins. Under conditions of low temperature and washing
stringency, (50 °C; 2 x SSC, 0.5 x SSC), the GMCP II-dig probe bound to the 714bp
full length GMCP II cDNA band, as well as to the 550bp P25 to P2 truncated GMCP
II and P26 to P2 potential GMCP I cDNA bands (Fig. 5.10a). After stripping the blot
(see Chapter 2.7.9), and re-probing with GMCP-II-dig under conditions of high
temperature and washing stringency (60 °C; 2 x SSC, 0.2 x SSC), probe binding to
the potential GMCP I band was abolished whilst the GMCP II bands were almost as
strong as previously (Fig. 5.10b). This result indicated significant differences in the
sequence identity of the two PCR products which would be consistent with the low
identity shown by the deduced amino acid sequences for GMCP II and bovine
duodenase. The P26 to P2 PCR product was cloned and sequenced, producing a
552bp band that had 94.6% identity with an equivalent SMCP I cDNA clone
amplified using the same primers (S. Macaleese, personal communication). In
contrast, the nucleotide sequence for GMCP I has an identity of only 58.8% with
GMCP II and 57.1 % with SMCP II (Fig. 5.11). The nominal peptide sequence for
GMCP I was deduced, producing a sequence that shares 93.3 % identity with the
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NH2-terminal amino acid sequence for isolated SMCP I, at least an 83 .3 % identity
with the NH2-terminal amino acid sequence for isolated GMCP I and 90.8 %
identity with isolated bovine duodenase (Fig. 5.12). In contrast, there was only
65.1% and 64.6% identity with the deduced peptide sequences for GMCP II and
SMCP II respectively.
Unfortunately, due to time constraints, it was not possible to continue the
sequencing of GMCP I beyond the P2 primer to ascertain the 3' coding and non-
coding regions of the enzyme. However, this has recently been achieved for SMCP
using primers specific to SMCP I which lie internal to P2 and the RACE dT primer
(S. Macaleese, personal, communication) (Fig. 5.11). The deduced nominal peptide
sequence obtained from these clones demonstrates an 89.8 % identity with the
peptide sequence for bovine duodenase (Fig. 5.12).
A B
II
Fig. 5.10 a and b Southern blot of full length (P19 to P 20) and truncated (P25 to P2)
GMCP II secondary PCR products (lanes 1 and 2) and GMCP I first PCR product
(Lane 3) probed with GMCP II (PI9 to P20)-dig under low (A) and high (B)





























































































































































































gmcp2 CTGTAGCCAC TTCCCTGCTT TTGACCACAA TCTCCAGCTG TGTGTGGGCA
smcp2 CTGTCGCCAC TTCCGTGCTT TTGACCACAA TCTCCAGCTG TGTGTAGGCA
gmcpl TATTGCTCGC TTCAAAGACT ACATCCCCAT CACGCAGATA TGTGCTGGAG
smcpl TATTGCTCGC TTCAAAGACT ACATCCCCGT CACGCAGATA TGTGCTGGAG
601 650
gmcp2 ATCCCCAGAG CACAAAATCT GCTTTTAAGG GAGACTCAGG GGGCCCTCTT
smcp2 ATCCCCAGAG CACAAAATCT GCATTTAAGG GAGACTCAGG GGGCCCTCTT
gmcpl ATCCAAGCAA AAGGAAGGAT TCTTTCTTGG GAGACTCTGG GGGCCCTCTT
smcpl ATCCAAGCAA AAGGAAAGAT TCTTTCTTGG GTGACTCTGG GGGCCCACTT
651 700
gmcp2 CTGTGTGCTG GGGTGGCCCA AGGCATTGTC TCCTATGGAC TGTTCAGTGC
smcp2 CTGTGTGCTG GGGTGGCCCA GGGCATTGTC TCCTATGGAC TGTCCAGTGC
gmcp1 C
smcpl GTGTGTGATG GTGTGGCCCA GGGCATTGTG TCCTATGGAA AAGATGATGG
701 750
gmcp2 AAAGCCCCCC GCCGTCTTCA CCCGGATCTC CCCTTACCGG CCCTGGATCG
smcp2 AAAGCCCCCT GCTGTCTTCA CCCGGATCTC CCCTTACCGG CCCTGGATCG
gmcp1
smcpl GACAACTCCA AATGTCTACA CCAGAATCTC CAGCTTTCTG TCCTGGATCC
751 800
gmcp2 ATGAAGTCCT GAAAGAAAAT TAA
smcp2 ATGAGGTCCT GAAAGAGAAT TAACCTGGAA CCTGGGCCAG CCTGAGGAGA
gmcp1
smcpl AGAGAACAAT GAGACAGTAC AAAAACCAGG GGATCAGCAT AATGTGTCCT
801 850
gmcp2
smcp2 AACCAGAGCA GGACTCCGGC AGGTTCTCGG TGCCACTCAC CCTGGATCTG
gmcp1
smcpl TGAGATGGAC CCCTCCATCT TCCCTGGGAT TGGAAGCATT GGTCAAAGTG
851 900
gmcp2
smcp2 CCTCTGGTTT TCCTCTTAAA CCCCCGTCAC GTCCCTAATC CTCAGGAAGG
gmcp1




smcp2 GTGGTTCAGA TCATAGAATT CCCAATAAAT TTCAGTGAAC ACCCGGCA
gmcp1
smcpl
Fig. 5.11 Comparison of currently obtained cDNA nucleotide sequences for GMCP II
(full length enzyme clone including the signal sequence and the 39 bp deletion),
SMCP II (full length enzyme clone including the signal sequence as well as 5' and 3'
non-coding regions), GMCP I (P26 to P2 region) and SMCP I (full length enzyme
clone including 3' non-coding region.). The positions of the start codons (ATG) for
GMCP II and SMCP II, the codons for the IIGG residues at the start of the mature
enzyme peptide sequences and the stop codons (TAA and TGA) for GMCP II, SMCP




gmcpl IIGGHEAKPH SRPYMAFLRF KI3GKSYRCG
Sfflt-pi IIGGHEAKPH SRPYMAFLQF KI3GKSYIGG
bovduod IIGGHEAKPH SRPYMAFLLF KT3C5KSHICG






gmcpl .RVILGAH IT ©.RERTCQYIP VRPAIPHPHY
smcpiJ, YTLGAHTIT DQERTQQVIQ VRRAIPHPPY
bovduod VTLGAHNIM ERERTQQVIP VRRPIPHPDY





giTtcpl 'T.fiAVSLIitLP P.SLFKYKPGM MaSLAGHGQJ,. GVTIMPSADlfJ, QEVfliEVQ-3'E
s.mcpi fDA-/3I.JHLP R3L.EKVKPGM MCSYAGWGQfi GYHMP3ADKL QEVDLEYQRE
bovduod USKVSPINLP RSLAEVKPGM .MCSVAGWGR.L GVNMPSTDKL QEVDLEYQSE
ill. - ■« E 20:0
gmep.l EKCIARFEDY IBITQICAGD F3.KRK SFLG DRGGPL
SlffC.pi EKCIARFKBY XPVTQIOAGE} FSKFK! 5FLS BflGGPItVGCG VAQGIYSYGR
bovduod EKCIARFKNY IPFTQICAGD PSKRRIISFSG S3GGPLVCHG VAQGIVSy'GK
SQ1 i n 250
gniep 1
Stncpil. DD-GTTP' iVTT RISSFLSWIQ RTMRQYKNQG' ISIMCP*
bovduod NDGTTPPVYT RIS3FLPWIK RVMYLFK
Fig. 5.12 Deduced amino acid sequences from the SMCP I (smcpl) and GMCP 1
(gmcpl) cDNA sequences compared with NEb-terminai amino acid sequences
obtained from isolated SMCP (Isol SMCP) and GMCP (Isol GMCP) as well as the
whole amino acid sequence for isolated bovine duodenase (Bov Duod) {all shown in
standard single letter notation). Note the high degree of identity between the deduced
amino acid sequences for SMCP and GMCP as well as the isolated proteases and
bovine duodenase ? * undetermined residue; * = stop codon site.; green residues ~
potential glycosylation sites. The catalytic triad of His, Asp and Ser residues are
shown in blue whilst the S] active site residues are shown in red. The standard
chymotrypsinogen numbered positions of these residues are shown above in red,
5.5 Discussion
This Chapter describes the successful cloning and sequencing of cDNAs
encoding goat mast cell proteases. Cloned central fragments for GMCP II were
initially isolated from total RNA preparations prepared from day 7 BMMC cell pellets
grown in rOvIL-3. This time point in the culture corresponded with increasing GMCP
expression in these cells in vitro (Chapter 7).
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After separating the PCR products by gel electrophoresis, it soon became
apparent that the resulting PCR products were too large to be amplified cDNA for
GMCP II. Also, sequence analysis of the products demonstrated the presence of two
non-coding regions within the sequence, which corresponded to the positions of two
introns present in genomic clones isolated previously from ovine BMMC. These two
findings suggested that the GMCP II PCR products had been amplified from either
unprocessed mRNA, in which intron-containing sequences had not been completely
spliced out, or from contaminating genomic DNA. Since the aim of this study was to
isolate cDNA coding for GMCP and not to define the enzyme's genomic DNA
structure, steps were taken to isolate the fully processed mRNA component from the
total RNA samples. As yet, therefore, little further is known about the number or
positions of introns within the genes encoding GMCP, although recent data obtained
from ovine genomic sequences suggests that there may be as many as four introns and
five exons in the equivalent SMCP II gene (S. Macaleese, personal communication).
The message selection procedures for isolating and transcribing mRNA into
cDNA proved successful, allowing the cloning and sequencing of 3 overlapping
GMCP cDNA fragments which, when concatenated, covered an area from 22bp
before the start of the coding sequence for the mature protein through to the 3' poly
dA tail of the mRNA. This contiguous assembly of fragments was highly homologous
with an equivalent SMCP II cDNA previously isolated from ovine BMMC, indicating
that cells from both species produced enzymes which were potentially very similar in
terms of their respective amino acid sequences.
This was confirmed when a clone containing almost the whole coding region
for the GMCP II pro-peptide was amplified using primers that bound to an area
coding for the SMCP II signal peptide and to an area incorporating the 3' stop codon.
This 'full length' clone was almost identical to the contiguous GMCP fragment clones
with the exception of two areas. In the first place, the full length clone's 5' signal
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peptide sequence was markedly different to the signal sequence obtained from the
original 5' GMCP cDNA fragment (Fig. 5.7). This indicated that the ovine P19
primer used to amplify the full length clone was preferentially binding to a different
signal peptide sequence to that present in the original oligo dT amplified 5' GMCP
cDNA fragment. This alternative signal peptide has been previously amplified from 5'
polyA tailed sheep mRNA samples (S. Macaleese, personal communication) and
suggests the presence of two different signal peptides encoding similar proteins in
both species. It is possible therefore, that the GMCP gene is capable of alternatively
splicing 5' exons containing different signal peptides onto the rest of the GMCP II
mRNA transcript. The presence ofGMCP mRNA transcripts encoding proteins with
different signal peptide sequences may indicate that different forms of translated
GMCP II could be stored in different ways within the cell, although the functional
significance of this remains to be determined. The second area of difference between
the contiguous GMCP II sequence and the full length clone lay between base pairs
137 and 177 where there is an apparent gap in the the full length clone's nucleotide
sequence (Fig. 5.7). The reasons behind this deletion are also unknown, but it may
have occurred during the first cycle of the initial PCR amplification when incomplete
strand separation of the RT product could have produced a 'looped out' area of cDNA
that was by-passed by the Taq DNA polymerase. Alternatively, it may also indicate
the presence of yet another gene product due to the splicing of an alternative 5' exon
sequence containing the deletion. However, to prove this, sequencing of at least three
different clones from independent PCR products amplified using the original primers
would be required to rule out the possibility of errors during the PCR reaction.
Overall however, this means that although this particular clone was subsequently used
successfully as a probe (Fig.5.10 a and b), it may not be suitable for use in a protein
expression system since it would possibly code for a defective protein product.
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Despite these anomalies, the cDNA sequence coding for the GMCP II pro¬
peptide in the whole enzyme clone still showed a high degree of identity with the
GMCP II fragment clones and the BMMC derived clone for SMCP II. This finding
further confirmed the similarities between the goat and sheep enzymes at the DNA
level. Peptide translations were carried out on the two GMCP II sequences and the
SMCP II sequence to check their similarity in terms of their deduced amino acid
sequences (Fig. 5.8). Apart from the different signal peptide obtained from the full
length GMCP II cDNA clone, all three showed a high degree of identity with only 5
out of 229 residues difference between the GMCP II and SMCP II mature enzyme
deduced amino acid sequences. Both also contained the G-E dipeptide found
attached to the immature pro-enzyme form of the protein as it emerges from the
rough endoplasmic reticulum following translation. This dipeptide is removed prior to
packaging within the mast cell granule, allowing the enzymes to alter their tertiary
structure by folding to produce the optimal active site conformation for substrate
cleavage (Urata et al., 1993). Immediately after the pro-enzyme di-peptide, the
mature enzyme sequences from both species started with an I-I-G-G tetrapeptide,
which is common to the majority ofmast cell chymase enzymes sequenced so far
(Springman and Serafin, 1995).
Also common to both enzymes are the histidine57 , aspartate 102 an^ serine-
195 residues (chymotrypsinogen numbering), that make up the 'catalytic triad' which
is associated with all known serine esterases (Springman and Serafin, 1995).
However, somewhat unexpectedly given the biochemical characteristics ofGMCP
(Chapter 3), sequence position 226 did not contain either aspartate or glutamate
residues. These negatively charged residues, when present in this position (or
possibly also at position 189, see below) divide the base of the S] portion of the
substrate binding pocket to produce an active site conformation that is associated with
the dual chymase and tryptase specificity of bovine duodenase and human cathepsin
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G. (Zamolodchikova et al., 1995b; Hof et al., 1996). Instead, both enzymes contained
an alanine226 an^ a serine] 39^ which has previously been associated with a
chymotrypsin-like substrate specificity in the rat intestinal chymase, RMCP II
(Remington, Woodbury, Ross, Reynolds, Matthews and Neurath, 1988).
It was also noted that the deduced amino acid sequences for these enzymes
exhibited poor identity with the NH/i-terminal amino acid sequences previously
obtained for isolated SMCP and GMCP (Pemberton et al., 1997a; Chapter 3), as well
as the complete amino acid sequence for bovine duodenase (Zamolodchikova et al.
1995b), which appears to be the bovine equivalent ofGMCP and SMCP (Pemberton
et al. 1997a). In contrast, a search carried out on the EMBL database (accessed via
Seqnet, see Chapter 2.14.2) showed that both enzymes had a greater DNA sequence
identity (84 to 86 %) with a human heart chymase enzyme which acts as an important
angiotensin I converting enzyme within cardiac muscle (Urata, Kinoshita, Perez,
Misono, Bumpus, Graham and Husain, 1991). Overall, the findings indicated that
these cDNAs clones were coding for novel mast cell chymases that are present in both
species, but have yet to be isolated or detected as discrete proteins either in vivo or in
vitro. As outlined above, the enzymes were classified as SMCP II and GMCP II, and
the information gained from their cDNA sequences was used to construct more-
specific primers for amplifying cDNA for GMCP I and SMCP I.
The GMCP I NTfj-terminus specific primer, in conjunction with a primer
specific for an area of consensus between the amino acid sequences obtained for
GMCP II and bovine duodenase (P2), was successful in producing a positive cDNA
clone after only one amplification step. This may reflect on the relative amounts of
cDNA coding for GMCP II (which always required two amplification steps)
compared with cDNA for GMCP I in the RT samples, although no quantitative
studies were carried out to investigate this further. The cDNA clone for GMCP I
coded for about two thirds of the enzyme with the 3' end currently left unsequenced
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due to time constraints within the project. However, this 3' sequencing has been
recently carried out for SMCP I (S.Macaleese, personal communication, Fig. 5.11)
producing a clone which enables the entire mature enzyme nominal peptide sequence
to be deduced (Fig. 5.12). The deduced amino acid sequence for GMCP I
demonstrates a high degree of homology with the SMCP I sequence and also shows a
much higher identity with the NH2-terminal sequences for isolated SMCP I, GMCP I
and bovine duodenase (Fig. 5.12). This is especially noTable for residues 5,7 and 19
which contain histidine, alanine and phenylalanine respectively instead of the
threonine, serine and tyrosine residues found in the GMCP II N-terminus (Fig. 5.8).
Indeed, the sequence identity of 83.3% for the GMCP I clone and the NH2-terminus
of isolated GMCP would probably be much higher if it wasn't for the 3 undetermined
residues in the isolated enzyme's sequence.
Like GMCP II, the deduced amino acid sequences for GMCP I and SMCP I
also contain the His, Asp, Ser catalytic triad associated with serine esterase activity
and both enzymes also exhibited potential N-linked glycosylation sites, although their
precise locations vary slightly between SMCP I and GMCP I (Fig. 5.12). These
glycosylation sites are not always linked to carbohydrates, but in the case of SMCP I
the presence of glycosylated and non-glycosylated forms of the enzyme would
possibly explain the presence doublet bands found in SDS-PAGE separated samples
of purified SMCP and immunoaffinity purified GMCP (A. Pemberton, personal
communication, Chapter 3).
Within the active site itself, the residue at position 226 has yet to be
determined for GMCP I although SMCP I has an asparagine226 residue which in
itself, would not suggest the presence of dual specificity. However, SMCP I and
GMCP I do possess an aspartate] 39 which, on the basis of structural modelling for
human cathepsin G, lies directly opposite residue 226 at the base of the SI pocket
(Hof et. al. 1996). In bovine duodenase, on the other hand, the position of these
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residues is reversed, with an asparaginejg9 and an aspartate 226 which is the
conventional arrangement for dual specificity (Zamolodchikova et. al., 1995b). Given
the spatial arrangement of residues at the two sites within the substrate binding
pocket, it is possible that an aspartate residue at either position may be sufficient to
produce the dual activity that is characteristic of GMCP I (Chapter 3) and SMCP I
(Pemberton et al., 1997a), although further computer modelling studies based on their
complete amino acid sequences would be required to confirm this.
In summary, cDNAs coding for two separate GMCP enzymes have been
cloned from goat BMMCs. Comparisons between a 5' and a whole length cDNA
clone for GMCP II indicated that alternative splicing may occur during RNA
processing. This may result in the production of transcription products that code for
different signal peptides. The whole length cDNA for GMCP II encodes an enzyme
which, in terms of it's deduced amino acid sequence, is more closely related to a
human heart chymase enzyme than to isolated GMCP, isolated SMCP or bovine
duodenase. In terms of its potential active site conformation, it also exhibits the
structural properties of a chymotrypsin-like enzyme rather than a dual specific
enzyme. In contrast, a second cDNA isolated for GMCP I encodes approximately
two thirds of an enzyme whose deduced amino acid sequence closely resembles
isolated GMCP, isolated SMCP and bovine duodenase. Although the the complete
sequence for its active site residues has not yet been determined, the presence of an
aspartate 189 residue indicates a possible structural characteristic by which dual
substrate specificity may occur.
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CHAPTER 6
ABOMASAL NEMATODE INFECTIONS IN GOATS: A
COMPARISON OF MAST CELL, EOSINOPHIL AND TOTAL
SERUM IgE RESPONSES IN YEARLINGS, KIDS AND LAMBS
UNDERGOING PRIMARY AND SECONDARY CHALLENGE
INFECTIONSWITH T. circumcincta
6.1 Introduction
Recent studies (Huntley et al., 1995), analysed the role of cellular immune
responses in previously infected adult goats and sheep exposed to an experimental
mixed challenge of T. circumcincta and T. vitrinus L3. As in earlier studies
(LeJambre and Royal, 1976; LeJambre, 1984; reviewed Lloyd, 1987; McKenna, 1984;
Pomroy et al., 1986), the findings demonstrated that adult does, despite previous
exposure to nematodes in the field, were generally incapable of restricting larval
establishment when compared with equivalently challenged adult ewes. Fundamental
differences were also observed in the MMC and GL numbers as well as SMCP
concentrations in goat intestinal tissues compared to sheep tissues (see general
introduction).
The aim of this chapter is to extend these preliminary findings by examining
cellular and humoral immune responses in groups of yearling goats, kids and lambs
undergoing both primary and secondary challenge infections with the abomasal
parasite T. circumcincta. This was carried out with emphasis on examining differences
in the MMC and GL responses shown by the two species. In contrast to the previous
study, where the adult animals were maintained on pasture before being treated with
anthelmintic and exposed to an experimental challenge, the animals in this study were
all kept under worm-free conditions prior to the start of the experiment. This allowed
assessments to be made on comparative primary responses to infection shown by
lambs and goats as well as providing novel data on both primary and secondary
responses shown by goat yearlings and goat kids. The use of a controlled
experimental trickle-challenge regime for 'priming' the continuously challenged
animals enabled comparisons to be made on the responses of animals that have
undergone exposure to known numbers of L3 prior to a secondary challenge
infection. The experimental challenge ofworm-free animals also circumvented
potential complications associated with the frequent use of anthelmintics in the
173
naturally infected animals used in earlier experiments. This has previously been shown
to affect the development of acquired immunity by limiting host exposure to parasites
in the field prior to experimental challenge (Gibson et al. 1970; Barger, 1988).
The use of yearlings and kids also allowed assessments to be made as to
whether an age-related immune responsiveness to nematodes occurs in goats in a
similar manner to that observed previously in sheep (Colditz et al. 1996). In addition,
the raising of polyclonal antibodies to GMCP and it's cross reactivity with SMCP
(Chapter 3) enabled mast cell responses to be determined, using GMCP-specific
reagents for immunohistological and tissue ELISA analyses. This was in contrast to
the previous study (Huntley et al., 1995), where only reagents specific for SMCP
were available. Finally, the availability of a monoclonal antibody that recognises both
caprine and ovine IgE (Kooyman et al., 1997) allowed the first comparative
measurements for total serum IgE levels in response nematode infections, in these
two species. Elevated levels of this immunoglobulin isotype have been described in a
wide variety of parasitic infections (Jarrett and Miller, 1982) and have also been
implicated in mast cell activation (reviewed Sutton and Gould, 1993).
6.2 Materials and methods
6.2.1 Animals
Eight eighteen month old Scottish cashmere goats (yearlings), ten six month
old Scottish Blackface cross lambs (lambs) and ten six month old feral cross kids
(kids) were used in the experiment. The animals were all born and reared indoors at
the MRI's Firth Mains Farm, Penicuik, Mid-Lothian. They had access to a crepe feed
(Dalgettys Lamb ration) and hay. At ten weeks of age they were weaned and offered a
daily ration of concentrate (Moredun Sheep Nuts, Dalgettys) and hay ad-lib.
At the start of the experiment, animals were randomly allocated into one of
two groups. The first group contained five yearlings, five kids and five lambs, the
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second group contained three yearlings, five kids and five lambs. The second group,
termed the continuously infected (CI) group, commenced a primary trickle-challenge
regime whilst the first group, termed the challenge control (CC) group, continued to
be maintained under worm free conditions.
6.2.2 Challenge protocol
Table 6.1 outlines the experimental timetable used during the challenge period
for groups of animals undergoing both primary and secondary infection regimes. The
CI group commenced their primary trickle-challenge at day 0. This consisted of 2000
T. circumcincta L3 given per five days a weekper os for 6 weeks, followed by a
single 50, 000 T. circumcincta L3 challenge dose on day 49. The CC group were
given the single 50, 000 T. circumcincta L3 challenge dose at day 49.
All animals were bled by jugular venipuncture at weekly intervals to provide
serum and EDTA treated whole blood for IgE and peripheral eosinophil counts
respectively (see below). Rectal faecal samples were also taken at weekly intervals
from CI animals to monitor their faecal egg output throughout the trickle challenge
period. Seven days after the administration of the T. circumcincta 50 OOOL3
challenge, all animals were euthanased and the intestinal tissues processed as












1 CC yearlings (3) - - 50,000 L3 49 56
2 CI yearlings (5) 2000 L3 five
times per week
35 50,000 L3 49 56
1 CC kids (5) - - 50,000 L3 49 56
2 CI kids (5) 2000 L3 five
times per week
35 50,000 L3 49 56
1 CC lambs (5) - - 50,000 L3 49 56
2 CI lambs (5) 2000 L3 five
times per week
35 50,000 L3 49 56
Table 6.1 Outline of the experimental protocol for challenging the continuously
infected (CI) and challenge control (CC) groups of animals. L3 = T. circumcincta
infective third stage larvae.
6.2.3 Faecal egg counts
These were kindly performed by members ofDr. F. Jackson's laboratory using
a modified flotation technique as described by Christie and Jackson (1982). Briefly,
weighed faecal samples were emulsified in lOmls of tap water per gram of faeces. A
10ml sub-sample was removed and passed over a 1mm aperture sieve. The retentate
was washed with an additional 5ml of tap water, compressed to recover as much fluid
as possible, and then discarded. The filtrate was centrifuged at 1000 rpm (228 x g) for
2 minutes. The resulting pellet was re-suspended in 12ml saturated NaCl prior to
centrifugation at lOOOrpm for another 2 minutes. The upper 1 to 2 mis of supernatant
was collected and transferred into a 4ml disposable polystyrene cuvette (LIP Ltd.,
Shipley), The cuvette was filled with saturated NaCl solution and sealed. Counts were
carried out on a compound microscope using a calibrated eyepiece graticule (Miller
square) at x 40 magnification Two longitudinal traverses of the cuvette were
performed, and the numbers of eggs falling inside the boundaries of the large graticule
square multiplied by 3 or those within the small square by 9 to obtain the total
numbers of eggs per gram of faeces
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6.2.4 Peripheral blood eosinophil counts
These were kindly performed by J. Lightbody of the Biochemistry Division at
Moredun Research Institute. A 50pl sample of fresh EDTA treated whole blood was
added to 450pl of Carpentier's eosinophil staining solution (Appendix A) and the
eosinophils counted using a "Fast-Read 10" disposable counting chamber (Immune
Systems Ltd., Bristol, U.K.). Blood eosinophil numbers are expressed as
cells x 10^ per litre ofwhole blood.
6.2.5 Post mortem processing of tissues
After euthanasia, the entire gastro-intestinal tract was removed and the
proximal end of the duodenum located. The small intestine was separated from the
abomasum and a section of jejunum taken for GMCP ELISA analysis as outlined in
2.3 The abomasum was opened along it's greater curvature and the contents
collected, individual abomasal pH was measured immediately using a stick pH meter
(Whatman pH p-Sensor). An abomasal fold was taken for GMCP ELISA analysis,
whilst an additional fold was fixed in 4% paraformaldehyde/PBS as described in 2.8.
The abomasum and it's contents were then soaked in a 0.85% saline solution at 37 °C
for 4 hours (Jackson, Jackson and Smith, 1984). Afterthis saline incubation, the
superficial mucosa was removed from the remainder of the abomasum , which was
then discarded. The contents, including the mucosa, were made up to 5 litres with
0.85% saline , and a 500ml (10%) subsample taken and fixed with 20ml formalin.
6.2.6 Abomasal worm counts
A 100ml aliquot (representing 2% of the total worm population), was taken
from each of the fixed subsamples recovered from the abomasum and stained with 10-
15mls of helminthological iodine (Appendix A). The stained sample was examined
under a stereo-microscope and the T. circumcincta larvae counted and staged as
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early, mid or late L4 or as male or female L^/early adults as described by Denham
(1969).
6.2.7 Histochemical and immunohistochemical evaluation of tissue sectionsfor
MMC, GL and eosinophils.
These were carried out on 4% paraformaldehyde fixed tissues as described in
2.8. Immunohistochemical staining was carried out using rabbit polyclonal antibody to
GMCP. Final results were expressed as cells/0.2mm^ of abomasal tissue.
6.2.8 ELISAs ofabomasal andjejunal tissuesfor GMCP/SMCP
These were carried out as described in Chapter 2.12 using a double antibody
sandwich ELISA for GMCP. Final results were quoted as pg GMCP/SMCP per gram
ofwet weight tissue.
6.2.9 Serum total IgE assays
These were carried out in duplicate as outlined in Chapter 2.13 on reduced
serum samples. The results were expressed as pg of total IgE/ml of serum.
6.3 Results
6.3.1 Faecal egg countsfrom CI animals
The mean (± SD) weekly faecal egg counts of the CI yearlings, kids and lambs
undergoing the trickle challenge infection regime are shown in Fig. 6.1. (faecal egg
counts from worm-free CC animals were all negative prior to the single challenge at
day 49). At day 21, the lambs produced significantly more eggs than the yearlings and
kids whilst, at day 35, both the yearlings and the lambs produced significantly more
eggs than the kids (p < 0.05). Between days 42 and 49, the lambs produced
significantly more eggs than the yearlings (p < 0.05). However, after day 49 there
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Fig. 6.1 Mean (± sem) numbers of eggs per gram of faeces recovered from CI animals
undergoing primary trickle challenge with 2000 circumcincta L3 5 times weekly.
6.3.2 Abomasai worm burdens
Table 6,2 shows the summary mean (± SD), abomasai pHs, L4 stages, L^/adult and
total worm numbers as well as the percentage establishment of larvae in the
CI and CC yearlings, kids and lambs. Figure 6.2a shows the relative numbers of early,
mid and late L4 stage larvae recovered from individuals in the CC group whilst Figure
6.2b shows the relative numbers of the combined L4 stages and L^/adults recovered
from individuals in the CI group.
Both the CC and CI yearlings and kids had significantly higher abomasai pHs
than the equivalent CC and CI lambs, whilst the CI kids also had significantly higher
abomasai pHs than the CC kids (P ■ 0.05). In the CC group, the mean total larval
burdens and mean percentage of larvae established were marginally higher in the kids
than either the yearlings or lambs, although the differences were not significant
(P>0.05). It was also found that the kids contained significantly more mid L4 stage
larvae than the yearlings and lambs (P - 0.001), where the majority of larvae had
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continued to develop to the late L4 stage (Table 6.2 and Fig. 6.2a). Due to the short
interval (seven days) between challenge and post mortem, none of the worms in the
CC animals had developed through to the L^/adult stages.
In the CI group the kids harboured significantly higher total numbers of
worms than either the CI lambs or the CC kids (P < 0.05), although neither the CI
yearlings or lambs contained significantly higher total worm numbers than the
equivalent CC animals. The mean total worm burdens present in the CI yearlings were
also considerably higher than the mean total worm burdens present in the CI lambs.
However,as can be seen in Fig. 6.2b the difference was not significant due to
considerable variations in the total numbers ofworms recovered from the individual
CI yearlings.
Percentage larval establishment figures showed that only approximately half
the numbers of larvae established in the CI lambs throughout the experiment when
compared to the CI yearlings and kids. Establishment ratios calculated for the two
groups (CC: CI) demonstrated a marked decrease in the CI lambs (1: 0.45) when
compared to either the CI yearlings (1: 0.81) or the CI kids (1: 0.69).
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Animal Abomasal Early L4 Mid L4 Late L4 L5/Adult Total %
(n) PH Estd
CC
Yearlings 4.13 3073 341 9138 0 12551 25.1
(3) (±0.29)d (± 1133) (±93) (± 1841) (± 2466)
Kids 4.06 2778 14834 0 0 17611 35.2
(5) (± 0.14)c (± 1437) (± 2015)b'C (±2118)
Lambs 2.36 1158 1242 11499 0 13900 27.8
(5) (± 0.4) (±219) (± 423 ) (± 2388) (±2278)
CI
Yearlings 5.06 14343 0 2123 7899 24361 20.3
(5) (±0.39)d (± 5264) (± 1109)a (± 1266) (± 5354)
Kids 5.66 12583 0 1106 15371 29060 24.2
(5) (± 0.49)a'c (± 3534)a (± 793) (± 3684) (± 1278)a>e
Lambs 3.6 4315 0 0 10644 14969 12.5
(5) (±0.47) (± 1546)a (± 2207) (± 2679)
Table 6.2 Mean (± SD) abomasal pHs, post mortem worm burdens and %
establishment of total larvae administered (% Estd.) results from the CI and CC
yearlings, kids and lambs. Superscripts denote significance (p< 0.05). a = CI versus
CC infected animals, b = between CC kids and yearlings, c = between CC or CI kids
and lambs d = between CC or CI yearlings and lambs and e = between CI kids and
































Fig. 6.2. a) Numbers of early, mid and late stage L4 larvae recovered from CC
animals seven days after a single primary challenge infection with 50, 000
T.circumclncta L3 . b) Numbers of combined L4 stage larvae and L5/adult worms
recovered from CI animals seven days after undergoing a secondary challenge














4.5 (± 2.9) 4.7 (± 1 0)b'c 5lftc 5.9 (± 3.1) 3.1 (±2.4)
Kids
(5)
3.1 (±2.0) 0.12 (±0.03) 3.7 6.0 (±2.67) 0.96 (± 0.6)
Lambs
(5)




12.3 (± 3.7)a 19.6 (±6. l)a'C 61c 12.6 (±4.0 5.8 (±3.7)
Kids
(5)
10.3 (± 3. l)a 9.2 (± 4. l)a'd 47a'd 11.1 (± 4.4 13.3 (±5.4)a>d
Lambs
(5)
10.5 (± 3. l)a 1.1 (±1.1) 9.4 10.4 (±3.5 3.12 (±1.5)
Table 6.3 Mean (± SD) abomasal mucosal mast cells (MMC), globule leukocytes
(GL), % of total mast cells (combined MMC and GL counts) as GLs (% GL), cells
reacting positively with polyclonal antibody to GMCP (a-GMCP) and tissue
eosinophil numbers (Eosinophils). All counts represent the number of cells/ 0.2mm^
section of tissue. Superscripts denote significance (p< 0.05). a = CC versus CI
animals, b = between CC yearlings and kids, c = between CC or CI yearlings and
lambs, d = between CI kids and lambs (see also text). Results for individual animals
are in Appendix B (p ii)
6.3.3 Tissue MMC and GL counts.
Table 6.3 shows the mean (+ SD) results for MMC and GL counts after
staining abomasal tissue sections from both groups with toluidine blue for MMC,
carbol chromotrope for GL, and antibody to GMCP (a-GMCP). Toluidine blue
stained MMC showed a significant (P < 0.05) increase in numbers in the tissues ofCI
yearlings, kids and lambs, compared to the equivalent CC animals. Mean GL numbers
were also increased in the CI compared to CC infected animals, although the increase
was significant for the yearlings and kids only (P < 0.001). The CC yearlings along
with the CI yearlings and kids contained a significantly higher proportion of their total
mast cell count (combined MMC and GL numbers) as GL (% GL, table 6.3) than the
CC kids and lambs or CI lambs (P < 0.005). Tissues stained with antibody to GMCP
did not reveal any significant differences in the numbers of positive staining cells
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between the CC and CI infected groups, although the mean numbers of positive cells
were greater in the CI group.
Correlations between total abomasal worm burdens and the combined cell
counts for histochemically stained MMC and GL (total mast cells, see Chapter 3 and
Chapter 4) demonstrated inverse relationships in the CC yearlings (R^= -0.69) and
lambs (R.2= -0.53) as well as the CI yearlings (R^= -0.39 ) and lambs (R^= -0.51 ).
Similar analyses on the CC and CI kids demonstrated no relationship and a positive
relationship (R^= 0.40) respectively. Regression analyses also demonstrated that
anti-GMCP staining correlated better with the total mast cell counts for the CC group
(R^ = 0.70; p < 0.0001) than for the CI group (R^ = 0.55; p < 0.002).
6.3.4 Tissue mast cellprotease concentrations
Animal (n) Abomasum Jejunum
CC
Yearling (3) 0.06 (±0.02) 1.2 (±0.8)
Kid (5) 0.09 (±0.02) 1.1 (±0.7)
Lamb (5) 0.4 (±0.2)b-c 5.4 (± 3.6)b'C
CI
Yearling (5) 0.04 (±0.02) 0.3 (±0.2)
Kid (5) 0.06 (±0.015) 0.8 (±0.48)
Lamb (5) 94.1 (± 41,6)a'b<c 18.5 (± 9.0)a b c
Table 6.4 Mean (± SD) values for abomasal and jejunal tissue GMCP content. Results
expressed as pg/g wet weight tissue. Superscripts denote significance (P< 0.05). a =
between CC lambs CI lambs, b = between CC or CI lambs and yearlings, c = between
CC or CI lambs and kids. Results for individual animals are in Appendix B (p ii).
Table 6.4 shows the mean (±SD) results obtained for the abomasal and jejunal tissue
GMCP concentrations for both CC and CI groups. In the CC animals, the jejunal tissues
from both species contained more protease than the abomasal tissues, whilst the lamb
abomasal and jejunal tissues contained significantly more protease than either the
yearling or kid tissues (p < 0.01). In the CI animals, there was a highly significant
increase in the tissue protease concentrations in the lamb abomasal and jejunal tissues
(P< 0.001). This was most marked in the abomasal tissues which, in contrast to the
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CC lambs, now contained significantly more protease than the CI lamb jejunal tissues
(P-: 0.01), In CI yearlings and kids however, there were slight reductions in the mean
tissue protease content for both the abomasal and jejunal tissues when compared with
the equivalent CC animals and, although the results were not significant, the jejunal









Fig. 6.3 Mean peripheral eosinophil counts obtained from weekly blood samples taken
from CC and CI animals (cells x 10^/litre of whole blood).
6.3 5 Eosinophil counts
Figure 6.3 shows the mean peripheral eosinophil numbers present in weekly blood
samples taken throughout the experimental period from yearlings, kids and lambs
undergoing both challenge regimes. There were no significant differences in cell
numbers noted between the groups at any stage throughout the experimental period.
However, the mean values obtained from the CC or CI kids were marginally higher
than those obtained from other animals until the 50, 000 T. circumcincki L-$ challenge
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at da>' 49. The mean counts obtained from all animals rose in the period between day
49 and day 54, when the last blood sample was taken, although, the increase was not
significant (P > 0.05) for any group.
Table 6.3 also shows the mean (± SD) results for eosinophil counts in carbol
chromotrope stained abomasal tissue sections. The mean values for CI yearlings and
kids were both higher than those obtained from equivalent CC animals, although only
the kid results were significantly elevated (P < 0.05). Conversely, the numbers of
eosinophils present in the CI lamb tissues were lower than the CC infected lambs, but
the decrease was not significant (P > 0.05).
6.3.6 Total serum IgE concentrations
Figure 6.4 shows a typical total serum IgE dot blot of reduced yearling serum
probed with the 1E7 monoclonal antibody for caprine and ovine IgE (see 2.13).
Figure 6.5 shows the comparative mean (+ SD) total serum IgE concentrations for
CC and CI yearlings (A), CC and CI infected kids (B) and CC and CI infected lambs
(C) obtained using this technique.
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1 2 3 4 5 6 7 8 9
Fig. 6.4 Total serum IgE dot blots of weekly serum samples from CC yearlings
(column 2 to column 4) and CI yearlings (column 5 to column 9). Samples from
individual animals run from row A (samples taken at the start of the trickle challenge)
to row K (samples taken at post mortem). Also shown are the 0.125 to 7 pg/ml
recombinant IgE standards (IB to IE) as well as positive and negative control
samples consisting of ADCM challenged doe gastric lymph (IF), specific pathogen
free (SPF) lamb serum (1G) and worm-free goat serum (1H).
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Fig. 6.5 Mean (± SD) total serum igE concentrations in ug/ml from weekly blood
samples taken from CC and CI yearlings (a), kids (b), and lambs (c). CI animals given
2000 T circumcincta L3 five times a week until day 49; CC animals maintained
worm-free until day 49 when both CC and CI animals were challenged with 50,000 T.
circumcincta L3.
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The CI yearlings demonstrated a strong initial mean total serum IgE response, which
was maintained throughout the primary trickle-challenge period (Fig. 6.5a). However,
due to a high degree of variability between individuals, the results were not
significantly different to the levels obtained from equivalent worm-free CC animals.
The CC yearlings also demonstrated a slight rise in serum total IgE levels between day
7 and day 14 despite being maintained under worm-free conditions until day 49
(although this response was mainly due to a single animal; Fig 6.4, column 2). Neither
the CC or CI kids demonstrated significant elevations in their mean serum total IgE
concentrations throughout the trickle challenge period. After the 50,000 L3 challenge,
however, both groups showed increases by day 54 (Fig. 6.5 b). The greatest
responses were found in the CC kids which produced significantly more total IgE
during this period than the CI group (P< 0.05). In the lambs, increases in mean serum
total IgE levels were not demonstrated in the CI animals until day 28 post infection
(Fig. 6.5c), whilst CC lambs were negative for serum IgE throughout the trickle-
challenge period. After the 50, 000 L3 challenge, the IgE concentrations in both lamb
groups had risen by day 56. This rise was most significant in the CC lambs (P<0.01).
6.4 Discussion
These results demonstrate the inability of goat yearlings and kids to reduce
their mean total gastro-intestinal nematode burdens when compared with equivalently
challenged lambs. They also highlight differences in kinetics ofworm establishment,
development and expulsion in the two species, which may result from differences in
their respective physiological and immunological responses to nematode infections.
A surprising initial finding was the significant reduction in faecal egg output
shown by the CI yearlings and kids when compared with the CI lambs during the
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trickle challenge period. This appeared to be at odds with previous studies (Lejambre
and Royal, 1976, Lejambre, 1984, Pomroy et al, 1986, Huntley et al. 1995) which
demonstrated that infected adult goats usually shed more eggs than equivalently
challenged adult sheep. Faecal egg output is, however, only a measure of nematode
fecundity, which may be influenced by a variety of immunological, physiological and
environmental factors that do not affect larval establishment. Reductions in fecundity
can therefore occur despite the presence of substantial intestinal nematode
populations (Douch and Morum, 1993). This was apparently the case in the current
experiment, since worm burdens recovered from CC and CI kids as well as CI
yearlings at post-mortem, were larger than the equivalent lambs. Although there were
no significant differences in the faecal egg outputs from any of the CI animals after
day 49, reasons for the reduced egg output in the CI goats during the middle part of
the trickle challenge period may be due to the presence of higher proportions of non¬
patent early L4 larvae (EL4) in the intestinal mucosa of the CI goats when compared
to the CI lambs.
EL4 accounted for 24.4% and 15.8% of the total population in CC yearlings
and CC kids compared to 8.3% in CC lambs, whilst a similar picture was also evident
in the CI group, with EL4 accounting for 58.8, 43.3 and 28.8% of the total
populations recovered from the CI yearlings, kids and lambs. Since a high degree of
retardation also occurred in the CC kids, this is unlikely to be attributable to an
acquired immunity, but may be linked to the biochemical or physiological conditions
prevailing in the abomasa. In this respect, the pHs in goat abomasa were found to be
70% higher in the CI animals and at least 40% higher in the CC goats compared to
similarly challenged lambs. The reasons underlying this are currently unknown, since
there is little previous data available for abomasal pH values in goats undergoing
either natural or experimental nematode challenges. The goats in the current study
were all housed and raised exclusively on lamb-formulated rations, which may have
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contributed to the production of these high abomasal pHs. Further experiments
involving similarly managed, worm-free control animals would be required to confirm
this. Another possibility is that the strain of parasite used in this experiment was
isolated and maintained in sheep which may have accounted for some of the
differences observed in nematode fecundity and development between the species.
However, this is unlikely, since the same strain was used in the previous study
(Huntley et al., 1995), where challenged does were found to have higher egg counts
and higher worm burdens than infected ewes.
Previous studies investigating the development of immune responses to T.
circumcincta demonstrated that one of the first expressions of acquired immunity in
young lambs was a reduction in the rate of development of incoming larvae (Seaton et
al., 1989a, b). Other studies have also demonstrated reductions in the fecundity of
adult females during the development of immunity to T. colubriformis and H.
contortus infections in lambs (Dineen and Windon, 1980; Gill et al., 1991). Although
both these changes were apparent in the CI yearlings and kids, at post mortem, the
CI lambs contained significantly fewer worms than the CI kids, marginally less than
the CI yearlings as well as lower L3 establishment ratios than either age group ofCI
goats. Additionally, there was also a trend, although not significant, for higher initial
establishment of L3 in the CC kids following the primary challenge seven days
previously.
In general, these findings are consistent with the previous observations of
Huntley et al. (1995), where it was demonstrated that adult does, although they had
extensive prior exposure to natural nematode infections, had considerably larger
abomasal worm burdens than worm naive lambs following experimental challenge. As
in the current experiment, there was also evidence of immunologically and/or
physiologically mediated effects upon larval development since the does retained high
proportions of their I circumcincta burden as L4. Unfortunately, abomasal pH values
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were not recorded. An additional finding in this current experiment was that
previously worm-free kids undergoing both primary (CC) and secondary (CI)
challenge regimes also exhibited a greater degree of larval retardation than the
similarly aged lambs. Overall, the findings from both experiments suggest important
differences in the mechanisms that regulate the kinetics of abomasal infections in the
two species. On the one hand, responses in kids, yearlings and does appear to retard
larval growth without reducing total worm numbers whereas on the other, responses
in lambs and ewes allow the development of established worms to the I^/adult stage
but at the same time, restrict establishment and/or increase expulsion of adult worms.
The wide variations in the abomasal worm burdens recovered from the CI
yearlings when compared with the CI kids also suggests the presence of an age-
related acquired response that becomes more effective at rejecting nematodes in
certain individual goats as they become older. The genetic basis of this variability in
the individual responses of older goats has been confirmed previously (Patterson,
Jackson, Huntley, Stevenson, Jones and Russel, 1995). However, even at the age of
eighteen months, their ability to regulate the size of the total worm population was
not as well developed as that of six month old lambs.
Elevated numbers of intestinal MMCs and intra-epithelial GLs are a
characteristic feature of helminthiasis in ruminants (Miller, 1984). As might be
expected there were significant differences between the numbers ofMMC and total
mast cells (combined MMC and GL counts, see Chapters 3 and 4) between the CI and
CC groups. Total mast cell numbers in the CC and CI infected yearling and lamb
tissues were found to be inversely related to the total abomasal worm numbers but in
the kids there was either no correlation (CC kids) or a positive relationship (CI kids).
This suggests that, while the presence ofMMCs and GLs may reflect the ability to
regulate worm numbers during primary and secondary infections in the lambs and
older goats, this was not the case in infected kids.
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Significantly greater proportions of the total mast cells in the CI yearlings and
kids were also found to be GLs (61 and 47% respectively), compared to the CI
infected lambs (9.4%). These findings are again in agreement with those ofHuntley et
al., (1995) who demonstrated that significantly greater proportions ofGL were
present in adult does compared to adult ewes, following a natural and artificial
challenge regime. The presence of elevated numbers ofGLs in the gut mucosa has
been closely correlated with increased resistance to nematode infections in sheep (O'
Sullivan and Donald, 1973, Gregg et al., 1978; Gill et al., 1991, see general
introduction), but given the high numbers ofworms present in the abomasa of adult,
yearling and kid goats, this is clearly not the case in this species. GLs have been
shown to be degranulated MMCs in sheep (Huntley et al., 1984) whilst in the goat,
the presence of low levels of GMCP within the cytoplasmic globules of some GL
(Chapter 3), suggests their mast cell origin in this species also. As such, their presence
may be indicative of increased mast cell activation, which has been associated with
type I hypersensitivity reactions that accompany the expulsion of nematodes from the
intestines of immune animals (Miller, 1996a). Therefore, the finding that the
secondary infected yearlings and kids were unable to reduce their total worm burdens
to the equivalent levels found in the secondary infected lambs, despite the presence of
significantly higher numbers ofGL, is a further indication of deficiencies in mast cell-
mediated expulsive mechanisms in the goat.
Cell counts from tissue sections stained with anti-GMCP demonstrated
increased mean numbers of positive cells in the CI group compared to the CC group
although the increase was not as significant as that found in equivalent histochemical
stained tissue sections. Regression analysis demonstrated a higher correlation between
total mast cell numbers and the cells staining positive with anti-GMCP in the tissues
of CC animals compared with the tissues of CI animals. This lack of correlation in
the trickle-challenged animals was probably due to the presence ofmuch larger
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numbers of poorly staining GL and degranulated MMC in the tissues of the CI
yearlings and kids (see Chapter 3 and Chapter 4) possibly as a result of chronic MMC
stimulation by worm antigens throughout the challenge period. This was borne out by
the finding that equivalent correlations on counts for the CC and CI lamb tissues
alone, where tissue protease concentrations were much higher (see below) and the GL
numbers significantly lower, remained almost constant at R^= 0.85 and 0.80
respectively (p < 0.001 in both cases).
ELISA results for tissue mast cell protease content using antibodies that are
cross reactive for both GMCP and SMCP (Chapter 3), demonstrated a significant
increase in the SMCP content of the CI lambs compared to the CC lambs. This
indicates that upregulation of SMCP production occurred in the lambs during the
trickle challenge period. This upregulation did not appear to be matched in the
equivalently infected yearling and kid tissues, which contained significantly less
GMCP in both the CC and CI animals. This could indicate a fundamental deficiency in
protease synthesis by the goat mast cells, although species differences in the kinetics
and quantities of protease synthesis and/or release from the goat and lamb mast cells
following challenge cannot be ruled out. For instance, earlier or more sustained
release ofGMCP from goat mast cells may have resulted in comparatively greater
depletion of the enzyme from the goat tissues by the time they were collected and the
enzyme concentrations assayed. Moreover, if incoming larvae are important for
triggering mast cell degranulation and GL formation, then these animals were all
sacrificed seven days after their last exposure to this source of antigens. Therefore, it
is also possible that mast cell protease production is maintained for longer in the
lambs than the goats through continued synthesis and storage in MMCs rather than in
GL. If so, this may also have contributed to the elevated residual SMCP
concentrations due to the presence of relatively higher numbers of MMC in the lamb
tissues. Further experiments aimed at investigating these two possibilities are
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warranted, these might include time course studies designed to examine comparative
changes in tissue protease concentrations during the 7 to 10 day period after a
primary or secondary larval challenge.
A further interesting finding was the significant increase in mast cell protease
concentrations in the CI lamb but not the CI goat jejunal tissues. This occurred
despite the predeliction of T. circumcincta for the abomasum, indicating that the
factors regulating SMCP synthesis in lambs may also influence MMCs at sites not
directly in contact with nematodes. Furthermore, mean cell counts for MMC and GL
in the jejunum (results not shown), did not demonstrate any significant increases when
comparing CC and CI infected animals from either species. The significance of this
remains to be fully determined, but suggests that increased synthesis and/or storage of
protease is induced in individual lamb but not goat jejunal MMCs following a period
of continuous challenge or secondary challenge with abomasal parasites.
Increased numbers of peripheral and tissue eosinophils are a characteristic
response to intestinal parasitism (Jones, 1993), and have been implicated in host
resistance to nematode infections (Buddie et al., 1992), although their exact role in
this context remains controversial (reviewed Rothwell, 1989). The peripheral blood
eosinophil results obtained in this experiment were found to be highly variable, with
no significant differences observed between the CC and CI groups. Likewise, there
were no significant differences in the responses shown between the goats, yearlings
and lambs within either group, although for reasons yet to be determined, mean
counts were found to be higher in the CC and CI kids Previous results from ewes and
does undergoing natural challenge at pasture suggests that continuous antigenic
challenge is required to maintain circulating eosinophil numbers, since blood
eosinophil levels decline significantly after housing and anthelmintic treatment
(Huntley et al., 1995). However, in the present study, artificial challenge over a
period of 49 days did not appear to increase the numbers of peripheral circulating
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eosinophils significantly in the CI animals. Whether higher experimental challenge
levels and/or dosing for longer periods are therefore required to induce blood
eosinophilia remains to be determined.
In the case of the tissue eosinophil numbers present in the abomasal tissues at
post mortem, significant differences between the CC and CI infected groups were
noted in the kids only. There were no consistent relationships detected between the
numbers of tissue eosinophils and the total numbers of abomasal worms or the
proportions ofworms recovered as L4 for animals in either group. These results
would therefore suggest that tissue eosinophils are unlikely to be directly responsible
for the differences in the established L4 and total worm burdens found between the
primary or secondary infected yearlings, kids and lambs.
Results from the serum IgE time course studies demonstrated possible age
and challenge dose-dependent influences on the production of total serum IgE in the
two species. Despite a high degree of variability amongst individuals, the CI yearlings
generated consistently higher mean IgE responses to the trickle challenge than either
the CI lambs or kids. This suggests that the younger animals are less able to produce
IgE responses in the face ofmoderate levels of larval challenge. This apparent inability
was overcome by administering the larger challenge at day 49, which generated a
sharp increase in the IgE response in the CC animals between five and seven days post
challenge. The larger dose also produced elevations in the mean total serum IgE
responses of the CI animals, suggesting a challenge-dose dependency for both primary
and secondary IgE responses. Interestingly, the secondary responses shown by the CI
animals did not start any earlier and were not significantly higher than the responses
shown by the CC animals. Indeed, in the kids, the CC response was significantly
higher than the CI response. This suggests that an anamnestic rise in total IgE levels
following secondary nematode infections does not occur in goats and lambs, which
agrees with previous findings in adult sheep (J. Huntley, personal communication).
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However, it should be emphasised that in this study, it was not possible to measure
specific IgE antibody levels, and it is recognised that total IgE concentrations may not
reflect the true IgE antibody status of these animals (Jarrett et al., 1980). Further
work into the development of assays able to detect the presence of parasite-specific
IgE is therefore required, to confirm whether the findings presented here can be fully
attributed to the host's response to gastrointestinal nematodes.
Overall, the findings in this experiment confirm and extend the observations
made by Huntley et al. (1995) regarding the inability of goats to regulate their gastro¬
intestinal worm burdens when compared to equivalently challenged sheep. Moreover,
they also provide further evidence for significant differences in mast cell functional
activity in both species, particularly with regard to the extremely low levels of GMCP
and high numbers ofGL present in the goat gastro-intestinal tissues. The next two
chapters will therefore focus on the functional responses shown by goat mast cells in
isolation. This will be achieved by generating and characterising goat BMMC and by
purifying goat MMC and GL from parasitised intestinal tissues before analysing their
respective activities following in vitro exposure to nematode antigen preparations.
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CHAPTER 7
THE EFFECTS OF RECOMBINANT OVINE INTERLEUKIN-3
AND RECOMBINANT OVINE STEM CELL FACTOR ON THE
GROWTH AND MEDIATOR EXPRESSION OF CAPRINE AND
OVINE BONE MARROW DERIVED MAST CELLS.
7.1 Introduction
The in vitro production of cytokine-dependent mast cells from haemopoietic
and lymphoid tissue has been demonstrated in a number of species, including mice
(Razin et al., 1984), rats (Haig et al. 1988a) and humans (Furitsu, Saito, Dvorak,
Schwartz, Irani, Burdick, Ishizaka and Ishizaka, 1989). Sources ofmast cell
stimulatory factors were initially derived from fibroblast monolayers and conditioned
medium harvested from the supernatants ofmurineWEHI-3 tumour cells or mitogen-
activated T cells (Razin etal. 1984, Levi-SchaefFer, Dayton, Austen, Hein, Caulfield,
Gravallese, Liu and Stevens, 1987). Conditioned medium derived from conacavalin A
stimulated mesenteric lymph node cells has also been used to grow mast cells
successfully from rat and sheep bone marrow (Haig et al. 1983; Haig et al., 1988b).
More recently, advances in cytokine gene cloning have provided access to
recombinant cytokines, allowing their individual and combined effects to be studied in
vitro. Both IL-3 and SCF stimulate the development and proliferation ofmast cells in
mice (Razin et al. 1984, Zsebo et al. 1990a, Rennick et al., 1995), rats (Haig et al.,
1988a, Haig et al. 1994) and the basophil or mast cell lineages in humans (Saito et al.,
1988; Durand et al., 1994, Metcalfe et al., 1995). In sheep, sequencing of the gene
for ovine interleukin 3 (Mclnnes et al. 1993) and the cDNA for ovine stem cell factor
(Mclnnes, unpublished, EMBL No.Z50743) has enabled expression of their respective
recombinant protein products for the work presented here.
The objectives of the study described in this Chapter were to :
a) Determine the effects of rOvIL-3 and rOvSCF either alone or in
combination on the generation ofmast cells from caprine and ovine haemopoietic
precursor cells.
b) Examine the effects of these cytokines on the growth kinetics, longevity and
granule-associated mediator content of these cell cultures.
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c) Look for significant inter-species differences in mast cell granule content.
d) Produce cultures containing sufficient numbers of viable mast cells for
future nematode allergen-induced mediator release studies.
7.2 Materials and methods
7.2.1 Animals
Suffolk cross lambs aged six - twelve months and Scottish cashmere goats
aged six months - four years were used in all experiments. The sheep were bred at the
MRI, and the goats bought from Sourhope farm, Kelso, Roxburghshire, Scotland. All
animals used had been previously exposed to nematode parasites whilst maintained
on pasture.
7.2.2 Culture techniques
Preparation of rOvIL-3 and rOvSCF
Cell supernatants containing these cytokines were generously provided by Dr
D. Haig and Dr. G. Entrican having been prepared, as described by Mclnnes et al.
(1993), for the production of rOvIL-3. Stable expression of rOvIl-3 and rOvSCF was
achieved in Chinese Hamster Ovary (CHO) cells using the Celltech® pEE14 vector
(Cockett, Bebbington and Yarrington, 1990). The gene for rOvIL-3 (Mclnnes et al.
1993) and the cDNA for the soluble form of rOvSCF (Mclnnes, unpublished, EMBL.
No.Z50743) were ligated into separate vectors adjacent to the human
cytomegalovirus immediate early promotor sequence. The vector contains the
glutamine synthetase (GS) gene as an amplifiable marker in CHO cells. After
transfection of ligated pEE14 1L-3/SCF plasmids into CHO cells, transfectants
expressing elevated levels of GS were selected in the presence of 25 - 250 pM
methionine sulphoximine (MSX; Sigma Cat. No. M 5379). Expression of rOvIL-3
and rOvSCF mRNA was checked by Northern blotting, and recombinant protein
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expression by gel electrophoresis. Batches of supernatant were collected and assayed
for biological activity in 24 well plate bone marrow cultures as described below.
Bone marrow cultures
Sternal bone marrow cells were isolated and established in culture as
described in 2.10.1. Cells were adjusted to 2 or 3 x 10~* cells per ml IMDM + 2-ME
+10%FCS + P/S and aliquoted into sterile 24 well plates for dose response testing of
2
the cytokine supernatants, or 75-225 cm flasks for time course studies.
Dose response studies
For dose response studies to determine optimal cytokine concentrations, lml
aliquots per well of isolated bone marrow cells at 2 x 10^ cells per ml were set up in
triplicate sets ofwells. To each set was added dilutions of rOvIL-3 alone or a
combination of rOvIL-3 and dilutions of rOvSCF. The rOvIL-3 and rOvSCF
supernatants were diluted in IMDM + 10%FCS + P/S + 2-ME to give a final range of
10"! to 10~6 v/v rOvIL-3 supernatant for the rOvIL-3 titration and 1(H to 10~4 v/v
rOvSCF alone or in the presence of an optimised dilution of 10~2 rOvIL-3 for the
rOvSCF titration. For each experiment, the same pattern was repeated in 2 further
plates to allow harvesting at 3 separate time points. A seventh set of triplicate wells
was also set up on each plate, containing IMDM and 10~1 v/v non-transfected CHO
supernatant (IMDM + CHO) as a negative control. All plates were incubated and fed
with fresh cytokines and IMDM as described in Chapter 2.10.2.
Individual plates were harvested for their supernatants and cells at 3 separate
time points (days 6, 12 and 18 for rOvIL-3 titrations and days 7, 14 and 21 for
rOvSCF titrations) as described in Chapter 2.10.3.
Time course studies
For time course studies, isolated bone marrow cells were set up at 3 x 10^
cells per ml in IMDM + 10%FCS + P/S + 2-ME, containing optimal concentrations of
3
rOvIL-3 and rOvSCF supernatant in 75-225 cm sterile tissue culture flasks (Corning,
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USA). The initial culture volume was noted, and the flasks incubated under the same
conditions as the 24 well plates. Every 48-72 hours supernatant and cells were
harvested and the cultures fed with fresh cytokines as described in 2.10.2 and 2.10.3.
At the same time, the total culture volume was adjusted to maintain the cells at < 3-5
x 105 cells per ml.
7.2.3 Enumeration and staining ofBMMC
Cytosmear preparations were prepared as described in Chapter 2.8.2. The
slides were either stained immediately with Leishman's (Gurr) for immediate
assessment of the cultured cell populations (see Chapter 8; Fig. 8.1c), or fixed in 4%
paraformaldehyde PBS as described in Chapter 2.8.6 and Chapter 2.8.2. Fixed slides
were subsequently stained for the presence ofmast cells using rabbit polyclonal
antibodies raised against goat mast cell protease (Chapter 3) as described in Chapter
2.8.7. Positive cells on the cytosmears (see Chapter 8; Fig. 8. Id) were counted as
described in Chapter 2.8.9
7.2.4Mast cell enzyme assays
Culture supernatants and cell extracts were prepared as described in Chapter
2.10.4. The supernatants and extracts were tested for their GMCP, SMCP, aryl-
sulphatase and [^-hexosaminidase content as described in Chapter 2.12.
7.2.3 Statistical analysis
Group mean results obtained from 3 separate cultures or more were compared
using a paired Students T-test as described in 2.14.1. Graphed data (except for Fig.




7.3.1 Cytokine dose response studies
Figures 7.1 and 7.2 show the total cell numbers for goat cells grown in 10"1 to
10~6 rOvIL-3 alone (Fig. 7.1) or 10~1 to 10~4 rOvSCF with or without rOvIL-3 at
10~2 (Fig. 7.2). The results demonstrated a dose response effect on total cell
proliferation when rOvIL-3 alone was used at 10~2 to 1(H> and rOvSCF at 10"! to
10~4 in combination with 10"^ rOvIL-3. Significantly larger numbers of cells were
produced by day 21 (Fig. 7.2) in cultures incorporating both cytokines at 10"! v/v
when compared with cultures containing 10~2 rOvIL-3 alone, 10"^ rOvSCF alone or
IMDM + CHO.
Figures 7.1 and 7.2 also show total mast cell numbers calculated from the
percentage of cells reacting with antibody to GMCP. In the rOvIL-3 dose response
cultures (Fig. 7.1), cells grown in 10~2 rOvIL-3 produced up to 50% GMCP-positive
mast cells by day 12 . This response appeared to be dose dependent at all three time
points for cells grown in rOvIL-3 at 10~2 tol0~6 although when 10"! rOvEL-3 was
used, significantly fewer cells (p<0.01) stained positive at both dayl2 and day 18. In
the rOvSCF dose response cultures (Fig. 7.2), cells grown in 10"! rOvSCF with 10~2
rOvIL-3 produced up to 65% mast cells by day 21. This response was dose
dependent for 10~1 to 10""4 rOvSCF at all three time points. In contrast, cells grown
in rOvSCF alone (Fig. 7.2) showed no significant increase in mast cell numbers when
compared with the IMDM + CHO control cultures. ELISA results for supernatants
harvested from all cultures were below the levels of assay detection (< 0.5 ng/ml).
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Fig.7.1Mean total and GMCP-positive mast cell numbers for goat bone marrow cells
set up in 10"* to 10~6 dilutions of rOvIL-3 or IMDM + 10~1 CHO supernatant.
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Fig7.2 Mean total and GMCP-positive mast cell numbers for goat bone marrow cells
set up in 10"! to 10"4 dilutions of rOvSCF with 10"2 rOvIL-3, 10"^ SCF only, 10~2
rOvIL-3 only or IMDM + 10-1 CHO supernatant . 10~1 - 10"4 = rOvSCF + 10~2
rOvIL-3; SCF = 10"^ rOvSCF alone; IL-3 = 10~2 rOvIL-3 alone; Con = IMDM +
10"! non-transfected CHO supernatant
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Since no significant differences (p>0.05) were detected in both the total and
mast cell counts for cells grown in 10~2 rOvSCF compared with 10~1 rOvSCF, whilst
the use of 10"! rOvIL-3 suppressed mast cell numbers, both cytokines were used at
10~2 v/v in the subsequent time response experiments.
7.3.2 Cytokine time course studies
Figure 7.3 shows the total cell numbers obtained from two typical flask
cultures maintained over 47 days. The cells were fed with 10~2 rOvIL-3 alone or
10~2 rOvIL-3 and 10~2 rOvSCF. Cells maintained in rOvIL-3 alone showed only a
moderate rise in total cell numbers with a peak of 7 x 10? total cells on day 7. In
contrast, the addition of 10~2 rOvSCF resulted in a marked rise in cell numbers
beginning on day 3 with a peak of 2.6 x 10^ cells by day 17. Total cell numbers
dropped earlier in the cultures stimulated with rOvIL-3 alone, so that on day 27 very
few cells were detected. The remaining cells had the appearance ofmonocyte/
macrophages on Leishman stained cytosmears and were GMCP-negative. The rOvIL-
3 and rOvSCF fed cells also declined in numbers after day 17, but after 3 weeks
growth, the cell numbers stabilised, and the cultures could then be maintained for up
to 7 weeks before degenerating.
Figure 7.4 shows the mean (n=3) percentage totals for GMCP-positive
staining cells obtained from time response cultures. In the early stages (day2 - day 5),
more cells grown in both 10~2 rOvIL-3 and 10"2 rOvSCF stained positive when
compared with those grown in 10~2 IL-3 alone (results only significant (p<0.05) at
d2). Thereafter, the percentage positive cells in the rOvIL-3 alone cultures increased
rapidly, overtaking the rOvIL-3 + rOvSCF cultures by day 7. Subsequently, the
percentage of GMCP-positive cells grown in rOvIL-3 alone declined over the next 12
days, and by day 3 1 there were no positive cells left in the culture. In contrast, the
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percentage ofGMCP-positive cells in the rOvIL-3 + rOvSCF cultures increased to
produce peak numbers ofmast cells by day 12, but following a slight decline between
day 12 and day 14, the numbers of positive cells stabilised so that by day 42, there
were still GMCP-positive cells present. Cells grown in 10~2 rOvSCF alone showed no
significant increase in the numbers ofGMCP-positive cells in the cultures from day 2
onwards. At day 7 and day 12 there were more cells positive for GMCP in these
cultures when compared to equivalent control cultures grown in IMDM + lO'^CHO
alone. However, by day 18 there was no protease detected in any of the remaining
cells which were again identified predominantly as macrophages from their
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Fig.7.3 Total cell numbers for flask grown goat bone marrow cells fed with









Fig. 7 .4 Mean (±SD) percentages (n=3) of the goat bone marrow time response
culture cells that react positively with antibody to GMCP
7.3.3 Enzyme concentrations
1) Mast cell proteases
Figure 7.5 shows the mean SMCP/GMCP content in ng per 10^ mast cells for lysed
cell pellets taken from 4 time response cultures per species. Day 0 sheep bone marrow
samples contained significantly more protease than the goat day 0 samples. Following
an initial (day 0 to day 5) decline in protease levels present in the sheep cells, the
protease concentrations in the cell pellets in all cultures increased slowly with no
significant differences noted between the species or combinations of cytokines used.
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After day 7, SMCP levels in the sheep cultures increased significantly compared to the
goat cultures giving a peak value of 13.82 ±1.6 ng per 10^ mast cells for rOvIL-3
cultures and 17.52 ±7.78 ng per 10^ mast cells for the rOvIL-3 and rOvSCF cultures.
In the goat cultures, equivalent concentrations ofGMCP were 5.42 ±1.7ng per 10^
mast cells and 5.0+3.05 ng per 10^ mast cells for rOvIL-3, or rOvIL-3 and rOvSCF
fed cultures respectively. No significant differences were noted in the protease content
of cultures from either species when comparing cells grown in rOvIL-3 alone with
cells grown in rOvIL-3 and rOvSCF during the first 3 weeks. However, from day 21
onwards, there was a rapid decline in the protease content of cultures from both
species fed with rOvIL-3 alone, with no protease detected after 4 weeks. In contrast,
by day 35 the sheep and goat cells grown in rOvFL-3 and rOvSCF still contained 7.46























Fig.7.5 SMCP/GMCP content of sheep and goat bone marrow cells grown in




Figure 7.6 shows the results for P-hexosaminidase content defined as units of activity
per lO^ mast cells. Enzyme activity was minimal until day two for all cultures, which
corresponded with the appearance of significant numbers of immature mast cells on
Leishman stained cytosmears. Thereafter, the sheep and goat cells grown in IL-3
alone show peak activity at day 14 (8.58 ±3.5 and 4.32 +0.4 units per 10^ mast cells
respectively) before declining to zero by day 35. The cells grown in the presence of
rOvSCF continued to increase their P-hexosaminidase content until day 28, with the
goat cells containing significantly more than the sheep cells at this time point.
However, by day 35, the P-hexosaminidase content of the goat cells had decreased to
6±5.0 units per 10^ mast cells which was not significantly different to the sheep cells
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Fig. 7.6 P-hexosaminidase content of sheep and goat bone marrow cells grown in




Figure 7.7 shows the results for aryl-sulphatase content defined as pg aryl-sulphatase
per 1C)6 mast cells. Throughout the culture period, the sheep cells contained
significantly more (P < 0.05) aryl-sulphatase than the goat cells. There were no
significant differences observed in the mediator content of cells cultured in rOvIL-3
alone when compared with those cultured in rOvIL-3 and rOvSCF during the first
two weeks of culture. However, after 3 weeks, the mediator content of the cells from
both species grown in EL-3 alone declined, so that by the 4th week they contained






Fig. 7.7 Aryl-sulphatase content of sheep and goat bone marrow cells grown in




Previous work by Mclnnes, Haig and Logan (1993) and Sture (1996)
demonstrated that rOvIL-3 alone was capable of producing mast cells from ovine
sternal haemopoietic cells. However the resulting cultures were of limited lifespan
(three to four weeks), and the cells generated appeared immature in terms of
morphology and mediator content when compared with mast cells isolated ex vivo
from sheep intestinal tissues (Huntley, 1991; Huntley et al. 1992). Pilot studies,
carried out prior to the work presented here, also demonstrated that rOvIL-3 alone
was able to stimulate the development and growth of caprine BMMC.
A major result of this study was that optimal amounts of rOvSCF, in
combination with rOvIL-3, significantly increased the total cell numbers produced in
both ovine and caprine bone marrow cultures. Both cytokines also increased the
longevity of the cultures for at least 3-4 weeks beyond the normal lifespan of cultures
generated in rOvIL-3 alone. These responses were only seen in cells grown in a
combination of rOvSCF and rOvIL-3, and not in cells cultured with either cytokine
alone indicating that the effect was dependent on synergy between the two cytokines.
The results differ from previous data obtained from rat cultures (Haig et al., 1994),
which demonstrated that recombinant SCF alone promoted the development cultured
mast cells in this species. However, the presence of a synergistic action of rOvSCF
and rOvIL-3 in rat and human mast cells has been demonstrated (Haig et al., 1994,
Metcalfe et al., 1995), whilst a role has also been suggested for SCF in promoting the
survival of cultured human mast cells by suppressing apoptosis (Iemura, Tsai, Ando,
Wershil and Galli, 1994, Galli et al. 1995). The prolonged survival of ovine and
caprine BMMC achieved by the addition of rOvSCF in the present study may, in part,
be due to the ability of rOvSCF to suppress an apoptotic mechanism which is still
functioning in cells that have been cultured in rOvIL-3 alone.
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There were no significant differences in the mediator content of cells from
either species grown in rOvIL-3 alone when compared with cells grown in rOvIL-3
and rOvSCF, which was also at variance with previous data obtained for rat (Haig et
al. 1994). In these studies, the RMCP-II content ofBMMC maintained in SCF was
significantly less than that of cells maintained in either IL-3 or LNCM alone whilst
there was also an increase in expression of the CTMC-associated protease RMCP-I.
RMCP-II could also be detected in the supernatants ofBMMC, especially when
BMMC numbers were increasing rapidly in SCF with or without the presence of EL-3
or LNCM. This indicated that SCF not only regulates the growth of rat BMMC, but it
also influences the production and release of protease mediators. SCF has been shown
to induce directly SCF receptor-dependent mast cell mediator release in mice and
humans (Galli et al.. 1995), but equivalent findings were not demonstrable in this
study. Supernatant samples taken from the dose response and time course cultures
were all found to be negative when tested by ELISA (< 0.5 ng protease/ml).
However, these results should perhaps be treated with caution since the culture
techniques used required relatively frequent changing ofmedium in the dose response
experiments, and the addition of large volumes ofmedium to maintain cell populations
at 3-5 x 10^ cells per ml in the time course experiments. This, combined with the
low levels ofmediator present in these cultured cells, may have resulted in the
dilution of any released protease to below detectable levels. , -
On examining the time course total cell count data, it can be seen that over the
period ofmaximal expansion in cell numbers (between day 2 and day 7), the mediator
content of the harvested pellets remained low, indicating possible immaturity of the
expanding population of cells.. This profile changed as cell proliferation slowed by
day 12 and the mediator concentrations generally increased indicating that a
maturation process was occurring. Thereafter, cells that were maintained in rOvIL-3
alone declined in numbers from 2-3 weeks onwards, with a concomitant decrease in
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their mediator content as they degenerated. In contrast, cells grown in both rOvIL-3
and rOvSCF continued to survive for a further 2-3 weeks, with relatively stable
concentrations of aryl sulphatase, protease and p-hexosaminidase.
Significant differences were noted in the mediator content of sheep bone
marrow derived cells when compared to their goat equivalents. The goat cells
generally contained less GMCP, P-hexosaminidase (with the exception of goat
BMMC grown in rOvIL-3 and rOvSCF) and arylsulfatase after the first five days of
culture. Whether these differences are due to incomplete biological cross reactivity of
the ovine cytokines on caprine cells, or fundamental differences in mediator synthesis
in caprine and ovine BMMC, has not been established. However, evidence in support
of the latter has come from observations that goat tissues and gastro-intestinal derived
isolated MMC contain less mast cell protease than their sheep equivalents (Huntley et
al. 1995, Chapter 3, Chapter 6 and Chapter 8).
The significantly lower concentrations of aryl-sulphatase present in the goat
BMMC cultures were also remarkable. Like P-hexosaminidase, this acid hydrolase
enzyme has been found in mast cells secretory granules from a variety of species
including rats, humans and sheep (Schwartz and Austen, 1981; Huntley, 1991;
Huntley, et al. 1992). However, they have been associated with the degradation of
ingested glycosaminoglycans, glycoproteins and glycolipids in intracellular
phagolysosomes. Phagocytosis has been demonstrated in rat mast cells (Vranian,
Conrad and Ruddy, 1981), but their function following release into the extracellular
environment from secretory granules is still not understood. Both enzymes have an
acidic pH optimum indicating that secretion into gastric or inflammatory acidic
environments would be required to permit expression ofmaximal activity (Schwartz
and Austen, 1984). Such circumstances may occur following release into the
abomasum during gastro-intestinal responses to nematode parasites. As yet, no
studies have been performed to examine the role of these enzymes in vivo in
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parasitised ruminants. However, the significant lack of aryl-sulphatase in goat BMMC
indicates a further mediator deficiency associated with these cells which may have
relevance to MMC responses associated with the regulation of gastro-intestinal worm
burdens.
In terms ofmorphology and mediator content, BMMC generated with rOvIL-
3 and rOvSCF from both species appear immature when compared with isolated
MMC (see Chapter 8 Figures 8. la and 8. lc) or cells grown using ovine LNCM
(Huntley, 1991). This would indicate that there are other factors required for full mast
cell maturation and granule-associated mediator expression. These may include the
cytokines IL-4, IL-9 and IL-10 which have been shown to affect murine and human
mast cell development (Metcalfe et al., 1995, Renauld et al., 1995, Rennick et al.,
1995) but as yet, ruminant equivalents of these reagents are not available for use in in
vitro studies.
The following chapter extends these findings by comparing the morphological,
biochemical and ultrastructural characteristics of goat and sheep BMMC with MMC
and GL isolated from goat intestinal tissues. This is followed by the results of studies




THE BIOCHEMICAL AND FUNCTIONAL
CHARACTERISATION OF ISOLATED GOAT MMC AND IN
VITRO DERIVED BMMC: ANALYSING THEIR RESPONSES TO
STIMULATION WITH SECRETOGOGUES AND CRUDE
NEMATODE ANTIGEN PREPARATIONS
8.1 Introduction
Characterisation studies carried out on in vivo and in vitro derived mast cells
from a variety of species have demonstrated significant differences in their
biochemical and functional properties depending on their tissue location or the culture
system under analysis (reviewed Galli, 1990; Huntley, 1992). Studies investigating the
role ofmast cells in nematode infections require access to populations of cells which
possess the phenotypic characteristics ofMMC found in the ruminant intestine.
Techniques which isolate these cells from parasitised intestinal tissues, allow in vitro
analysis of the types and quantities of mediators released from activated MMC in
response to exposure to nematode antigens (Huntley, Wallace and Miller, 1982;
Huntley et al., 1984; Huntley, 1991; Jones, Huntley and Emery, 1992).
However, there are a number of practical difficulties associated with their use
ex vivo. Firstly, it can be hard to achieve sufficiently pure MMC/GL populations in
the harvested cells, secondly the cells may be damaged or functionally inactive
following the purification procedure (Huntley, 1991) and thirdly, it can be difficult to
ensure that the isolated MMC are of a homogenous phenotype. This last point is well
illustrated in the rat, where isolation of homogeneous MMC populations from
intestinal tissues is difficult due to the co-purification of CTMC present within serosal
and submucosal tissues (Befus, 1986; Huntley, 1991).
An alternative approach is to generate mast cells in vitro for functional
studies, and the previous chapter outlined the optimal conditions for the growth of
caprine BMMC using two currently available recombinant ovine cytokines. However,
before they can be used to replace isolated cells for functional studies, they must be
analysed to ensure that they also possess MMC-associated phenotypic and functional
characteristics.
Although the secretogogue responses of sheep MMC have yet to be fully
defined, BMMC from sheep generated using LNCM (Haig et al., 1988a) and rOvIL-3
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(Mclnnes et al., 1993; Sture, 1996) provide a convenient source of cells for further
studies into the ontogeny and function of ovine mast cells. Functional studies carried
out on these cells demonstrate that they can be stimulated to release their granule-
associated mediators in the presence of optimal concentrations of calcium ionophore
A21387 (Huntley 1991; Huntley et al., 1992a), but are generally refractory to sP or
Compound 48/80 (Sture, 1996). As outlined in the general introduction, this response
is usually associated with MMC in laboratory animals and humans. Moreover,
biochemical investigations, including analyses of proteoglycan content, protease
content as well as quantification of other mediators such as acid hydrolases, biogenic
amines and leukotrienes have also demonstrated their similarity to isolated ovine
MMC (Huntley, 1991; Huntley et al., 1992a).
Phenotypic analyses have yet to be carried out on mast cells derived from goat
tissues, and the aim of this chapter will firstly be to isolate MMC and GL from the
tissues of animals undergoing natural and experimental parasitic infections. These cells
will be analysed for their protease and acid hydrolase content, and attempts will be
made to activate them using secretogogues and crude worm antigen preparations. In
addition, ultrastructural and biochemical comparisons will be made with goat BMMC
generated in vitro in the presence of rOvIL-3 and rOvSCF. BMMC will also be
analysed for their functional activity in the presence of secretogogues as well as
nematode antigen preparations following sensitisation with sera or gastric lymph from
animals previously exposed to intestinal nematodes.
Comparisons between these goat and sheep mast cell populations may reveal
important differences in their structural and functional characteristics. Moreover, the
results should also characterise more fully the phenotype of goat and sheep BMMC
cells grown in the presence of rOvIL-3 and rOvSCF. Finally, findings obtained from
the worm antigen release studies may indicate the source of allergens important in
triggering mast cell-mediated immune responses to nematode parasites.
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8.2 Results
8.2.1 Morphological, biochemical and ultrastructural comparisons between isolated
goatMMC andBMMC grown in rOvIL-3 and rOvSCF
The isolation procedure was carried out as outlined in Chapter 2.9. Isolations
were attempted from six female goats all more than three years of age (Table 8.1).
The first three (3352, 3097 and 3021), had been maintained at pasture undergoing
natural exposure to parasites. The last three (A62, A26 and Y 55), had been
maintained indoors for approximately 6 months prior to the experiment so they were
given a mixed infection of 2000 T. circumcincta L3 and 2000 T. vitrinus L3 per os
once a week for 8 weeks prior to slaughter (see Chapter 2.2.9), to stimulate an
intestinal mastocytosis.
Animal % MMC + GL in Yield of isolated % MMC + GL in
tissue digest MMC/GLx 106 isolated cells
3352 6.5 7.5 69.2
3097 4.75 2 62.5
3021 4.75 5.5 57.5
A62 5.5 3.5 72
A26 5 3 65
Y55 2.5 ND ND
Table. 8.1 Goat MMC purification results showing the total numbers of cells
recovered from discontiuous percoll gradients and the % MMC and GL numbers in
the isolated cells as determined by counts on Leishman stained cytosmears. 2.8 x 10^
dispersed jejunal cells from each animal were layered onto Percoll gradients. ND =
not done, no cells recovered from the interface (see text). Cells from A62 and A26
were used for secretogogue release studies.
Leishman stained cytosmears of the purified cells demonstrated the presence
of small, basophilic staining, highly granulated cells and larger cells containing less
basophilic staining cytoplasmic globules. In both cell types, the granules or globules
were so densely packed that they obscured the cell nuclei (Fig. 8. la). Staining the
cytosmears with antibody for GMCP demonstrated that both cell types contained
protease (Fig 8. lb), although staining was weaker in the larger cells. In these latter
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cells, the staining appeared diffuse within large granules or globules, when compared
with the dense granule staining observed in MMC in tissue sections or BMMC (Figs
3.8 a and b and 8.1c). There was also evidence of disruption to the granular structure
of the smaller cells in both the Leishman and anti-GMCP stained sections. On the
basis of their cytoplasmic morphology, Leishman staining and protease content, the
smaller cells were identified as MMC, whilst the larger cells were identified as GL.
Contaminating cell types in the purified preparations included erythrocytes (Fig. 8.1a),
eosinophilic staining cells, monocytes and a few lymphocytes, which were all negative
when stained with anti-GMCP. Total cell recoveries ranged from 2 to 7.5 x 10^ cells
per animal, although in one animal (Y55), there were no cells present at the Percoll
interface following centrifugation. The reason for this remains unknown but it may
have resulted from aggregation of the cells in the initial tissue digest. In comparison,
goat BMMC cultures grown in IMDM, stimulated by the addition of optimal amounts
of rOvIL-3 and rOvSCF (Chapter 7) and harvested at day 16, contained up to 80%
mast cells as counted on Leishman stained cytosmears (Fig. 8.1c), although only 40-
50% of these cells reacted positively with anti-GMCP (Fig. 8. Id). Compared to the
isolated MMC, BMMC varied in size and were much less granulated, with some cells
containing cytoplasmic vacuoles. Cells with a similar morphology to isolated GLs
were not observed in the cultures. Attempts were made to induce GL formation in
some BMMC cultures by the repeated addition of secretogogues or worm antigens to




Fig. 8 la Cytosmear of isolated goat MMC and GL stained with Leishman's. Note the
highly prominent granules of the MMC and the globules in the larger GL cells
(arrows), also the granule disruption in the MMC and the presence of contaminating












Fig. 8 .1b Cytosmear of isolated goat MMC and GL stained with polyclonal rabbit
anti-GMCP 4% Paraformaldehyde (x 250).
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Fig. 8 .1c Cytosmear of day 16 goat BMMC generated using rOvIL-3 and rOvSCF
stained with Leishman's. Note the immature cytoplasmic granules (arrow) Mitotic
figures in the cell in the centre indicate that the mast cell population is still expanding











Fig. 8 Id Day 16 goat BMMC generated using rOvIL-3 and rOvSCF stained with
polyclonal rabbit anti-GMCP Note the granular cytoplasmic staining pattern and the
proportions of positive staining and negative staining cells 4% Paraformaldehyde
(x 250).
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Table 8.2 summarises data for the GMCP, aryl-sulphatase and P~
hexosaminidase content in isolated goat jejunal MMC/GL as well as goat and sheep
BMMC grown in rOvIL-3 and rOvSCF and harvested on day 16. Corresponding data
from Huntley (1991) quantifying the mediator content of sheep BMMC grown in
mesenteric LNCM and sheep MMC/GLs recovered from sheep abomasal tissues is
also included for comparison.











MMC 84.4 (±49) 74.4 (± 16.3) 0.07 (±0.02) ±
Goat
BMMC 5(±1) 1 (±0.17) 4.9 (±0.51) ±
Sheep








3875 (±563)** 88 (±4.7) 0.18 (±0.08) +
Table 8.2. Mean (±SEM) comparative mediator content data for goat and sheep mast
cells. Cell lysates derived from isolated MMC/GL (MMC) as well as day 16 goat and
sheep BMMC grown in rOvIL-3 and rOvSCF or day 21-35 sheep BMMC grown in
mediastinal lymph node-derived conditioned medium (LNCM). Results of immuno¬
fluorescence experiments to detect the presence of surface immunoglobulin are also
shown (Surface bound Ig, see below). *= data from Huntley et al. 1992. **= lysates
tested with SMCP ELISA, all other samples were tested with the cross-reactive
GMCP ELISA (Chapter 3). Results for goat jejunal MMCs are the mean of five cell
isolation experiments (see Table 8.1). Results for the BMMC represent the mean of at
least 4 cell preparations from 2 separate cultures.
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The results show that the isolated goat MMC/GL contained significantly more
GMCP than goat and sheep BMMC grown using recombinant cytokines (P < 0.01).
However, they also contain less protease than sheep BMMC grown in LNCM, whilst
a particularly striking finding was the substantial difference in the protease content of
goat MMC (84 ng/10^ mast cells) when compared to sheep MMC (3875 ng/lO^ mast
cells). Sheep BMMC grown using recombinant cytokines were also found to contain
significantly less (p < 0.001) SMCP than either the equivalent sheep BMMC
stimulated using LNCM or the sheep abomasal MMC/GL preparations. In contrast to
their protease content, no notable differences in arylsulphatase content were observed
in the isolated MMC from both species or sheep BMMC grown in LNCM or
recombinant ovine cytokines. However, the isolated MMC did contain more
arylsulphatase when compared with the sheep BMMC cells. In accordance with the
findings in the previous chapter, goat BMMC were found to be particularly deficient
in aryl-sulphatase, containing significantly less (p < 0.0001) than the other cells. As
noted in earlier studies on sheep BMMC (Huntley, 1992 and Sture, 1996), in vitro
derived BMMC from both species were found to contain significantly more p-
hexosaminidase than the isolated goat or sheep MMC (p < 0.001). In addition, the
goat and sheep BMMC grown using recombinant cytokines also contained more P-
hexosaminidase than the LNCM stimulated sheep BMMC cultures.
A morphological assessment of cytoplasmic granule formation was made by
transmission electron microscopy (TEM). Figures 8.2a and b shows micrographs of
day 16 goat and sheep BMMC grown using rOvIL-3 and rOvSCF. Figure 8.2c shows
a fully granulated, isolated goat MMC, whilst figures 8.2d and e show a degranulating
isolated goat MMC and an isolated goat GL respectively. The goat and sheep BMMC
(Fig. 8.2a and b) contain much less electron dense material within their cytoplasmic
granules when compared with those in the isolated MMCs (Fig. 8.2c and d). The
granules of the BMMC also appear incomplete and poorly formed, containing
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material that is more reminiscent of the floccular matter prominent within the
coalescing cytoplasmic structures of the GL (Fig. 8.2e) than the homogeneous opacity
of the isolated MMC granules. Sheep BMMC also contain marginally more electron
dense material within their cytoplasmic structures than goat BMMC, which may
correlate with the greater amounts ofmast cell protease and aryl-sulphatase found
within these cells (Table 8.2). The degranulating MMC (Fig. 8.2d) was probably
damaged during the purification process, and may not be representative of a mast cell
undergoing activation by normal physiological mechanisms. Nevertheless, the
cytoplasmic granules exhibit some of the characteristics previously reported in human
nasal and lung mast cells undergoing FcsRI mediated activation. These include a
reduction in individual granule size with relocation to the periphery of the cytoplasm
and loss of their homogeneous appearance to form intense staining rope-like
structures which typically precedes the particulate appearance of fully discharged
granules (Freidman and Kaliner, 1981). However, possibly due to species differences,
the scroll and lattice-like structures often observed in human mast cells cytoplasmic
granules (reviewed Dvorak, 1986) were not observed. The GL in Figure 8.2e exhibits
the large, coalescing cytoplasmic globules that dominate the cell and obscure the
nucleus in Leishman stained cytosmears (Fig. 8.1a), although there are still one or two
areas of electron-dense material, indicating that the cells have not discharged
completely.
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Fig 8.2a Day 16 goat BMMC generated in rOvIL-3 and rOvSCF, note the lack of
electron dense material in the granules (arrow) (xlO 000). Cell pellet fixed in 3%
gluteraldehyde and 0.1M sodium cacodylate for 24 hours at 4 °C.
Fig. 8.2b Day 16 sheep BMMC generated in rOvIL-3 and rOvSCF, note the presence
of some electron dense material in the cytoplasmic granules (arrow) (xlO 000). Cell
pellet fixed in 3% gluteraldehyde and 0.1M sodium cacodylate for 24 hours at 4 °C.
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Fig. 8.2c Fully granulated isolated goat MMC (xlO 000). Cell pellet fixed in 3%
gluteraldehyde and 0.1M sodium cacodylate for 24 hours at 4 °C.
Fig. 8.2d Degranulating isolated goat MMC, note non-homogeneous 'rope-like'
densities in the discharging granules (arrow) (xlO 000) Cell pellet fixed in 3%
gluteraldehyde and 0.1M sodium cacodylate for 24 hours at 4 °C.
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Fig. 8.2e Isolated goat GL, note remaining electron dense granules (arrow) (x 3550).
Cell pellet fixed in 3% gluteraldehyde and 0.1M sodium cacodylate for 24 hours at
4 0C.
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8.2.2 Demonstration of immunoglobulin binding on the surface ofgoatMMC and
goat BMMC
This was carried out as described in Chapter 2.11.3 using IgE positive serum
samples obtained from the animals used in the experiment described in Chapter 6.
Controls consisted ofBMMC cells incubated in IgE positive serum that had been heat
inactivated at 56 °C for 2 hours, MMC, or IgE positive serum-sensitised BMMC that
had been incubated with an anti-border disease virus monoclonal antibody (VPM-12)
in place of the anti-ovine light chain antibody (VPM-8). Figures 8.3 a to d show
immunolocalisation confined to the surface ofMMC (Fig. 8.3 a) and the IgE positive
serum incubated BMMC cells (Fig. 8.3c), but little reactivity was observed in
preparations ofMMC incubated with VPM-12 (Fig. 8.3b) or BMMC incubated with
heat-inactivated serum (Fig. 8.3d) (BMMC incubated with IgE positive serum and
VPM-12 were also negative, not shown). The experiment was repeated for pre-
sensitised sheep BMMC generated in rOvIL-3 and rOvSCF, which also exhibited
surface localisation of reaction product (not shown). The findings are in accordance
with those ofHuntley (1991), who demonstrated surface bound immunoglobulins on
LNCM stimulated sheep BMMC and isolated sheep MMC (Table 8.2).
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Fig. 8.3a Goat MMC/GL incubated with mouse anti-ovine light chain monoclonal
antibody (VPM-8) and anti-mouse IgG FITC. (x 400)
Fig. 8 3b Goat MMC/GL incubated with an irrelevant mouse anti-border disease
virus monoclonal antibody (VPM-12) and anti-mouse IgG FITC. (x 400)
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Fig. 8.3c IgE positive serum-sensitised day 16 goat BMMC grown in rOvIL-3 and
rOvSCF incubated with VPM-8 and anti-mouse IgG FITC. (x 400)
Fig. 8 3d Heat inactivated IgE positive serum-sensitised day 16 goat BMMC grown
rOvIL-3 and rOvSCF incubated with VPM-8 and anti-mouse IgG FITC (x 400)
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8.2.3 Functional characterisation ofgoat BMMC andMMC: Their responses to
secretogogues.
Duplicate 0.2 - 2 xlO^ aliquots ofMMC or BMMC were incubated with 10~4
to 10"^M calcium ionophore A21387, 10~2 to 10"^M sP or 250pg/ml Compound
48/80 for 45 minutes at 37 °C (Sture, 1996). After centrifugation, the resultant cell
pellets along with the supernatants were collected and tested for their GMCP, aryl-
sulphatase and P-hexosaminidase content as outlined in Chapter 2.12. Paired controls
incubated in ionophore diluent or Earles + 2% FCS only were also tested for positive
activation or background spontaneous release respectively. The final background
corrected results for mediator release into the supernatant were then expressed as a
percentage of the total cell mediator content detected in equivalent cell lysate
preparations as described in Chapter 2.12.6.
Duplicate aliquots of freshly purified MMC from 2 animals (A26 and A62)
were initially stimulated with secretogues as outlined above. However, supernatants
from the diluent only controls demonstrated very high spontaneous release ofGMCP
(56.7 ± 28.1%), aryl-sulphatase (56.4 ± 19.8%) and P-hexosaminidase (56.6 ±
21.2%) which was higher than the secretogogue stimulated samples or diluent
controls. Due to time constraints and difficulties associated with obtaining further
supplies of isolated mast cells, these experiments were discontinued and the remaining
functional characterisation work was performed on goat BMMC generated in vitro.
The secretogogue-induced GMCP, P-hexosaminidase and aryl-sulphatase
release release results for day 16 to 22 goat BMMC grown in rOvIL-3 and rOvSCF
are shown in Table 8.3. They demonstrate a significant (p< 0.05) dose response
effect, with maximal release demonstrated when the cells are stimulated with 10"^M
calcium ionophore (mean 70 to 80% release for P-hexosaminidase and aryl-sulphatase
and 39.3% for GMCP). The cells were relatively refractory to the effects of the other
secretogogues, although compound 48/80 and lO'^M sP stimulated the cells to









A21387 10"4M 12.1 (±4.7) 19.2 (±4.4) 11.3 (±2.6)
A21387 10"5M 24.3 (±7.3) 18.2 (±0.6) 23.4 (±9.8)
A21387 10"6M 39.3 (±6.35) 70.2 (±11.8) 76.6 (±3.4)
A21387 10"7M 21.7 (±5.9) 25.5 (±5.3) 12.5 (±14.2)
*Diluent + ethanol
release
14.5 (±1.1) 18.6 (±4.4) 16.7 (±2.3)
Compound 48/80
(250 pg/ml)
23.5 (±2.1) 0 2.3 (±2.1)
Substance P 10~7M 3.5 (±4.5) 0 0.7 (±0.8)
SubstanceP 10~4M 8.2 (±4.5) 0 0
**
Diluent only 8.1 (±6.7) 0.35 (±0.3) 10.5 (±3.8)
Table 8.3. Mean (±SD) percentage mast cell GMCP, aryl-sulphatase and P-
hexosaminidase release after 45 minutes incubation with secretogogues using day 16
to day 22 goat BMMC fed with 10"2 rOvIL-3 and 10~2 rOvSCF. All tests were
carried out on duplicate samples in three experiments, each experiment used cells
taken from separate time response cultures. *Cells incubated in diluent containing the
equivalent concentration of ethanol required to dissolve 10~4M A21387 (see 2.11.1).
A21387 results are corrected for this spontaneous release. **Cells incubated in
diluent only. Compound 48/80 and substanceP results are corrected for this
spontaneous release. ***Aryl-sulphatase tested in two experiments only due to the
low levels of this enzyme found in day 16 goat BMMC. Mediator release results from
individual experiments shown in Appendix B (pp iii - v).
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8.2.4 Functional activation ofgoat and sheep BMMC: Their response to stimulation
with crude nematode antigen preparations.
Results from the secretogogue release experiments indicated that the BMMC
cultures possess a functional phenotype similar to isolated MMCs characterised
previously from other species (reviewed Barrett and Pearce, 1993). An experiment
was therefore set up to examine the cell responses to stimulation with crude nematode
antigen preparations from T. circumcincta and H. contortus L3 and I^/adults. These
preparations were kindly donated by Dr. D. Knox and Dr. J. Huntley having been
prepared as outlined in 2.11.4 using larvae and adults cultured or collected by Dr. F.
Jackson. Freshly thawed aliquots of antigen were diluted to 100pg/ml in Earles
medium without FCS immediately prior to use, to minimise proteolytic damage to
potential antigens within the extracts.
Aliquots of day 16-22 goat and sheep BMMC containing 0.5 - 2 x 10^ cells
were pre-incubated in IgE-positive goat serum. In addition, goat BMMC were also
pre-incubated with abomasal afferent lymph collected from an ADCM infected adult
doe that had been cannulated (Smith , Jackson, Jackson and, Williams, 1983a;
Patterson, 1996) and challenged with 50, 000 T. circumcincta L3 10 days before
sampling. The lymph sample, kindly provided by Dr. D. M. Patterson, contained 2.52
pg/ml total IgE by dot blot assay. Negative control samples consisted of cells pre-
incubated with serum that had been heat inactivated at 56 °C for 2 hours.
Unfortunately, due to limitations in the amounts of available lymph, it was not
possible to sensitise the sheep BMMC or incubate equivalent negative controls for the
lymph sensitised goat BMMC cells. Following sensitisation, the cells were washed and
incubated as described in 2.11.5 with 50gg/ml of T. circumcincta L3
excretory/secretory antigens (7IC.L3ES), T. circumcincta L3 whole worm
homogenate antigens (T.C.L3WWA), I circumcincta L5 excretory/secretory antigen
(T.C.L5ES), I circumcincta L5 whole worm homogenate antigens (T.c. L5 WWA),
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H. contortus L5 excretory/secretory antigens (H.c. L5ES) or H. contortus L5 whole
worm homogenate antigens (H.c. L5 WWA). After incubation, the cell pellets and
supernatants were harvested and tested for their GMCP, (3-hexosaminidase and aryl-
sulphatase content. Aryl-sulphatase results could not be obtained for cells incubated
with T.c. L3 WWA due to the presence of high levels of innate aryl-sulphatase
activity in the antigen preparation which interfered with the assay (Fig. 8.4c).
Duplicate samples of the goat BMMC were tested in three experiments whilst
duplicate samples of sheep BMMC were tested in two experiments. Each experiment
involved using cells from different time course cultures. The results were corrected
for spontaneous release from cells undergoing the sensitisation step only. The mean
(± SD) percentage mediator release results for P-hexosaminidase, GMCP and aryl-
sulphatase release are summarised in Figure 8.4a, b and c respectively.
The data shows that although there was considerable variation in individual
results, mean percentage release was generally highest for goat and sheep cells pre-
sensitised with IgE positive serum or lymph and incubated with the T. circumcincta
antigen preparations. This resulted in the cells releasing approximately 10 to 40% of
their mediator content although the highest mean percentage release results (60.2 ±
14.6% and 68.5 ± 11.73% for lymph and serum sensitised goat BMMC and 50.3 ±
42.1% for the serum- sensitised sheep BMMC), were obtained for GMCP release in
the presence of T.c. L3WWA. Despite the mean percentage release results being
invariably greater for sensitised cells, none of the results were significantly higher (p
> 0.05) than those obtained for the corresponding heat inactivated serum-sensitised
control cells. The mean percentage release results obtained for the heat inactivated
serum-sensitised control cells were also higher than expected although the overall
pattern of release with each antigen preparation was similar to that seen in
non-heated serum and lymph-sensitised cells. A further consistent feature, was the
apparently selective release of GMCP and aryl-sulphatase from sensitised and control
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goat cells stimulated with the T.c.L5 and H.c.L5 worm antigen preparations (Fig.8.4
b and c). This effect was also seen to a lesser extent for ^-hexosaminidase release
from goat cells stimulated with T.C.L5 ES (Fig.8.4a).
Fig. 8.4 a,b and c (following pages). Mean (±SD) % release of ^-hexosaminidase a),
GMCP b) and aryl-sulphatase c) from day 16-22 goat and sheep BMMC grown in
rOvIL-3 and rOvSCF. Cells sensitised with goat serum (IgE-positive serum) or lymph
from animals immunised with T. circumcincta or serum from the same animals that
had been heated to 56 °C for 2 hours (heat inactivated serum). Cell release stimulated
with crude excretory/secretory (ES) and whole worm homogenate (WWA) larval
antigen preparations: T.C.L3 = T. circumcincta L3, T.C.L5 = T. circumcincta L5.
H.C.L5 = H. contortus L5. (Aryl-sulphatase release from cells stimulated with
T.C.L3WWA not shown due to interference with the assay by the worm antigen
preparation.). Results shown for the goat BMMC are the mean of 3 separate
experiments carried out in duplicate samples. Results shown for the sheep BMMC are
the mean of 2 separate experiments carried out on duplicate samples. Individual
mediator release results for each experiment are shown in appendix B (pp vi - viii).
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8.3 Discussion
The results outlined in this chapter indicate that there are some similarities in
the structure, biochemistry and function of isolated goat MMC and goat BMMC
grown using recombinant ovine cytokines. In terms ofmorphology, Leishman's stain
reveals the presence of numerous granules in both cell types and, although the
BMMC granules are much smaller and less dense than the MMC granules, GMCP
can be localised to them by immunohistochemical staining. In addition, weak staining
for GMCP can also be localised to the large cytoplasmic globules ofGL that are co-
purified with isolated MMC, further indicating that the relationship between the two
cell types is similar to that demonstrated previously in sheep (Huntley et al., 1984).
The granule constituents of both cell populations are also similar with both
cell types containing GMCP, aryl-sulphatase and (5-hexosaminidase. The quantities of
particularly GMCP and aryl-sulphatase are significantly lower in the goat BMMC
when compared to the isolated goat MMC/GL. Isolated goat MMC/GLs also
contained approximately 45 times less GMCP per cell but similar quantities of aryl-
sulphatase and P-hexoaminidase when compared with values obtained for SMCP in
isolated sheep abomasal MMC (Huntley, 1991). Interestingly, this difference in
protease concentrations is of a similar magnitude to that found for adult sheep
abomasal and goat jejunal tissues (Huntley et al., 1995). However, it should also be
noted that there was morphological and ultrastructural evidence of granule disruption
in the isolated goat MMC (Fig 8.1a and b; Fig. 8.2d) and that they demonstrated a
high degree of spontaneous release in attempted functional characterisation studies.
As a consequence, the mediator results obtained from these samples may be
artificially low due to cell damage and/or degranulation during the purification
procedure.
Ultrastructurally, the granules in goat BMMC appear poorly formed when
compared with those in isolated MMC. In particular, the scarcity of electron-dense
material (fig 8 .2a) which is indicative of proteoglycan granule matrix bound protease
and histamine (Dvorak, 1986), agrees with the lack of protease found in BMMCs by
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ELISA. Moreover, the presence of particulate material within the BMMC and GL
suggests the presence of either incompletely formed granules in the BMMC which
may represent cellular immaturity, or in the GL, granules which have already
discharged, leaving the residual material seen within their cytoplasmic globules. The
apparent relationship between goat MMC and GL is also strengthened by the presence
of some electron-dense granules adjacent to the cytoplasmic globules of the GL which
parallels the pattern of anti-GMCP staining often seen in GLs in tissues in vivo
(chapter 3, Fig. 3.8; a and b).
Sheep BMMC generated in LNCM contained significantly more protease than
either goat or sheep BMMC generated using recombinant ovine cytokines (Table 8.2).
In addition to SMCP, Huntley (1991) also found evidence of a heavier antigenically-
related 31.5 kD [^H]- di-isopropyl fluorophosphate (DFP) binding serine-protease
band which appeared by day 7 in LNCM stimulated sheep BMMC cultures. This
band was not detected in equivalent samples of isolated sheep abomasal MMC. For
safety reasons, [^Hj-DFP binding analyses were not carried out on goat MMC or
BMMC samples, although Western blots ofDay 16 goat BMMC cell extracts probed
with anti-GMCP failed to detect the presence of an extra band (see chapter 3, Fig. 3.5
lane 3). This failure may be due to lack of protein expression or lack of sensitivity in
the blotting procedure. Alternatively, post translational modifications such as
glycosylation, to a single parent protease may occur in sheep BMMC, but not goat
BMMC, producing the different electrophoretic mobilities shown by the two bands.
There is evidence that glycosylation is a feature of some samples of SMCP isolated
from abomasal tissues and possibly immunoaffinity-purified GMCP (A. Pemberton,
personal communication, Chapter 3, Fig. 3.3b), whilst at least 2 potential
glycosylation sites were detected on cDNA sequences obtained for GMCP/SMCP I
and II (chapter 5). However, glycosylation ofGMCP present in goat MMC or BMMC
remains to be demonstrated and would require experiments involving incubation of
GMCP samples with glycosidase enzymes. It should be noted that sheep BMMC
cultures produced by Huntley (1991) were grown using LNCM and not rOvIL-3 and
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rOvSCF which may have resulted in these cells being exposed to additional cytokines
or growth factors responsible for controlling protease expression. It is therefore also
possible that this extra protease represents SMCP II (see Chapter 5) although further
biochemical characterisation studies including NH^-terminal sequencing would be
required to confirm this. In any case, the the significantly higher concentrations of
SMCP detected in the LNCM stimulated sheep BMMC may have been due, at least in
part, to increased expression of the additional cross-reactive 31.5 kD protease.
Attempts to characterise isolated goat MMC in terms of their functional
response to calcium ionophore A21387, sP and compound 48/80 were unsuccessful
due to excessive spontaneous release from unstimulated control samples. It is likely
that the cells were damaged during the isolation process, since histochemical and
ultrastructural observations indicated extensive disruption to the arrangement of their
cytoplasmic granules (Fig. 8.1 a and b; Fig. 8.2d). Similar problems were encountered
previously with isolated sheep MMC (Huntley, 1991) although since then,
improvements in the technique have enabled functionally viable cells to be isolated
from this species (Jones et al., 1992; Bendixsen et al., 1995).
In view of this failure to functionally characterise isolated goat MMC, it was
not possible to categorise goat BMMC as being 'MMC-like' in their response to
ionophores. However, the majority of characterisation studies on BMMC generated in
vitro using LNCM, IL-3 and SCF carried out in rats, mice, humans and sheep have
produced cultures where the majority of cells are biochemically and functionally
similar to MMCs. (Haig et al, 1982; Shanahan, Lee, Denburg, Bienenstock and Befus,
1986; McMenamin, Haig, Gibson, Newlands and Miller, 1987; Haig et al., 1988a;
Broide, Metcalfe and Wasserman, 1988; Macdonald et. al., 1989; Sredni, Friedman,
Bland and Metcalfe, 1983; Gilead, Rahamin, Ziv, Or and Razin, 1988; Huntley et al.,
1992).
In the present study, the greatest release from goat BMMC occurred with
10~6m A21387. This was in agreement with earlier studies using sheep BMMC
grown in LNCM (Huntley, 1991, Huntley et al., 1992). However, the goat BMMC
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also demonstrated approximately 25% and 10% GMCP release in response to
stimulation with Compound 48/80 and sP respectively, which has been associated
with the activation ofmast cells with a CTMC phenotype (Barrett and Pearce, 1993).
This moderate response to CTMC-associated secretogogues has been demonstrated in
mouse, and more recently, sheep BMMC generated with IL-3 (Chiu and Burrall,
1990; Sture, 1996) and suggests that they may either be atypical in their functional
activity, or that there is phenotypic heterogeneity within the cultured BMMC
populations.
Since the majority of goat BMMCs produced functional responses in keeping
with an MMC phenotype, it was considered that experiments to examine the
functional responses of these cells following exposure to nematode antigens were
justified. The results demonstrated a high degree of variability in the BMMC
responses from both species, although there was a trend towards enhanced release
from cells pre-sensitised with serum or lymph and challenged using T. circumcincta
antigen preparations. This may indicate that an antibody-mediated release mechanism
involving surface bound T. circumcincta specific IgE was involved, since the BMMC
were pre-sensitised with serum or lymph, containing elevated total IgE levels, from
animals undergoing active infection with T. circumcincta (chapter 5; Patterson, 1996).
However, cells pre-incubated with heat inactivated serum also released notable
quantities ofmediators. This effect was demonstrated in both goat and sheep BMMC
incubated with T. circumcincta antigens and in goat BMMC incubated with H.
contortus antigens. The results were all corrected for spontaneous release, which
represented the basal secretion during incubation, indicating that release occurred in
these control samples following addition of the nematode antigen preparations. This
may have been mediated as a result of incomplete inactivation of serum IgE, despite
heat treatment, or it may also indicate the presence of other antibody-dependent
release mechanisms that do not involve IgE but perhaps IgM or IgG. In this respect,
the release of acid hydrolases, PGf>2 leukotrienes following cross linking of IgG
bound to Fey receptors on the surface of murine BMMC has been previously reported
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(Katz et al. 1992). Although, if this was the case in the current experiments, then it
occurred despite the fact that heat inactivated serum sensitised control cells did not
exhibit immunofluorescence for surface immunoglobulin (Fig 8.3 d). Another
possible explanation would be the presence of an additional, and as yet undefined,
antigen dependent but non-antibody mediated release mechanism operating in both
the IgE positive and heat inactivated control sensitised samples.
Overall, these findings demonstrate that worm antigen preparations may be
able to stimulate mediator release from goat and sheep BMMC in vitro and, although
the results from this experiment are not significant due to large variations between
samples, mean release is possibly enhanced by pre-incubating the cells with IgE-
containing serum or lymph The ability of the different L3 and L5 stages of T.
circumcincta at stimulating BMMC degranulation also suggests that the response may
not be confined to stage-specific larval antigens, although greatest release was usually





The work described in this thesis has contributed to studies on the
comparative roles played by MMC and GL in gastro-intestinal nematode infections of
small ruminants. By using the goat as an experimental model, insights have been
gained into MMC and GL responses which may be involved in host regulation of
gastro-intestinal nematode burdens. Moreover, confirmation of the relative inability
of goats to regulate their worm burdens when compared with sheep (Huntley, 1995;
Chapter 6) provides ample opportunities for future comparative studies investigating
other aspects of the ruminant mucosal-immune response to nematodes.
In terms of caprine MMC responses, the most notable achievement was the
purification of low amounts of a neutral granule protease (GMCP) from parasitised
goat jejunal tissues (Chapter 3) which, after histochemical and immunological
analysis, was localised to goat gastro-intestinal MMC and GL. After further
biochemical and molecular analyses, this enzyme was also shown to possess similar
characteristics to the more abundant equivalent sheep mast cell enzyme, SMCP. The
development of an EL1SA for GMCP which was cross-reactive for SMCP validated
the previous use of SMCP antibodies for the measurement ofGMCP (Huntley et al,
1995), and allowed subsequent measurements of comparative mast cell chymase
concentrations in tissues and cell supernatants to be made with confidence.
The production of antibodies to GMCP also enabled the most detailed
examination of goat MMC, GL and GMCP distribution carried out so far (Chapter
4). This study, along with preliminary immunohistochemical findings outlined in
Chapter 3, localised GMCP to the majority ofMMC and GL in the gastro-intestinal
mucosa and also demonstrated its presence in some mast cells present in other
peripheral tissues. It was found that significant numbers of toluidine blue staining cells
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in certain tissue sites did not contain GMCP. This indicated that, as in sheep,
phenotypic heterogeneity occurs in goat mast cells on the basis of their protease
content. The presence of a putative goat mast cell tryptase enzyme that appears to be
antigenically distinct from GMCP was also noted. This enzyme was detected, using
anti-human tryptase antibodies, in a significant proportion ofMMC and GL in the
gastro-intestinal tissues. Previous observations have identified a similar distribution
for a putative mast cell tryptase enzyme in sheep. This protease requires further
characterisation, since it is possible that it could be an important enzyme in goat
intestinal tissues, playing a significant, although, as yet unspecified, role following
MMC activation.
Molecular characterisation studies carried out on cDNA isolated from goat
BMMC (Chapter 5) further demonstrated the similarity between GMCP and SMCP at
the DNA level whilst cDNAs encoding novel proteases in both the sheep and goat
BMMC were also found. These enzymes, designated as GMCP II and SMCP II, have
yet to be detected as distinct proteins in mast cell populations either in vivo or in
vitro. However, given their relatively poor identity with GMCP I and SMCP I in
terms of their predicted amino acid sequences (50-60%), it is possible that they
represent antigenically distinct proteins which were not recognised by the antibodies
used in this study. It would therefore be interesting to find out whether these
proteases are also expressed, and if so, in which cell populations (BMMC and/or
MMC) and in what quantities. Meanwhile, studies involving the sequencing of the 3'
end of GMCP I also require completion to determine whether the dual specific
properties shown by the isolated enzyme (Chapter 3) are dependent on the presence
of charged acidic residues at positions 189 and/or 226 of the primary amino acid
sequence.
Apart from GMCP I, dual-specificity has now been noted in a number of
other serine proteases including cathepsin G from human neutrophils (Hof et al.,
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1996), SMCP I (Pemberton et al., 1997a) and, bovine duodenase (Zamolodchikova,
1995a). Further studies examining the in vitro and in vivo properties of dual-specific
enzymes are therefore necessary to determine the physiological relevance of their
partial trypsin-like activity. These studies will be aided by the determination of
primary amino acid sequences for both GMCP and SMCP (Chapter 5; S. Macaleese,
unpublished observations) which will enable more detailed assessments to be made on
the spatial arrangement of residues present within the enzymes' active sites. Such
information will hopefully lead to to a greater appreciation of the structural
requirements for potential ruminant mast cell protease substrates and inhibitors
present in vivo.
Seven days after equivalent secondary challenges with T.circumcincta it was
found that there was 100-1000 times less GMCP compared to SMCP present in goat
and sheep abomasal tissues respectively (Chapter 6). This was coupled with
significant increases in the tissue protease content of trickle-challenged lambs
compared to primary challenged lambs, which were not detected similarly challenged
goats. In addition, the post mortem distribution and numbers of larvae present at each
stage of development within gastro-intestinal tissues of the two species were also
found to be significantly different. These findings suggest that lambs, in contrast to
goat yearlings or kids, are able to regulate their worm burdens either by reducing the
establishment of incoming larvae and/or by increasing the expulsion of already
established adult worms. Similar findings regarding sheep immune responses were
made by Huntley et al. (1992b) where it was found that gastro-intestinal mastocytosis
and elevated tissue levels of SMCP were associated with resistance in sheep trickle-
challenged with H. contortus. These responses involved the rapid expulsion (RE) of
both incoming and established larvae in a process which, on the basis of current
evidence, appears to be much less prevalent in the goat. Given the significant
differences found in tissue protease levels found between the species, this suggests
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that mast cell responses and tissue protease levels may play a critical role in mediating
RE-type responses seen in trickle-challenged lambs as they develop acquired
immunity to nematodes. However, the current study also highlighted other possible
causes for the increased numbers of retained larvae in the goat tissues, including the
presence of significantly higher abomasal pHs in the goats compared to the sheep.
Further experiments are therefore required to examine the causes underlying
alterations in goat abomasal pH values following infection, as well as their potential
effects on the development and fecundity of intestinal worms.
The precise mechanisms by which dual-specific ruminant MMC-derived
proteases may influence the development of gastro-intestinal immunity have yet to be
established, although ex vivo evidence in a rat intestinal perfusion model indicates that
RMCP II plays a significant role in causing rapid increases in intestinal-epithelial
permeability following MMC activation (Scudamore et al. 1995 a and b). The absence
of significant histological damage to the perfused mucosa following administration of
RMCP-II also suggests that these alterations in permeability occur through the
selective cleavage of protein substrates present within paracellular junctional
complexes (Scudamore 1995 b). Possible targets for this mechanism may include the
rat equivalent of a chicken zonula occludens protein, occludin, which from its
predicted amino acid sequence, has several chymotrypsin-sensitive sites in its
extracellular domains. Perfusion techniques have not been applied to ruminant studies,
although isolation and purification of both GMCP and SMCP (as well as bovine
duodenase) should make further investigations into activities of ruminant mast cell
proteases against putative junctional protein complex substrates in vitro more feasible.
Furthermore, studies in vivo could also be conducted to examine the relationships
between intestinal tissue protease concentrations and the comparative permeabilities
of parasitised goat and sheep mucosal epithelia to macromolecules including
immunoglobulins, serum albumin and parasite antigens during and after challenge with
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nematode larvae. Such experiments could exploit the the surgically modified intestinal
loop technique described recently in sheep (Pernthaner et al. 1996), which would
allow the local administration of purified mast cell proteases as well as the serial
sampling of intestinal contents and mucus. Recent gene knockout experiments
producing transgenic mice lacking the gene for the murine intestinal MMC protease
MMCP-1 may also provide answers regarding the in vivo role ofmast cell proteases
in murine models of intestinal nematode infections (H. R. P. Miller, personal
communication) although, due to technical difficulties, this approach is unlikely to be
applied directly to ruminant studies in the near future.
The ELISA for GMCP could not detect protease in serum samples from
parasitised goats or sheep or abomasal gastric lymph collected from ADCM
challenged does (data not shown). These results may simply have been due to
protease concentrations in the samples being below the sensitivity threshold of the
assay, although another possible reason is the presence of serine protease inhibitors
such as alpha-1-proteinase inhibitor and alpha-2-macroglobulin in the serum and
lymph. Evidence for the latter was suggested by the finding that pre-incubation of
detectable concentrations of purified GMCP or SMCP with goat and sheep serum
respectively caused complete inhibition of the enzymes' catalytic activity against BLT
(Chapter 3). In the sheep, these inhibitors have been shown to bind irreversibly to
SMCP in serum, making the resulting complexes non-reactive with anti-SMCP
antibody (A. D. Pemberton and J.F. Huntley personal communication). Therefore, it is
possible that substantial amounts ofGMCP released from MMC may be present in
this undetectable form. If so, the differences observed in tissue concentrations of
GMCP and SMCP in parasitised animals may be due to variations in the kinetics of
protease storage and release, and not due to different levels of synthesis in the two
species. Further studies to investigate GMCP synthesis and release kinetics as well as
the potential interactions between GMCP and serum or lymph derived inhibitors are
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therefore warranted. In the case of the former, experiments could involve comparative
ELISA analysis of tissue samples taken at serial time points following primary and
secondary nematode challenges or they could make use of the availability of cDNA
probes for GMCP I and SMCP I (Chapter 5) to analyse comparative protease mRNA
levels in the same samples by Northern blotting or semi-quantative RT-PCR.
The study described in Chapter 6 also provided the first comparative data on
serum IgE levels present in these two species. Unfortunately, due to technical
limitations, the findings were restricted to total serum IgE levels and not parasite-
specific IgE. However, both species demonstrated elevations in their total serum IgE
levels following a large primary or secondary challenge with 50,000 T. circumcincta
L3. IgE levels in yearling goats during trickle challenge were also found to be
marginally higher than in the equivalently challenged lambs. Such findings may have
been due to age differences between the yearling goats and the six month old lambs,
or from more continuous or longer antigenic stimulation due to comparatively higher
intestinal worm burdens present in the goats. However, until techniques have been
developed to measure parasite-specific IgE antibody selectively, interpretation of this
data will have to remain largely speculative.
Histochemical, immunohistochemical and ultrastructural analyses of goat GL
both in situ and after isolation suggested that they are related to MMC on the basis of
their GMCP content, putative tryptase content and residual granule morphology.
(Chapter, 3; Chapter 4 and Chapter 8). In contrast, findings by Konno etal. (1994),
demonstrated that that y5 T cell receptors are present on the surface of caprine GL
and that there are differences in the glycoaminoglycan content between caprine GL
and MMC. On the basis of these findings, they concluded that goat GL are not
derived from MMC but represent a y5 T cell subset of caprine granulated intra¬
epithelial lymphocytes (GIEL). However, the surface receptor and biochemical
characteristics of goat GIEL have not been fully investigated, whilst the presence of
251
GMCP in goat MMC/GL cells suggests that they are not derived from GIEL since
studies in other species have demonstrated antigenically distinct proteases in this latter
cell population (Huntley, McGorum, Newlands and Miller, 1984b). In the light of
these conflicting proposals for the origin of caprine GL, further investigations to
characterise completely the surface receptor and biochemical properties of caprine
MMC, GL and/or GIEL are now required. Such studies could be facilitated by the
application of the techniques described for the isolation of goat MMC and GL
(Chapter 8) although, due to a current lack of goat-specific reagents, surface receptor
characterisation studies will probably have to rely on the cross-reactivity of
heterologous ovine and bovine monoclonal antibodies. (Konno et al. , 1994; Navarro
et al., 1995). However, the results of the current studies in the goat do appear to
support similar findings in sheep, where intestinal GL have been convincingly
demonstrated as an end-stage maturation ofMMC (Huntley et al. 1984a).
The consistent finding that a much larger proportion of the total mast cell
population present in parasitised goat intestines were present as GL despite the
continued presence of significantly higher total worm burdens (Huntley et al., 1995;
Chapter 6) is intriguing, particularly as the presence of these cells in the sheep is
strongly associated with the ability to rapidly expel worms (O'Sullivan & Donald
1973; Stankiewicz et al., 1995). Whether the increased proportions ofGL present in
parasitised goat tissues are due to chronic antigenic stimulation ofmast cells by the
continual presence of relatively higher levels of nematode antigens, or whether it is
due to the failure or absence of some negative feedback mechanism which limits sheep
MMC activation and subsequent GL formation, is currently unknown. The possibility
of functional differences in GL activity between the two species also requires
investigation in experiments similar to the functional studies on goat BMMC
described in Chapter 8. These experiments could include measuring the functional
activity of sheep versus goat GL in vitro, through the release ofmediators and/or
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cytokines, following activation with secretogogues or IgE/antigen complexes.
However, such studies require techniques which enable the in vitro study of pure
populations of caprine and ovine GL and, as yet, these have not been successfully
developed. Crude attempts were made to induce GL formation in vitro from caprine
and ovine BMMC by continual stimulation with secretogogues and worm antigens.
These were unsuccessful despite the demonstration ofBMMC activation through the
release ofmediators (data not shown). This suggests that other components are
required to induce the cell-type switching in vivo. These may include factors released
by other cell types in the intestinal micro-environment including, T cells, B cells and
epithelial or stromal cells. Future studies in this area might therefore consider co-
culturing BMMC with other cell types at the time of antigen-mediated cell activation
to see whether this proves more successful.
The present study demonstrated the heterologous activity of ovine rOvEL-3
and rOvSCF in generating goat BMMC (Chapter 7), indicating that these cytokines
are important in the differentiation and maintenance ofmature MMC populations
within small ruminant intestinal-tissues in vivo. The current availability of rOvIL-3 and
rOvSCF cDNA probes (Mclnnes et al., 1993; C. Mclnnes unpublished observations)
will enable further studies investigating the comparative levels of cytokine expression
within goat and sheep intestinal tissues. Results from such experiments may provide
further insights into local factors controlling the phenotype and activity of the
increased mast cell and GL populations observed in the gastro-intestinal tissues of
both species following challenge (Chapter 3 and Chapter 6).
In terms of in vitro studies into ruminant intestinal mast cell function, the most
convenient cell source would be obtained by the production of transformed cell lines
exhibiting the phenotypic characteristics of isolated ruminant MMC. However, this
has yet to be achieved in goats and sheep. Attempts at producing immortalized ovine
BMMC through retroviral-mediated transfection of oncogene DNA have so far
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proved unsuccessful (Huntley, 1991). Until this can be realised, cytokine generated
BMMC cultures remain the most convenient, and consistent, method for analysing the
functional activity of ruminant mast cells in vitro. This was highlighted by the studies
in Chapter 8 where goat jejunal MMC and GL were found to be functionally inactive
following isolation, possibly due to damage incurred during the purification process.
As a result, although structural and biochemical characterisation studies demonstrated
qualitative similarities in mediator content between isolated MMC and BMMC it was
impossible to characterise fully the BMMC as being phenotypically MMC-like on the
basis of their functional activity. Nevertheless, secretogogue release studies carried
out on caprine BMMC demonstrated similarities with MMC-like functional
characteristics as demonstrated in other species and, on this basis, activation studies
involving nematode antigens were carried out.
In the nematode antigen release studies (Chapter 8), the most significant
findings were that mediator release from both caprine and ovine BMMC is possibly
induced from non-sensitised cells by worm antigens alone and that this response may
be enhanced by pre-sensitising with serum or lymph containing homocytotropic
antibodies. Binding of these antibodies to the surface of both MMC and BMMC
could also be demonstrated by immunofluoresence. Unfortunately, confirmation that
this Ig was IgE was not possible due to the lack of antibodies recognising ovine or
caprine native IgE. It is therefore possible that the enhanced release observed was
mediated by an antibody isotype other than IgE. Eurther studies utilising monoclonal
antibodies to other ovine antibodies such as IgGj and IgM could be used to rule out
the binding of these isotypes, but due to time constraints, this was not possible.
However, the finding that maximal cell activation followed cell sensitisation with
native serum and lymph samples from immune animals containing detectable levels of
total IgE suggests that antigen-mediated cross-linking of IgE bound to FcsRI
receptors may be occurring. Mediator release achieved by sensitised BMMC activated
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with nematode antigen preparations was usually found to be approximately half that
obtained when using optimal concentrations of calcium ionophore A21387 during the
characterisation studies. This could indicate that different activation mechanisms are
operating in each case although, again due to time constraints and limited reagent
stocks, comprehensive dose and time response studies for the nematode antigen
release experiments were not carried out. Thus, although the BMMC were usually
harvested at time points when they contained optimal amounts ofmediators (Chapter
7), the highly variable percentage release obtained in the presence of the different
nematode antigen preparations may have resulted from sub-optimal antigen
concentrations and/or incubation periods in the release protocol. Future work in this
area should therefore be aimed at standardising and extending these studies through a
comprehesive series of time and dose response experiments for each individual
antigen preparation.
The fact that BMMC sensitised with heat treated serum and lymph also
released significant quantities of their mediators in response to stimulation with
nematode antigens was also highly important as this may indicate the presence of
additional release mechanism(s) which induce mast cell degranulation despite the
apparent absence of surface bound immunoglobulins. Such antibody-independent
mechanisms may be important in vivo for stimulating rapid MMC-mediated responses
prior to the onset of the classical cell-mediated and humoral immune responses
following exposure and APC processing of parasite antigens. As outlined in the
general introduction, activated MMC have been shown to release a potent variety of
mediators and cytokines that can influence Th and effector cell responses as well as
humoral responses through Ig production and isotype switching. Therefore, it is
possible the 'sentinel-like' anatomical distribution ofMMC in the gastro-intestinal
mucosa coupled with this rapid antibody-independent response mechanism, plays an
important role in initiating and co-ordinating other aspects of the host's immune
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response as soon as mucosal exposure to nematodes occurs. However, the antigens,
receptors and signal transduction pathways involved in mediating this response are all
currently unknown and require further study. Future experiments should also involve
controls to test that the response is not due to endotoxin-mediated cytotoxicity of the
antigen preparations, whilst efforts should also be made to ensure that residual IgE
antibody, despite heat treatment and negative surface immunofluorescence, was not
responsible either. In the case of the latter, pilot studies incorporating non-sensitised
BMMC incubated with I c. L3 WWA alone demonstrated similar release responses to
BMMC incubated with heat inactivated serum (data not shown). This provided
further evidence for a possible non-antibody mediated release mechanism and also
indicated that release due to residual antibody activity in the heat treated serum
control samples was likely to be negligible. The current release experiment also
calculated mediator release as a percentage of the total BMMC content present in cell
lysate preparations (Chapter 2.) however, future studies would also benefit from a
more appropriate positive control involving the use ofmast cells that have been
triggered by surface cross-linking of IgE. This could possibly be achieved by
incubating sensitised BMMC with an optimal concentration of anti-ovine light chain
antibody.
The main aim of the current study was to assess the responses of caprine mast
cells to stimulation with different nematode antigens and as a result, the granule
associated mediators measured were chosen for their specificity (GMCP), relative
abundance ((^-hexosaminidase) and convenience ((3-hexosaminidase and aryl-
sulphatase). However there are other granule-associated mediators that have yet to be
examined in these cell populations, including most notably histamine, serotonin (5-
HT) and PGD2 which have all previously been demonstrated in ovine BMMC and
MMC (Huntley, 1991). In addition, this release protocol could also be modified to
investigate the comparative production of other mediators, including cytokines, which
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may be involved in the regulation of both mast cell-mediated and other cellular and
humoral responses to nematodes (see general introduction). This is becoming
increasingly possible with the development of cDNA probes and monoclonal
antibodies to a variety of cloned and expressed ruminant cytokines (reviewed Wood
and Seow, 1996). The expression of different recombinant ruminant cytokines may
also allow further studies on the in vitro generation ofBMMC enabling production of
cell populations that more closely resemble isolated MMC in terms of their granule
morphology and quantitative mediator content (Chapter 8).
In summary, the findings presented here have confirmed that significant
differences exist in terms of the mediator content of goat and sheep intestinal mucosal
MMC in vivo. However in vitro studies have also demonstrated that mast cell
populations from both species can be activated to release their granule-associated
mediators following exposure to secretogogues and nematode antigen preparation. It
is my contention therefore, that MMC are intimately involved in intestinal
hypersensitivity reactions which help to reduce nematode burdens in immune animals
by preventing larval establishment and increasing the expulsion of adult worms. Key
to this response is the antigen-mediated release of of neutral granule proteases from
MMC which, although it has yet to be demonstrated conclusively in ruminants, may
potentiate nematode expulsion by selectively altering mucosal epithelial permeability
to the pathotopic transfer ofworm antigens and immunoglobulins. In this respect, the
profound lack ofGMCP found in parasitised goat gastro-intestinal tissues could
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Dissolve in 1 litre dd H20 to provide a xlO stock solution. Dilute 1:10 in dd H20 and
adjust pH to 7.2-7.3 prior to use
1M Tris/HCl stock solution
Dissolve 121.12g Tris (Sigma Cat. No. T-8524) in 900mls dd H20, pH to 7.5 by
dropwise addition of concentrated HC1. Make up to 1 litre with dd H20. 0.01%
NaN3 may be added as a preservative.
20mM working Tris buffer made by mixing 20ml of the above with 980mls ddH20
GMCP purification and characterisation buffers
Tissue homogenate extraction buffers:
GMCP purification
homogenising buffer: 20mM Tris/HCl pH 7.8
tissue extraction buffer: 20mM Tris/HCl pH 7.8 + 1.0M NaCl
GMCP/SMCP ELISA extraction buffer for tissues and cell pellets
20mM Tris/HCl pH 7.8 + 1,5M NaCl + 0.01% NaN3
FPLC buffers:
CM-Sepharose column
bufferA: 20mM Tris HC1 pH 7.8
bufferB: 20 mM Tris HC1 pH 7.8 + l.OMNaCl
Mono S column
bufferA: 20mM Tris HC1 pH 7.8
bufferB: 20 mM Tris HC1 pH 7.8 + l.OMNaCl
n
Synthetic substrates tested against GMCP:
Carboxybenzoyl-L-Tyrosine nitrophenol ester (Sigma Cat. No. C-3637 )
Carboxybenzoyl-L-Tryptophan nitrophenol ester (Sigma Cat. No. C-5502 )
Carboxybenzoyl-L- Phenylalanine nitrophenol ester (Sigma Cat. No. C-4502)
Carboxybenzoyl-L-Alanine nitrophenol ester (Sigma Cat. No. C-4635 )
Carboxybenzoyl-L-Argnine nitroanilide (Sigma Cat. No. C-4893 )
Carboxybenzoyl-L-Tyrosine nitroanilide (Sigma Cat No. B-6760 )
all were dissolved in 100% dimethyl-sulphoxide (Sigma Cat. No. D-8386) to produce
5mM stock solutions
Carboxybenzoyl-L-Lysine thiobenzyl ester (Sigma Cat. No. C-3647 ) was dissolved in
DMSO to produce a lOmM solution which was diluted 1: 1 with a lOmM solution of
5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB; Ellman's reagent) (Sigma Cat. No. D
8130)
Working buffer for substrate assays:
0.1M Tris/HCl pH 7.8
(Reactions stopped by adding lOOpl 100% methanol)
SDS-PAGE buffers
SDS gels:
12% resolving gels (lOmls)
2.5mls 1M Tris/HCl pH 8.8 (resolving buffer)
4mls 30% acrylamide, 0.8% bis-acrylamide in ddH20 ( Easigel, Scotlab, Glasgow)
2.8mls ddH20
0.5mls 10% sodium dodecyl sulphate (SDS) in ddH20
10 pi N,N,N',N'-tetramethylethylendiamine (TEMED) (Biorad systems Cat. No. 161-
0800 )
lOOpl 10% ammonium persulfate in ddH20
Azocasein gels made up as above but with 20mg azocasein (Sigma Cat. No. A 2765)
added prior to casting.
7.5% resolving gels (lOmls)
2.5mls 1M Tris/HCl pH 8.8 (resolving buffer)
2.5mls 30% acrylamide, 0.8% bis-acrylamide in ddH20
4.4mls ddl l20
0.5mls 20% SDS in ddH20
in
10 nl TEMED
lOOpl 10% ammonium persulfate in ddH20
4% stacking gels (5.4mls)
1.4mlslM Tris/HCl pH 8.8 (stacking buffer)
0.7mls 30% acrylamide, 0.8% bis-acrylamide in ddH20
3.09mlsddH2O
0.14mls 20% SDS in ddH20
10 pi TEMED
lOOpl 10% ammonium persulfate in ddH20
Sample buffer:
Reducing buffer (lOmls)
2.5 mis stacking buffer
2.3 mis ddH20
2.0 mis glycerol
2.0mls 20% SDS in ddH20
1 ml P-mercaptoethanol (Sigma Cat. No. M 6250)
0.2 mis 0.1% bromophenol blue (sodium salt) (Sigma Cat. No.B 7021)
Non-reducing buffer made up as above but without the addition of (3-
mercaptoethanol
Laemmli Tris/glycine running (tank) buffer pH 8.3 (x 5 stock solution, dilute in





Silver stain development solutions:
Fixing solutions
a) 50 mis methanol, 10 mis glacial acetic acid made up to lOOmls with
ddH2Q
b) 5mls methanol, 7mls glacial acetic acid made up to lOOmls with ddH20
Reducing solution
lmg dithiothreitol (Sigma Cat. No. D-5545) in 20mls ddH20
Staining solution
lOOmg AgN02 in lOOmls ddH20
iv
Developing solution
3g NaCC>3 and 50pl 37% paraformaldehyde in lOOmls ddH^O
Stop solution
67.6 g citric acid dissolved in lOOmls ddH^O
Coomassie stain for azocasein substrate gels and amino acid sequence blots:
Stain
5g Coomassie brilliant blue R (Sigma Cat. No. BO 149)
450mls ethanol
lOOmls glacial acetic acid
add dye to the ethanol /acetic acid, leave overnight at room temperature, filter
(Whatman's No.l) and add 450mls ddH^O
Destainer
250mls ethanol, 750mls glacial acetic acid make up to 2 litres with ddH^O




0.3M Tris, 20% methanol; pH 10.4
(150mls 1M Tris + lOOmls methanol + 250mls ddH^O)
Anode buffer 2:
25mM Tris, 20% methanol; pH 10.4
(12.5mls 1M Tris + lOOmls methanol + 387.5mls ddT^O)
Cathode buffer:
25mM Tris/40mM, 40mM 6-amino-n-caproic acid (mwt.
131.2; Sigma Cat. No. A 2504), 20% methanol pH 9.4
(12.5mls 1M Iris + 40 mis 0.5M 6-amino-n-caproic acid + lOOmls
methanol + 347.5mls ddlT^O)
v
Western and dot blotting
Blocking , washing and antibody diluent buffer:
PBS + 0.02% Tween 80 (polyoxyethylenesorbitan-monooleate, Sigma Cat
No. P-1754) + 0.5MNaCl
Immunoaffinity column buffers
Protein A, Protein G and Polyclonal anti-GMCP columns:
bufferA: PBS + 0.5MNaCl
bufferB (elution buffer): 0.1M Citrate + 0.5M NaCl pH 2.2
Neutralisation buffer: 1M Tris pH 10.8
Antibody production
Adjuvants
Primary dose: Freund's complete adjuvant (Sigma Cat. No. F 5881)
(polyclonal antibody) or QuilA (Superfos Biosector Batch No. C77-67)
(monoclonal antibodies)
Booster doses: Freund's incomplete adjuvant (Sigma Cat. No.F 5506)
(polyclonal antibody) or QuilA (monoclonal antibodies)
Monoclonal antibodies
NS0 murine myeloma cell culture medium
500mls RPMI 1640 (Gibco BRL, Life technologies Ltd. Cat. No.
04305140D) + 10ml penicillin/streptomycin solution (P/S) (10000 units
penicillin and 10000 jig streptomycin per ml.
Hybridoma cell culture media
Plating medium containing hypoxanthine, thymidine and aminopterin (HAT):
500mls RPMI 1640 + lOmls P/S + 50-75 mis heat inactivated FCS
(Advanced Protein Products Cat. No. AS 302 50) + 0.075g oxaloacetic acid
(OAA) (Sigma Cat. No. O 9405) + 0.025g pyruvate (PYR) (Sigma Cat. No. P
3662) + 0.0041g insulin (INS) (24 I.U.mg"! ; Sigma Cat. No. I 4011) + 10ml
x 50 HAT (Sigma Cat. No. H 0262) + 5mls 1M 3-[N-morpholino]
propanesulphonic acid (MOPs) (Sigma Cat. No. M 5162 )
VI
FCS heat inactivated at 55 °C for 2 hours prior to use in all tissue culture
media
Feeding medium (for use after the first sub-cloning of the hybridoma cells)




4g paraformaldehyde dissolved in lOOmls PBS. Heat in a fume cupboard to
dissolve the paraformaldehyde. Cool to room temperature for tissue fixation
or 40°C for cytosmear fixation.
Modified Bouin's Fixative
Add lOmls of 40% paraformaldehyde and 5mls of glacial acetic acid
tol90mls saturated aqueous picric acid.
Graded alcohol series for dewaxing, rehydrating and dehydrating slides: (all steps
carried out with fresh solutions and require regular agitation)
Dewaxing: 2x5 minutes in 100% xylene
Rehydrating: 3 minutes n equal parts 100% ethanol (740P) and 100% xylene
3 minutes n 740P
3 minutes n equal parts 740P and ddH20
5 minutes n ddH20
Dehydrating: 5 minutes n 89% ethanol (640P)
3 minutes n equal parts 740P and ddH20
3 minutes n 740P
3 minutes n equal parts 740P and 100% xylene
Clearing: 2x5 minutes in 100% xylene
Histochemical stains
Haematoxylin
Ehrlich's haematoxylin original formula, Gurr® microscopy materials, (BDH,
Cat No. 350172Q)
Toluidine blue (Enerback 1966a)
0.5% toluidine blue (Sigma Cat. No.T 3260) in 0.5N HC1 pH 0.5 (Check pH
and filter (Whatman's No. 1) before use)
Vll
Carbol chromotrope (Lendrum 1944)
5g chromotrope (Chromotrope 2R, Gurr® microscopy materials, (BDH, Cat
No. 34020HP)
lOg Phenol
dissolve in 1 litre ddH^O.
Leishman's stain
Leishman's staining solution (eosin methylene blue compound 0.2% w/v in
methanol, Gurr® microscopy materials, (BDH, Cat No. 35022)
Carboxybenzoyl-l-lysine thiobenzyl ester (BLT) stain
incubation solution for 4% PF/PBS fixed cytosmears or tissues:
50ml 0.2M Tris pH 8.2 (pH with concentrated HC1)
10 mg Fast Blue BB (Sigma Cat. No. F 0250) - dissolve thoroughly
4.2mg Carboxybenzoyl-L-Lysine thiobenzyl ester (Sigma Cat. No. C-3647)
Immunohistochemical solutions
Endogenous peroxidase blocking solution
methanol + 0.5% H2O2
(0.5mls H2O2 added to 98.5 mis methanol)
Blocking and antibody diluent solution
4% bovine serum albumin /PBS
(Dissolve 4g BSA in 100ml PBS)
Peripheral blood eosinophil staining
Carpentier's Stain
2% aqueous Eosin Y (Sigma Cat. No. E 6003), 0.5g in 25ml dd^O
37% formaldehyde (Sigma Cat. No. F 1635) saturated with calcium
carbonate. Make up saturated formaldehyde by adding 0.5g CaCC>3 per 100ml
formaldehyde. Carpentier's stain prepared from 2ml of 2% Eosin Y and 3ml




dissolve in 500ml tap water
VI11
DNA sequencing
TBE buffer (x5 stock solution, dilute in ddHgO before use)
272.5g Tris, 139g Boric acid and 100 mis 0.5M EDTA
dissolve in 5 litres ddH^O
Gels
Formaldehyde and agarose gels for RNA and DNA detection respectively
were all separated using Hoefer gel apparatus (Horizon 58 or 11-14; Hoefer
Scientific) submerged in 1 x MOPs buffer (Sigma Cat. No. M-5162 )
(formaldehyde gels) or 1 x TBE Buffer (agarose gels).
Formaldehyde gels for RNA detection
0.4g agarose (Sigma Cat. No. A 9539)
4ml 10 x MOPs pH 7.0;
36ml RNase/DNase free dd^O
Melt in a microwave oven (600 Watts medium setting for 2 minutes) allow to
cool to < 50°C. Add 2ml of 37% formaldehyde (37g formaldehyde in 100ml
RNase/DNase free dd^O) before casting the gel
Agarose gels for DNA detection
Mix 0.8g agarose (Sigma Cat. No. A 9539) in lOOmls TBE and add 80pl of
0.5mg/ml ethidium bromide solution. Heat in a microwave oven (600 W
medium setting for 2 minutes) allow to cool to < 50°C before casting the gel.
Northern running buffer/Agarose sample buffer
50% glycerol
0.1 mg/ml bromophenol blue (Sigma Cat. No. B 5525)
in RNase/DNase free dd^O
PCR reactions
Primary PCR mixture
5 pi 10 x PCR buffer (Boerhinger Mannheim Cat. No. 1 647 679)
5pl primer 1 (lOpM)
5pi primer 2 (lOpM)
2pl reverse transcriptase reaction product




Reaction mixture overlayed with 40jal mineral oil to prevent evaporation
2pl DNA Taq polymerase (1 unit/pl) (Boerhinger Mannheim Cat. No. 1 647
679)
Secondary PCR mixture
5 pi 10 x PCR buffer
5pi primer 3 (lOpM)
5pi primer 4 (lOpM)
1 pi primary PCR product
5 pi 2pM dNTPs
26pl sterile ddB^O
40pl mineral oil to prevent evaporation
2pl DNA Taq polymerase (1 unit/pl)
PCR amplification programme (used for all amplifications, contains a final 30 minute
extension step to produce overlapping ends for ligation into PCR 2.1™ vector)
Temperature (°C) Time (minutes) Number of cycles Process
94 10 1 cDNA strand separation
72 0.5 1 add Taq 'hot start1
55 0.5 1 binding
72 0.5 1 polymerising
94 0.5 30 cDNA strand separation
55 0.5 30 binding
72 1 30 polymerising
72 30 1 extension step
25 till samples removed
Southern blotting and probe hybridisation hybridisation buffers
Denaturing solution
1.5M NaCl + 0.5N NaOH
(87g NaCl and 20g NaOH dissolved in 1 litre dd^O)
Agarose gels containing PCR products for digoxigenin-labelled
oligonucleotide probing washed for 15 minutes and 30 minutes in this
solution
Neutralising solution
1.5M NaCl + 0.5M Tris + 0.001M EDTA pH 7.5
(87g NaCl, 60.56g Tris and 2mls of 0.5M EDTA dissolved in 1 litre dd^O.
pH to 7.5 with concentrated HC1)
X
Denatured agarose gels neutralised for 15 minutes and 30 minutes prior to blotting
onto Hybond N+ nylon membranes overnight
20 x SSC stock buffer: 3M NaCl + 0.3M Na-citrate pH 7.0
Dilute with ddH?0 to the required concentration (2 x SSC , 1 x SSC, 0.5 x
SSC or 0.2 x SSC ) and add 0.1% SDS (w/v)
Maleic acid butler: 0.1M maleic acid + 0.15M NaCl pH 7.5
(11.61g maleic acid and 8.76g NaCl dissolved in 950ml ddH20. pH to 7.5
with 5M NaOH, make up to 1 litre with ddH20)
Maleic acid Tween wash buffer: Maleic acid buffer + 0.3% Tween 20 (Sigma
Cat No. P -1379) (1.2mls Tween 20 in 400mls buffer)
Blocking buffer:
1% Blocking solution (Boerhinger Mannheim Cat. No. 1 096 176) in maleic
acid buffer
Buffer 3: lOOmM Tris + lOOmMNaCl + 5mM MgCl2 pH 9.5
Buffer for stripping blots: 0.2M NaOH + 0.1% SDS
(0.8g NaOH + 1ml 10% SDS in lOOmls dH20)
Nutrient media for the selection and maintenance of pCR™2.1 plasmid transformed
E.coli cells.
When handling E.coli cells and nutrient media, all materials used were initially flamed
to prevent contamination.
Luria-Bertolani broth (LB) agar plates containing kanamycin and x-galactopyranoside
(x-gal)
Heat 500mls LB agar ( 32g LB agar powder per litre of sterile ddH20; Sigma
Cat. No. L 2897) for 10 minutes on low in a 600W microwave oven
Mix and simmer on low for a further 5 minutes
Incubate in a water bath at 55 °C for 55 minutes
Add 5 mis 5mg/ml kanamycin (Sigma Cat. No. K 0879) dissolved in sterile
ddH20
Add 400pl lmg/ml 5-bromo-4-chloro-3-indolyl [3-D-galactopyranoside
(x-gal) (Sigma Cat. No. B9146)
pour into sterile petri dishes and flame prior to storing at 4 °C
XI
LB containing universals for overnight growth of selected E.coli colonies
lOmls LB media ( 25g LB broth base per litre of sterile ddH20 Sigma Cat.
No. L 3522) aliquoted into sterile, glass universals.
Add 10 pi of lmg/ml ampicillin (Sigma Cat. No. A 2804) dissolved in sterile
ddH20
MMC isolation, tissue culture and mast cell release media
HBSS/heparin tissue culture medium for bone marrow and MMC isolation
500ml Hank's balanced salt solution diluted from xlO stock solution in
ddH20 (Gibco BRL, Life technologies Ltd. Cat. No. 041-04020/1M).
10ml penicillin/streptomycin solution.
10 000 units heparin (tissue culture grade 1A, Sigma Cat. No. H3149)
IMDM/10% FCS tissue culture medium for BMMC
500ml Iscove's modification of Dulbecco's medium (Gibco BRL, Life
technologies Ltd. Cat. No. 041-01980M)
50ml FCS (Advanced Protein Products Ltd. Cat. No. AS-302-50) (heat
inactivated in a water bath at 56°C for 30 minutes)
10ml penicillin/streptomycin solution
50pl 2-ME (50mM 2-mercaptoethanol)
Earles + 2% FCS tissue culture medium for cell release studies
500ml Earles salt solution containing Ca^+ and Mg^+ without HCO3 diluted
from xlO stock solution in ddH20 (Gibco BRL, Life technologies Ltd. Cat.
No. 042-04050H)
10ml FCS
Discontinuous Percoll™ gradients for MMC isolation
Stock Isotonic Percoll (IP) solution
11.5 mis sterile Percoll™ (Pharmacia Bio-tech, Uppsala Cat. No. 17 0891 01)
+ 1ml xlO Hanks balanced salt solution without HCO3 (Gibco BRL, Life
technologies Ltd. Cat. No. 041-04020)
XII
55% IP = 55mls IP + 45mls xl HBSS without HCO3
65% IP - 65mls IP + 35mls x 1HBSS without HCO3
80% IP = 80mls IP + 20 mis x 1HBSS without HCO3
Gradients made up with 2mls 80% IP overlayed with 4 mis 65% IP. Cells resuspended




0.1M NaHC03 (0.84g NaHC03 in 100ml ddH20)
0.1MNa2CO3 (1.06gNa2CO3 in 100ml ddH^O)
Titrate the 0.1M NaHC03 to pH 9.6 with the Na2C03. Store at -20°C in 20ml
aliquots until use.
Sample diluent and wash buffer
PBS + 0.05% Tween 20 (Polyoxyethylenesorbitan-monolaureate; Sigma Cat.
No. P 1379) (lml Tween 20 in 2 litres of PBS)
Antibody diluent buffer
PBS + 0.5% Tween 80 (Polyoxyethylenesorbitan-monooleate) (Sigma Cat.
No. P 1754) + 0.5M NaCl = 5mls Tween 80 and 29.22g ofNaCl in 1 litre of
PBS
p-hexosaminidase assay buffers
Citrate buffer for substrate, pH 4.5
Solution A
300ml 1M NaOH (1M NaOH = 40g NaOH + 1 litre ddH20)
31. 5g Citric acid
Make up to 1 litre with ddH20
Xlll
Solution B
0. IN HCL ( 1 N HCL = 89mls concentrated HC1 + 1 litre ddH20 )
Working citrate buffer solution = 67.8ml of solution A + 32.2ml of solution
B, titrated to pH 4.5
Substrate
p-nitrophenyl-N-acetyl-P-D-glucosaminide (Sigma Cat. No. N9376). 5mM
substrate solution = 1.7mg substrate per ml of citrate buffer, pH4.5 (substrate
dissolves slowly, leave on a rotary mixer for 60 minutes at room
temperature before using.)




The above is made up to 500ml with ddH20
Solution B
0.2N NaOH
Working glycine NaOH solution = 52.8mls of solution A + 47.2mls of solution N,
titrated to pH 10.7. (Chill the solution on ice prior to use)
Aryl-sulphatase assay buffers
Acetate buffer for substrate pH 5.7
0.2M sodium acetate (27.22g sodium acetate in 1 litre ddH20), titrated to pH
5.7 with concentrated HC1
Substrate
p-nitrocatechol sulphate (Sigma Cat. No. N-7251) 6.255mM substrate
solution = 9 75mg substrate per 5ml acetate buffer, pH 5.7
Stop solution
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BMMC Secretogogue release data
p-hexosaminidase
Ionophore Experiment 1 Experiment 2 Experiment 3 Mean SD
A21387 10"4M 13.7 10.2 10.2 11.3 2.0
A21387 10"5M 13.9 22.7 33.6 23.4 9.8
A21387 10"6M 79.1 72.7 77.9 76.6 3.4











2.6 4.2 0.03 2.3 2.1
Substance P 10"
2M
0.4 0 1.6 0.7 0.8
Substance P 10"
4M
0 0 0 0 0
* *Diluent only 12.8 6.1 12.6 10.5 3.8
* * *Aryl-sulphatase
Secretogogue Experiment 1 Experiment 2 Mean SD
A21387 10"5M 16 22.3 19.2 4.4
A21387 10"6M 18.6 17.8 18.2 0.5
A21387 10"7M 78.6 61.8 70.2 11.8







0 0 0 0
Substance P 1 0"7m 0 0 0 0
Substance P lO'^M 0 0 0 0
**
Diluent only 0 0.7 0.35 0.49
GMCP
Ionophore Experiment 1 Experiment 2 Experiment 3 Mean SD
A21387 10"4M 7.5 11.9 16.9 12.1 4.7
A21387 10"5M 23.8 31.8 17.3 24.3 7.2
A21387 10"6M 44.9 40.6 32.4 39.3 6.3







21.9 19.9 24.1 23.5 2.1
Substance P lO'^M 8.7 0.2 1.6 3.5 4.5
Substance P 10~4M 3.6 12.5 8.6 8.2 4.4
'
Diluent only 6.4 2.4 15.5 8.1 6.7
Individual results for secretogogue release experiments described in Chapter 8. Values
for each eperiment represent the mean percentage madiator release for duplicate
samples.
* Cells incubated in diluent containing the equivalent concentration of ethanol
required to dissolve 10~4M A21387 (see chapter 2). A21387 results are corrected for
this spontaneous release.
** Cells incubated in diluent only. Compound 48/80 and substanceP results are
corrected for this spontaneous release.
*** Aryl-sulphatase data based on two experiments only due to the exceptionally low
levels of this enzyme found in day 16 goat BMMC
y
BMMC worm antigen release data
Goat BMMC i) % Beta-hexosaminidase release
Heat inactivated serum sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 12.54 14.59 0.00 9.04 7.90
T.circumcincta L3 WWA 16.04 0.00 3.48 6.51 8.44
T.circumcincta. L5 ES 7.26 10.33 0.02 5.87 5.29
T.circumcincta L5 WWA 0.00 0.02 0.00 0.01 0.01
H.contortus L5 ES 0.00 0.00 0.00 0.00 0.00
H.contortus L5 WWA 0.00 0.03 0.00 0.01 0.02
Lymph sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 9.04 19.06 8.62 12.24 5.91
T. circumcincta L3 WWA 15.80 23.74 10.44 13.66 6.69
T.circumcincta. L5 ES 12.11 8.08 11.50 10.56 2.17
T.circumcincta L5 WWA 0.72 0.41 0.50 0.57 0.16
H.contortus L5 ES 0.00 1.08 0.54 0.81 0.54
H.contortus L5 WWA 0.41 0.60 1.48 0.83 0.57
IgE positive serum sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 21.29 28.96 13.80 21.35 7.58
T.circumcincta L3 WWA 15.85 3.57 16.00 11.81 7.13
T.circumcincta. L5 ES 16.41 20.62 8.17 15.07 6.33
T.circumcincta L5 WWA 0.45 4.63 0.45 2.54 2.41
H.contortus L5 ES 0.00 1.05 0.00 0.52 0.61
H.contortus L5 WWA 0.00 6.91 2.18 3.03 3.53
Goat BMMC ii) % GMCP release
Heat inactivated serum sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 9.96 10.25 0.00 6.74 5.83
T.circumcincta L3 WWA 22.24 62.77 29.08 38.03 21.70
T.circumcincta. L5 ES 6.02 4.72 0.00 3.58 3.17
T.circumcincta L5 WWA 0.00 0.71 0.00 0.36 0.41
H.contortus L5 ES 0.00 13.94 0.00 6.97 8.05
H.contortus L5 WWA 11.72 9.72 9.54 10.33 1.21
Lymph sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 0.00 17.55 16.83 11.46 9.93
T.circumcincta L3 WWA 62.71 73.45 44.57 60.24 14.60
T.circumcincta. L5 ES 1.98 6.54 2.47 3.66 2.51
T.circumcincta L5 WWA 0.00 0.71 0.00 0.36 0.41
H.contortus L5 ES 0.00 29.74 0.00 14.87 17.17
H.contortus L5 WWA 0.00 21.80 9.54 10.45 10.93
IgE positive serum sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 4.97 17.47 16.83 13.09 7.04
T.circumcincta L3 WWA 81.37 65.97 58.34 68.56 11.73
T.circumcincta. L5 ES 4.81 13.06 25.47 14.45 10.40
T.circumcincta L5 WWA 23.52 0.00 0.00 11.76 13.58
H.contortus L5 ES 0.00 36.69 0.00 18.34 21.18
H.contortus L5 WWA 26.43 26.21 0 00 17.55 15.20
SVI
Goat BMMC iii)% Aryl-sulphatase release
Heat inactivated serum sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 17.72 8.16 18.40 14.76 5.73
T.circumcincta. L5 ES 3.38 9.71 17.40 10.16 7.02
T.circumcincta L5 WWA 3.65 1.00 0.00 2.32 1.89
H.contortus L5 ES 0.00 0.00 7.75 3.88 4.47
H.contortus L5 WWA 0.00 5.73 3.89 3.21 2.93
Lymph sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 19.32 17.03 15.46 17.27 1.94
T.circumcincta. L5 ES 6.41 47.14 16.02 23.19 21.29
T.circumcincta L5 WWA 6.41 38.78 0.00 22.60 20.79
H.contortus L5 ES 0.00 32.95 1.24 17.10 18.68
H.contortus L5 WWA 0.00 31.90 1.98 11.29 17.87
IgE positive serum sensitised
expt 1 expt 2 expt 3 mean SD
T.circumcincta L3 ES 41.80 11.92 17.51 23.74 15.89
T.circumcincta. L5 ES 42.69 58.49 13.14 38.11 23.02
T.circumcincta L5 WWA 28.98 49.06 0.00 39.02 24.66
H.contortus L5 ES 0.00 30.83 0.00 15.42 17.80
H.contortus L5 WWA 10.17 10.00 0.00 6.72 5.82
Sheep BMMC i) % Beta-hexosaminidase release
Heat inactivated serum sensitised
expt 1 expt 2 mean SD
T.circumcincta L3 ES 7.87 3.43 5.65 3.15
T.circumcincta L3 WWA 6.55 1.38 3.97 3.65
T.circumcincta. L5 ES 3.28 2.49 2.88 0.56
T.circumcincta L5 WWA 0.00 0.00 0.00 0.00
H.contortus L5 ES 0.48 0.00 0.24 0.34
H.contortus L5 WWA 0.00 0.00 0.00 0.00
IgE positive serum sensitised
expt 1 expt 2 mean SD
T.circumcincta L3 ES 23.98 20.53 22.26 2.43
T.circumcincta L3 WWA 13.09 9.18 11.14 2.76
T.circumcincta. L5 ES 5.35 4.00 4.67 0.95
T.circumcincta L5 WWA 0.35 0.00 0.17 0.25
H.contortus L5 ES 0.52 0.00 0.26 0.37
H.contortus L5 WWA 0.00 1.38 0.69 0.97
I
ii) % GMCP release
Sheep BMMC
Heat inactivated serum sensitised
expt 1 expt 2 mean SD
T.circumcincta L3 ES 1.53 0.00 0.77 1.08
T.circumcincta L3 WWA 9.02 1.10 5.06 5.60
T.circumcincta. L5 ES 0.35 0.00 0.18 0.25
T.circumcincta L5 WWA 0.00 0.00 0.00 0.00
H.contortus L5 ES 0.00 0.00 0.00 0.00
H.contortus L5 WWA 0.00 0.00 0.00 0.00
IgE positive serum sensitised
expt 1 expt 2 mean SD
T.circumcincta L3 ES 30.44 14.48 22.46 11.28
T.circumcincta L3 WWA 20.54 80.12 50.33 42.13
T.circumcincta. L5 ES 6.06 0.00 3.03 4.29
T.circumcincta L5 WWA 0.00 0.00 0.00 0.00
Ii. contortus L5 ES 0.00 0.00 0.00 0.00
H.contortus L5 WWA 0.00 0.00 0.00 0.00
iii)% Aryl-sulphatase release
Sheep BMMC
Heat inactivated serum sensitised
expt 1 expt 2 mean SD
T.circumcincta L3 ES 15.10 9.04 12.07 4.29
T.circumcincta. L5 ES 11.16 9.95 10.55 0.86
T.circumcincta L5 WWA 0.39 0.00 0.19 0.28
H.contortus L5 ES 0.68 0.00 0.34 0.48
H.contortus L5 WWA 0.97 0.00 0.49 0.69
IgE positive serum sensitised
expt 1 expt 2 mean SD
T.circumcincta L3 ES 26.93 34.06 30.50 5.04
T.circumcincta. L5 ES 10.81 14.97 12.89 2.94
T.circumcincta L5 WWA 0.00 0.00 0.00 0.00
H.contortus L5 ES 0.00 0.00 0.00 0.00
H.contortus L5 WWA 0.00 0.00 0.00 0.00
Individual results for worm antigen release studies described in chapter 8. Values lor each
experiment represent the mean percentage release for duplicate samples. Results corrected for
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